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INTRODUCTION 
Bone tissue is the most frequently used tissue for transplantation in orthopedic 
and oral and maxillofacial surgical procedures. Bony defects in the oral and 
maxillofacial area can be the result of trauma, cancer, infection and congenital 
disease, but also induced by the loss of teeth. Despite increased oral healthcare 
and prevention over the last decades, full edentulism is still observed for around 
4% of people in the age of 20 to 64 in the United States of America.1 Moreover, 
partial edentulism percentages, especially loss of (pre)molars, are even much 
higher.1 Resorption of original alveolar bone will occur directly after tooth loss 
because of the loss of mechanical loading.2'3 Additionally, this process may as 
well continue for years eventually resulting in severe atrophic jaw bones.l-4 
Dentists and oral and maxillofacial surgeons have thought of ways to replace 
missing teeth and thereby maintain the original alveolar ridge dimensions over 
time. Treatment options for tooth loss have evolved from traditional fixed or 
removable (partial) dentures to implant supported constructions in the last few 
decades. Dental implants are titanium screws that can be placed into the lower 
or upper jaw (mandible and maxilla, respectively) at the side of lost teeth. Treat-
ment with dental implants has several benefits over traditional treatment op-
tions, including a positive effect on the decline in original alveolar bone mass.5'6 
To allow implant placement, sufficient quantity and quality of the existing 
jawbone are a prerequisite. In most cases, substantial resorption of the original 
alveolar ridge has already taken place in the time period between tooth loss and 
dental implant placement. In these complex cases with a decreased alveolar 
bone volume, the insertion of dental implants is compromised because the 
atrophic bone tissue does not allow adequate primary fixation.7-9 In view of this, 
maxillary bone resorption rates are even increased compared to those of the 
mandible.1° Furthermore, maxillary bone tissue is also often of inferior quality.11 
Additionally, in the posterior maxillary (pre)molar region, the presence of the 
maxillary sinus may even further compromise dental implant placement. The 
maxillary sinus is located superior to the roots of the (pre)molars and after tooth 
removal continuously expands because of pneumatization, which further 
contributes to the reduction of alveolar bone dimensions.12 Consequently, 
because of tooth loss and consequent loss of mechanical loading, both alveolar 
ridge resorption and maxillary sinus pneumatization are accelerated, often 
resulting in inadequate bone volumes for dental implant placement. 
In order to overcome the problem of reduced alveolar bone quantity and quality 
several bone augmentation techniques have been described.B These recon-
structive procedures can be performed prior to, or simultaneously with implant 
placement to ensure implant supported constructions with a long-term 
  prognosis.13:14 In view of this, socket preservation, horizontal and vertical ridge 
augmentation and maxillary sinus floor augmentation procedures, all result in 
adequate reconstruction of the alveolar ridge.13 
Oral and maxillofacial anatomy 
The soft tissues that give structure to the human face have a foundation on the 
cranium and facial bones. The most important facial bones include the nasal 
bone, zygoma, mandible and maxilla as shown in Figure 1 a. The mandible is the 
largest and strongest bone of the facial bones and consists of the corpus mandi-
ble and a left and right mandibular ramus. Teeth are situated in the mandibular 
alveolar ridge. The maxilla consists of the corpus maxillae, zygomatic, palatine 
and frontal processes and the maxillary alveolar ridge, the latter in which the 
upper jaws teeth are located. Beside bony structures also teeth are part of to the 
foundation and by supporting the lips and cheeks, providing an aesthetically 
acceptable appearance. Both teeth in the lower and upper jaw contribute to the 
preservation of bony oral and maxillofacial structures. 
The maxillary sinus is the largest of the paranasal sinuses and is located in the 
corpus maxillae (Figure 1 b). lt is surrounded by bony structures, such as the si-
nus floor which consists of the alveolar process of the maxilla and the sinus roof 
which consists of the orbit floor. At the (possible) edentulous stage in life, sinus 
volume will increase, thereby reducing a large part of the alveolar ridge. 
Moreover, this volume increase may even result in only a very thin alveolar bone 
wall on both the lateral and occlusal sides. The maxillary sinuses are part of the 
respiratory system and the lining consists of a layer of loose connective tissue, a 
surface layer of ciliated columnar cells and sub-epithelial mucous secreting 
serous cells. Underneath the connective tissue and immediately adjacent to the 
bone is the periosteum, all together named the Schneiderian membrane. This 
membrane might have a transport function for fluids like pus and mucus 
towards the ostium. The ostium is positioned in the superior medial wall and 
opens into the semilunar hiatus. This location provides the possibility to perform 
a sinus augmentation procedure without interfering with normal sinus function. 
Bone augmentation procedures 
Alveolar ridge deformities are classified according to their morphology and 
severity (Figure 2). 11' 15 The predictability of a reconstructive augmentation 
procedure is influenced by the horizontal and vertical extent of the edentulous 
alveolar ridge. Defects that exhibit both a horizontal and vertical component are 
less favorable for pre-implant surgical procedures because of insufficient initial 
bone volume.13 Several augmentation techniques have been described in 
literature, including distraction osteogenesis, guided bone regeneration and 
onlay and inlay bone augmentation.13 Moreover, all of these procedures have 
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Figure 1: Oral and maxillofacial anatomy 
demonstrated high and comparable levels of long-term dental implant 
survival.16 On the other hand, a relatively high complication rate has been 
reported for distraction osteogenesis and guided bone regeneration.16-18 Taking 
this into consideration, autologous bone onlay or inlay augmentation must still 
be considered the favorite bone augmentation technique. 
Bone reconstructive procedures have extensively been described for augmenta-
tion and filling up of extraction sockets in order to preserve alveolar ridge 
dimensions after tooth removal.13 Moreover, if peri-apical bone or socket walls 
are damaged, bone grafts are used to preserve the original shape of the alveolar 
ridge.13 Although preservation of alveolar bone has been described, critical-
sized alveolar ridge defects in the horizontal and vertical dimensions are still a 
very common cause of compromised implant placemenU-9 Ridge augmentation 
is a procedure that can recapture the natural contour of the jawbone and gums. 
Applied augmentation materials must be rigidly fixed to the bony surface 
underneath the gums.13 In addition, the augmented area may be protected with 
(non)-resorbable membranes to seclude this area, prevent soft tissue ingrowth 
and hence ensure a successful outcome.13 Furthermore, another appealing 
option for vertical dimension reconstruction and dental implant placement in 
the posterior maxilla was introduced in the 1980s by Boyne and James and 
Tantum and was called maxillary sinus floor augmentation (Figure 3).19'20 
Maxillary sinus floor augmentation represents a technique based on the 
elevation of the Schneiderian membrane from the sinus floor, after which this 
created area is filled with an augmentation material. In order to lift the 
Schneiderian membrane, the maxillary sinus must be exposed by a modified 
posterior Caldweii-Luc operation. Caldweii-Luc procedures were described as a 
surgical method with specific application for clearing an infected or blocked 
  mm 
Figure 2: Alveolar ridge resorption 
airway caused by sinusitis or in case of malignancies present in the sinus cavity.21 
The modified surgical procedure consists of the creation of a bony window in 
the lateral maxillary wall after which the Schneiderian membrane can carefully 
be elevated.22 In view of sinus floor augmentation, this newly created space can 
subsequently be filled with an augmentation material. If sufficient bone quantity 
and quality is obtained, dental implants can directly or after a certain healing 
time be installed in the posterior maxilla.23 
Since these early reports in the 1980s, several modifications have been made 
regarding the surgical technique.13 In addition to the modified posterior 
Caldweii-Luc procedure, various other versions of maxillary sinus floor augmen-
tation surgery have evolved over time, each successful in different cases. As 
such, Summers introduced the crestal approach in 1994, in which osteotomes 
are used to fracture the sinus floor after which bone grafts can be introduced 
through the osteotome holes.24'25 However, the absence of direct visual inspec-
tion of the Schneiderian membrane and the grafted area is a major disad-
vantage of this technique. Although this technique, as well as other inventive 
approaches including the balloon or hydropneumatic approach, have been de-
scribed, the original augmentation procedure has been refined and is still the 
most frequently used method.n In addition, the efficacy and predictability of the 
original maxillary sinus floor augmentation procedure have been determined in 
numerous studies.14 Successful outcome can be defined as the elevation of the 
maxillary sinus floor in order to provide an adequate space and mass of the jaw 
bone for safe and successful dental implant placement. At this moment, it can 
be concluded that maxillary sinus floor augmentation surgery is one of the most 
reliable procedures in pre-implant surgery. 
15 
.--
0 
lo.... 
Q) 
........ 
a. 
ro 
....c 
u 
16 
Bone and bone substitute materials 
Bone tissue and bone substitute materials have been extensively used for 
augmentation procedures in oral and maxillofacial applications. For such 
augmentation materials, three different biological processes are associated with 
successful bone regeneration and augmentation: osteogenesis, osteoinduction 
and osteoconduction (see Table 1 for definitions). Osteogenesis is the formation 
and development of bone, an osteogenic graft is derived or composed of tissue 
involved in the natural growth or repair of bone. Osteoinduction is the stimula-
tion of osteogenesis, osteoinductive grafts can be used to enhance bone regen-
eration and may cause bone grow into an area where it is normally not found. 
Osteoconduction provides a physical matrix or scaffold suitable for the deposi-
tion of new bone. Osteoconductive grafts guide and allow bone growth and 
apposition from existing bony surfaces but do not induce bone formation itself. 
Ideally for clinical applications, degradation of these augmentation materials is 
in optimal balance with bone formation, which means that the space that 
becomes available during material degradation is directly filled up by newly-
formed bone tissue. 
Augmentation materials can be categorized into four main groups: 
-autologous bone grafts; 
- allografts (harvested from human cadavers); 
- xenografts (harvested from nonhuman species); and 
- alloplasts (synthetic materials). 
Autologous bone is still considered as the gold standard for augmentation pro-
cedures owing to its excellent clinical results in the past decades.14'26-30 
Moreover, autologous bone provides a satisfactory source of osteogenic cells 
without the risk of transmission of diseases or reduced biocompatibility.30 
Furthermore, it is preferred because of its osteoinductive and osteoconductive 
nature. Relative large volumes of autologous bone can be harvested from the 
iliac crest, smaller amounts can be obtained from the oral cavity.30 Unfortunate-
ly, harvesting of such an autologous bone graft is associated with serious draw-
backs. The major disadvantage is that donor site surgery requires a 
prolonged operating time and may cause severe donor site morbidity.14'29 
Furthermore, there is only a limited amount of autologous bone available that 
can be used for oral and maxillofacial reconstructive procedures. 
Allografts and xenografts have been used as alternatives to autologous 
bone.14'27-30 A number of review articles concluded that with these alternatives to 
autologous bone, excellent bone augmentation results and a high long-term 
implant survival are feasible.14'28-31 However, these alternatives have the poten-
tial for severe disease transmission.14 Because an allograft is obtained from living 
donors having bone removed during surgery or from cadaveric donors, viral 
  
Diminished 
bone height 
Figure 3: Maxillary sinus floor augmentation surgery and dental implant placement 
infections (e.g. hepatitis and HIV) are causes for concern.14 Moreover, transmis-
sion of infectious particles (prions), which may possibly results in Creuzfeldt-
Jacob disease, have been reported.32 However, it must be noted that the risk of 
disease transmission is almost negligible if these biological materials are 
adequately processed, including demineralization and lyophilization.33 Remarka-
ble is the fact that the most common type of graft infections are of bacterial 
origin, which is typically caused from contamination of the graft or the wound 
during the surgical procedure. 
During the last three decades, a large number of synthetic alloplasts have been 
developed as alternatives for biologically-derived bone grafts.14'27-31 '34 The major 
advantages of these alloplastic materials compared to other augmentation 
materials are their safety, costs and unlimited off the shelf availability. However, 
in order to allow application in a clinical situation, these synthetic materials 
need to fulfil I a number of criteria. The most important are biocompatibility, bio-
degradability and easy handling. 
The majority of alloplasts consist of the same components as normal bone 
tissue, evidenced by the large proportion of synthetic bone substitutes that are 
based on ceramics (e.g. calcium phosphate, CaP). As such, ceramic materials 
have a long history as bone substitute materials as they show an excellent bio-
compatible and osteoconductive behavior. However, current research efforts 
focus further on changing biomaterials from a biologically passive osteoconduc-
tive role to one in which the properties of the material will induce the process of 
tissue regeneration.35 Moreover, osteoinduction of a bone substitute material 
has been described to be useful for speeding up the process of appositional 
bone growth and may offer a solution for patients with a compromised bone 
forming capacity.3s Early attempts to enhance bone growth by using biologically 
active factors, such as bone morphogenetic proteins (BMPs), showed promising 
results.36 Moreover, an increasing amount of studies demonstrated product safe-
ty with BMP-2 in bone augmentation proceduresY-40 However, such growth 
factors are a very expensive treatment option and yet clear dosages are 
unknown. Moreover, the in vivo delivery of soluble molecules such as BMPs is 
often inefficient. An increasing number of reports demonstrated that bone 
17 
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Requirement Definition 
Bioactivity The ability to form a direct chemical bond with bone and thus a uniquely 
strong biomaterial interface 
Biocompatibility The ability to perform with an appropriate host response in a specific 
situation 
Biodegradability The ability to gradually vanish and leave space for new tissue growth 
without hindering the regeneration process 
Osteoconduction The capacity to guide bone-forming tissue on a surface or down into 
pores 
Osteogenesis The formation and development of bone tissue 
Osteogenic Graft that is derived or composed of tissue involved in the natural 
growth or repair of bone 
Osteoinduction The ability to induce bone formation by influencing the differentiation or 
maturation of stem cells into bone-forming cells 
Table 1: Definitions 
formation can also be induced by porous calcium phosphate materials.41 The 
underlying mechanism leading to bone induction by alloplasts remains largely 
unknown. However, the osteoinductive potential of biomaterials can be 
controlled by tailoring material characteristics such as chemical composition, 
surface topography, and geometry, which in turn affect resorption rate and cell-
material interactions.35 In addition, osteoinductive materials have been 
described to be a safe and cheap alternative to the use of autologous bone 
grafts or more expensive growth factors in reconstructive procedures.35 
In order to improve the clinical handling properties of alloplastic bone substi-
tutes, Brown and Chow were the first to describe a successful attempt in making 
self-hardening calcium phosphate cement (CPC).42;43 Such injectable bone 
substitute materials allow optimal defect filling and easy shaping. CPCs consist 
of a mixture of calcium phosphates which can be applied as a paste that usually 
consolidates at the application site due to precipitation or exothermic 
reactions.42 Although numerous reports on in vitro and in vivo investigations 
dealing with these CaP cements have been published, there are still some major 
problems to overcome. CPCs, unlike blocks or granules, have a solid structure 
characterized by a limited porosity resulting in decreased degradation rates.42;43 
As a solution for this problem, macroporosity can be induced by a large number 
of strategies. Promising methods are foaming agents which are released during 
setting or the incorporation of degradable microspheres to induce a controlled 
and delayed CPC porosity for appositional bone growth.44-46 
  OBJECTIVE OF THE STUDY 
To date, no clear evidence or guideline exists for the use of autologous bone or 
bone substitute materials for reconstructive augmentation procedures in oral 
and maxillofacial applications. Moreover, no clear evidence is yet identified that 
should prompt a clinician to prefer the one or the other in an individual patient. 
Furthermore, the influence of other clinical factors such as patient specific bone 
conditions, healing time or the use of a (non)-resorbable membrane on the 
biological result is also mainly unknown. In order to enhance clinical and biolog-
ical properties of bone substitute materials, innovative research attempts focus 
on osteoinductivity, biodegradability and handling properties. The 
general hypothesis on the use of bone substitutes for oral and maxillofacial 
applications is that their performance is predominantly related to bone substi-
tute material properties, recipient site characteristics, and patient conditions. In 
view of this, the overall aim of the research described in this thesis was to assess 
the value of various types of augmentation materials for oral and maxillofacial 
bone procedures. Moreover, the secondary aim was to evaluate the possible 
future clinical use of innovative synthetic augmentation materials in preclinical 
animal models. In more detail, the research described in this thesis is associated 
to the following scientific questions: 
- Which approach is the best when using autologous bone grafts for human 
maxillary sinus floor augmentation surgery? 
- Which augmentation material is best for application in human maxillary sinus 
floor augmentation procedures and at what graft healing time is required? 
-Are there any patient specific parameters that predict the outcome of maxillary 
sinus floor augmentation surgery using autologous bone grafts? 
- How is the in vitro and in vivo degradation and biological performance of 
instantaneous and delayed porous CaP cement? 
- How do CaP-PLGA composites and osteoinductive microstructured CaP 
granules perform in a sheep maxillary sinus floor augmentation model and can 
they be suggested for further clinical bone augmentation procedures? 
19 
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INTRODUCTION 
Placement of dental implants requires the presence of adequate bone height en 
width. In case of lack of bone volume, additional surgical techniques are needed 
to generate primary implant stability.1 If extensive alveolar defects are present, 
onlay or inlay grafting procedures have been advised.1-7 To allow implant place-
ment in the lateral part of the maxilla, sinus floor augmentation has become a 
routine procedure,8-11 resulting in an implant survival rate of 90 percent for 3 to 5 
years.7,12 In this procedure, first a small window is created in the lateral wall of 
the maxilla. Subsequently the sinus epithelium is elevated and the created space 
filled with a grafting material. For sinus floor augmentations autologous bone is 
the most common used material and as such still considered to be the gold 
standard/·13 although numerous alternative materials have been used with vari-
able results. 
Both intra oral and extra oral sites can be considered as donor sites,14 As such, 
the chin and retromolar region, as also the iliac crest, calvarium, tibia and rib 
have been described,15·16 An advantage of intraoral donor sites is that the graft 
can be harvested under local anesthesia. However, the amount of bone that can 
be gained is limited. If larger bone volumes are needed, the iliac crest is the most 
common used donor site. Alternatives, such as bone substitutes do not provide 
the cellular elements necessary for osteogenesis, as they are only osteoconduc-
tive.17·18 For bone transplants, in addition to donor site, other variables may 
influence the final outcome.9 For example, some studies advise to apply a 
resorbable or non-resorbable barrier membrane over the sinus graft osteotomy 
site.19-22 
Till now, no studies have been published that evaluated histological and 
histomorphometric data from a large amount of patients inventorying these 
variables. To answer the question which approach is the best in using autolo-
gous bone grafts after sinus floor augmentation surgery, a meta-analysis was 
conducted. 
"Sinus Augmentation" OR "Sinus Lift" 428 hits
AND (Human OR Patient OR Clinical) 401 hits
AND (Histology OR Histomorphometric OR Histomorphometry 147 hits
J 
Table 1: Literature search 
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 MATERIALS AND METHODS 
Search protocol and selection of articles 
An on line and manual search was conducted of the Medii ne database from Jan-
uary 1995 till April 2009 using the PubMed search machine entering the 
following search terms: "(Maxillary) Sinus augmentation or (Maxillary) Sinus lift" 
and "human or clinical or patient" and "histology or histomorphometry or histo-
morphometric". A hand search was performed in the following journals: Clinical 
Oral Implant Research, International Journal of Oral and Maxillofacial Implants, 
International Journal of Periodontics and Restorative Dentistry, and the Journal 
of Periodontology. Additionally, the references of the retrieved articles were 
searched. The results were limited to humans as well as articles published in the 
English literature. Articles were regarded eligible if they met the following inclu-
sion criteria: the target population comprised adult patients suffering from 
maxillary atrophy; the intervention was maxillary sinus floor augmentation using 
an autologous bone graft; histomorphometric data about bone formation were 
present. Each potentially appropriate study included at least two patients per 
specific treatment in whom an autologous bone graft was used as the only 
augmentation material after conducting the maxillary sinus floor elevation 
procedure. 
Articles were excluded if they reported only one patient or if histomorphometric 
data were absent. Each retrieved citation was reviewed by two independently 
working reviewers. Most articles were excluded on basis of information provided 
by the title or abstract. If the citation could not be excluded unequivocally, the 
complete report was obtained by the two reviewers. Any disagreement between 
them was resolved by consensus. The two reviewers extracted from each eligible 
article all pertinent information regarding patients' demographics, maxillary 
sinus floor augmentation surgery, and outcome data. Demographic data 
included age, gender, follow-up rate and duration. Also, the number of patients, 
the number of treated maxillary sinuses, possible usage of collagen or non-
resorbable membranes, further operative data and all results from histomor-
phometry were noted. To ensure consistency of the results for the included 
studies clear definitions of outcome were defined. For example, "Total Bone 
Volume" (TBV) was based on histomorphometric data as a percentage of the 
whole field of view. 
Subsequently, the included studies were carefully analyzed concerning data on 
age, gender, immediate or delayed implant placement, membrane usage, 
biopsy time, histological section thickness, graft site, particulated versus block 
grafting technique and TBV. Where adequate data were available, subgroups of 
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similar interventions with respect to, for example, surgical techniques, donor 
site, membrane and biopsy time, were isolated and subjected to backward 
linear regression to identify them as possible sources of covariance . 
Meta-analysis 
Linear regression, a form of meta analysis, was performed to determine the 
effect of the independent variables: 'age', 'donor site location', 'block graft', 
'particulated graft', presence of a 'resorbable barrier membrane' over the lateral 
window, 'simultaneous and delayed' implant placement, 'biopsy time' and 
'histological section thickness' on the histomorphometric outcome after autolo-
gous bone grafting in maxillary sinus floor augmentation. The amount of TBV 
was used as the dependent variable. To evaluate the influence of 'biopsy time' 
on the histomorphometric data outcome, the subgroups were divided into 3 
different groups: 0-4 months, 4-6.5 months and longer than 6.5 months. To 
reduce the initial model, stepwise backward linear regression was applied with a 
threshold for the P value of above 0.1 for removing a variable from the model. 
The overall averages were controlled for study characteristics and can therefore 
be considered meta-effect sizes. Thus, more powerful estimates of the true 
effect sizes than those derived in a single study under a given single set of 
assumptions and conditions can be given. 
Included studies and donor sites 
The basis search provided 147 t itles for consideration (Table 1). 25 articles met 
our inclusion criteria. Frequently (17), autologous bone volume percentages 
were extracted from comparative experiments in which they were used as a 
control group. The majority of these 25 articles were prospective controlled 
studies (21 ), two randomized clinical trials, one pilot study followed by one case 
series. Only two prospective randomized clinical trials met the inclusion criteria 
(Table 2). Of the 25 articles derived from the main search, 15 discussed the use of 
autogenous bone from the iliac crest for augmentation of the maxillary sinus 
floor. The use of chin bone as grafting material was found in six of the 25 articles. 
The use of intra oral bone, the chin excluded, was investigated in seven out of 
25 articles. 
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Chapter 02 
Number of Mean Particulated Simultaneous (1) or Mean biopsy Slice Mean Total Bone Author Ref. delayed (2) implant Sinuses Age or Block placement time (Months) thickness Volume(%)
Pejrone et al. (2002) 26 26 57 Block 1 0 7 59.3±6.3
Lorenzetti et al. (1998) 27 8 51.75 Both 1 0 8 60
Thor et al. (2007) 25 11 55 Particulated 2 3 12.5 11±3
Raghoebar et al. (2005) 24 5 58.4 Both 2 3 2 41 .1±8.3
Consolo et al. (2007) 23 2 47 Particulated 2 4 5 26±5.2
Tadjoedin et al. (2000) 28 3 54 Particulated 2 4 5 40.94±3.32
Consolo et al. (2007) 23 2 47 Particulated 2 5 5 29.2±4
Crespi et al. (2007) 21 6 51.4 Particulated 2 5 30 34±21 
Tadjoedin et al. (2000) 28 3 54 Particulated 2 5 5 42.24±4.48
Barone et al. (2005) 22 18 46.7 Particulated 2 5 so 70±19.9
Gerressen et al. (2009) 43 15 54.9 Particulated 2 5.2 ? 29.35±4.04
Gerressen et al. (2009) 43 15 54.9 Particulated 2 5.2 ? 37.87±12.18
Thor et al. (2007) 25 11 55 Particulated 2 6 12.5 13±6 
Groeneveld et al. (1999) 46 3 55 Particulated 2 6 5 26.2±5.9
van den Bergh et al. (2000) 42 3 so Particulated 2 6 3 26.6±5.9
Consolo et al. (2007) 23 2 47 Particulated 2 6 5 29
Szabo et al. (2001) 44 4 52 Particulated 2 6 ? 37.05±8.66
3
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Szabo et al. (2005) 49 20 52 Particulated 2 6 5 38.34±7.4
Tadjoedin et al. (2000) 28 3 54 Particulated 2 6 5 43.65±2.38
Lorenzetti et al. (1998) 27 8 51.75 Both 2 6 8 53
Pejrone et al. (2002) 26 26 57 Block 2 6 7 54.1±6.8
Suba et al. (2006) 48 17 52 Particulated 2 6.5 5 34.7±11.86
Con solo et al. (2007) 23 2 47 Particulated 2 7 5 20
Turunen et al. (2004) 21 17 so Both 2 7 20 25.1±7.2
Turunen et al. (2004) so 17 so Both 2 12 20 25.1±6.3
Pejrone et al. (2002) 26 26 57 Block 2 12 7 63.9±8.7
Table 3: Iliac bone grafting 
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Chapter 02 
Number of Mean Particulated Simultaneous (1) or Mean biopsy Slice Mean Total Bone Author Ref. delayed (2) implant Sinuses Age or Block placement time (Months) thickness Volume(%)
Lundgren et al. (1996) 14 10 53 Block 1 0 10 58±19
Lorenzetti et a I. ( 1998) 27 3 52.33 Particulated 1 0 8 65.6
Lorenzetti et a I. ( 1998) 27 3 51.33 Block 1 0 ? 65.6
Zerbo et al. (2003) 19 5 39.2 Block 2 3 5 39.38
Zerbo et al. (2003) 19 6 32.33 Block 2 4 5 39.78
Lorenzetti et a I. ( 1998) 27 3 51.33 Block 2 4 8 62.9
John and Wenz (2004) 47 4 52 Particulated 1/ 2 5 so 53.5±2.52
Lundgren et al. (1996) 14 10 53 Particulated 2 6 10 40±12
Zerbo et al. (2003) 19 3 33.67 Block 2 6 5 40.9
Zerbo et al. (2004) 29 2 53.8 Particulated 2 6 5 41±10
Zijderveld et al. (2005) 33 3 53.83 Particulated 2 6 5 41±10
Lorenzetti et a I. ( 1998) 27 3 52.33 Particulated 2 10.6 8 69.3
Lundgren et al. (1996) 14 10 53 Particulated 2 12 10 48±10
Table 4: Intra oral chin bone grafting 
3
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r 1 A"'"" I ,,, Number of Mean Particulated Simultaneous (1) or Mean biopsy Slice Mean Total delayed (2) implant Bone Volume Sinuses Age or Block placement time (Months) thickness (%) 
Lundgren et al. (1996) 14 10 53 Particulated 1 0 10 45±15
Peleg et al. (2004) 20 97 Particulated ? 4.5 ? 31.5
Le Lorc'h-Bukiet et al. (2005) 35 24 59 Particulated 2 5 4 49.4±18.4
Crespi et al. (2007) 21 10 51.4 Particulated 2 5 30 69.7±16.1 
I 
Crespi et al. (2009) 36 15 54.2 Particulated 2 5 30 78.4±16.72
Scarano et al. (2006) 34 16 61 Particulated 2 6 30 40.1±3.2
Hall man et al. (2002) 37 11 54 Particulated 2 12.5 10 37.3±31.3
Table 5: Intra oral miscellaneous bone grafting 
Author Ref. Number of Mean Donor Site Membrane Mean biopsy Slice Mean Total Bone Sinuses Age time (Months) thickness Volume(%)
Zerbo et al. (2003) 19 5 39.2 Chin Collagen 3 5 39.38
Zerbo et al. (2003) 19 6 32.33 Chin Collagen 4 5 39.78
Peleg et al. (2004) 20 97 Intra oral Collagen 4.5 ? 31.5 
Crespi et al. (2007) 21 6 51.4 Iliac crest Collagen 5 30 34±21 
Crespi et al. (2007) 21 10 51.4 Intra oral Collagen 5 30 69.7±16.1
Barone et al. (2005) 22 18 46.7 Iliac crest Collagen 5 so 70±19.9
Zerbo et al. (2003) 19 3 33.67 Chin Collagen 6 5 40.9
Table 6: Membrane use 
34  
 8 RESULTS 
lo.... 
Q) 
......., Donorsite 
a. 
ro Iliac 
....c 
U Bone grafts were harvested from the anterior as well as the posterior iliac crest. 
From these articles, adequate data were found to discern 26 individual 
subgroups describing 273 sinus floor augmentation procedures (Table 3). Histo-
morphometric results from biopsies were described for sinus floor augmenta-
tion procedures up to 12 months after initial surgery. Bone blocks, particulated 
bone grafts or a combination of both were used. Several authors combined au-
togenous bone with Platelet Rich Plasma (PRP),23-25 but those subgroups were 
left out of consideration. At the moment of sinus floor augmentation, bone 
grafts showed a TBV of approximately 60%,26•27 varying from 32.5 to 78.4%. After 
backward linear regression significant evidence was present, that the use of iliac 
bone grafts will result in a lower amount ofTBV than intra oral bone grafting. 
Intra oral bone: chin 
From the included articles 13 different subgroups could be identified describing 
the use of chin bone. In seven of them autologous bone was used as particulate 
and in six as bone blocks, with a total of 65 sinus floor augmentation procedures 
(Table 4). These studies evaluated biopsies taken both immediately after sinus 
floor augmentation as after a healing period with a range of 3-12 months. At the 
moment of initial surgery, a TBV of 58-65% was presented.14•27 After healing 
(3-12 months) the TBV varied between 39.38% to 69.3%. After backward linear 
regression, significant evidence was found, that the use of chin bone grafts will 
have a positive effect on the amount of TBV compared to iliac bone grafts. Chin 
bone grafts increase the TBV with 10.7% at a confidence interval of [1.3%,20.1 %] 
and a p-value of 0.026 (Table 8). 
Intra oral bone: miscellaneous 
Seven subgroups could be discerned within the included articles describing the 
histomorphometric results from 183 augmented sinuses grafted with intra oral 
bone, excluded the chin. As intra oral donor sites the anterior maxillary wall, the 
zygomatico-maxillary buttress, the lateral mandibular body and ramus were 
chosen (Table 5). Although not of intra-oral origin, also parietal bone was 
included in this group. All studies described results from particulated bone 
grafts, no bone blocks were used. Biopsies were examined immediately after 
initial surgery and after a healing period of 4.5-12.5 months. At the moment of 
initial augmentation surgery, bone grafts presented a TBV of 45%.14 After heal-
ing, TBV differed within a range of 39.38% to 69.3% over time. After statistical 
analysis there was significant evidence that the use of intra oral bone grafts had 
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 8 Statistical analysis 
lo.... QJ The 11 variables entered into the regression model are shown in Table 7 along 
........ a. with their p-values. The R-square for the full model (all 11 variables) was 0.475. 
~ After removal of non-significant variables with backward selection, five signifi-
U cant variables remained in the model. All five variables showed a significance of 
p<0.1 with a model R-square of 0.453, thus explaining the variation in TBV as 
described in the histomorphometric results. In Table 8, the results of the linear 
regression analysis of the predicting variables on TBV are given. Only the 
variables 'patients age', 'intra oral chin bone', 'intra oral miscellaneous bone', 
'particulated' grafts and 'histological section thickness' remained in the model. 
All effects have been corrected for different parameters inside the model by 
backward regression. After linear backward regression a reference value for total 
bone volume of 46.5 was found. 
Patients age 
For each year the patient is above 50, an increase of 0.84% of TBV is to be 
expected with a confidence interval of [0.07%,1.61 %] 
Donor site 
Usage of a intra oral chin bone graft increases the TBV with 10.7% with a confi-
dence interval of [1.3%,20.1 %], while usage of bone from miscellaneous intra 
oral sites leads to an increase of 13.5% bone with a confidence interval of 
[2.1 %,24.9%]. Therefore, iliac bone grafts result in a significant lower amount of 
TBV. Taken into account that the confidence intervals of intra oral and chin bone 
grafts had a significant overlap, the difference between the donor site regarding 
amount of TBV was not statistically significant. All data were divided into 3 
different biopsy time groups, Q:s; t :::;4 months, 4<t:s; 6.5 months and t> 6.5 
months. There was no significant evidence that the amount of TBV was 
influenced by either immediate or delayed implant placement or graft healing 
time, thus the biopsy time of the samples. No evidence could be found that the 
use of a resorbable membrane over the lateral window had any effect, positive 
or negative, on the amount of total bone volume. 
Particulated and block grafting 
Particulation of the bone graft showed a negative effect on TBV, as a decrease of 
-17.8% was seen with a confidence interval of [-28.2%,-7.5%]. Block grafting had 
no significant positive or negative influence on the histomorphometric 
outcome. 
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criteria, also a pilot study and one case series was included. Backward linear re-
gression was performed. The dependent variable to assess the quality of the 
bone graft was solely the TBV because of the general absence of other histomor-
phometric indices in the studies. Only the variables 'patient age', 'intra oral chin 
bone', 'intra oral miscellaneous bone', 'particulated grafts' and 'slice thickness ' 
seemed to have a significant effect and remained in the model. 
Patient age 
In a first glance it seems surprising that, for each year the patient gets older, an 
increase of 0.84 percent of TBV is to be expected. However, one should realize 
that bone remodeling, e.g. the quantitative and qualitative changes in bone 
tissue and in bones themselves, do not only occur during growth but also 
during normal aging. These changes in the elderly result in a loss of bone mass 
and bone strength,3° as a sign of decreased ability to regenerate bone. As the 
biopsies are generally taken within the first year after the sinus augmentation 
procedure, we hypothesize that, although speculative, the slight increase ofTBV 
for each year the patient gets older, may be explained by the reduced remodel-
ing capacity of the patient. 
Donor site 
Intra oral grafting from miscellaneous sites, including the chin region, offers the 
advantage of local, instead of general anesthesia, a limited distance between 
donor site and augmentation site and the avoidance of cutaneous scars. 
Although the amount of bone to be gained is rather low, chin bone not only can 
be grafted in particulate, but even in block form. Predominantly, autologous 
bone grafts obtained from the iliac crest were investigated. Although several 
drawbacks were reported, including donor site morbidity and prolonged opera-
tion time, a relative larger amount of bone is available that can be harvested in 
multiple forms (particles, strips and blocks). In this meta-analysis, it is shown that 
bone grafts from the iliac crest lead to significant lower bone volume than chin 
bone. Some argue that embryology plays a role; ectomesenchymal mandibular 
bone grafts survive better than mesenchymal iliac bone grafts in an 
ectomesenchymal environment as the maxillary sinus.32 Furthermore, the 
mechanical stress distribution on the bone graft will be different, or be lost after 
grafting of the maxillary sinus so resorption may occur more rapidly. In addition, 
Lundgren et al. concluded that the advantage of inserting implants and 
performing sinus floor augmentation simultaneously (immediate placement) is 
that loading and subsequent preservation of the chin bone graft can be initiated 
earlier.14 However, they also showed an increased bone volume fraction in the 
graft throughout the healing time, even though the transplanted bone grafts 
received no stimulatory loading forces.14 
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 lt has been shown that also bone grafts, harvested from intra oral sites other 
than chin, lead to a significant higher TBV as compared to iliac crest bone. 
Complications related to the harvesting of intra oral bone are seldom reported 
especially using the shaving technique described by Peleg et al..20 Scarano et al. 
compared different materials in maxillary sinus floor augmentation including 
intra oral autologous bone grafts.34 Almost all autologous bone particles were 
completely surrounded by newly formed bone.34 A low resorption process was 
present and the graft showed a pattern similar to that of host bone.34 
Le Lorc'h-Bukiet et al. concluded that bone remodeling seems to be more active 
in the cancellous portion than in the cortical portion.35 After 10 months of graft-
ing the bone chips were incorporated in newly formed bone and almost 
completely resorbed.35 Crespi et al. used autologous bone from the ascending 
ramus of the mandible. After 5 months biopsies were taken and both lamellar 
and woven bone was observed.36 Gene expression profiles revealed expression 
of certain genes, indicative of osteoblast differentiation and bone formation.36 
Hallman et al. allowed autologous bone graft to heal for an average time of 7,5 
months and advocated the placement of extra micro implants to evaluate the 
bone-implant contact interface without interfering with the healing of standard 
implants.37 This technique also made it possible to correlate the histological and 
histomorphometric findings with the clinical outcome of the standard implants 
placed in the same area.37 In 2003 Wallace et al. concluded in a meta-analysis on 
the survival of endosseous dental implants that membrane utilization is a useful 
adjunctive therapy that results in an increased survival rate of implant in the 
grafted maxillary sinus.9 lt was also reported that the increase in implant survival 
could be explained by the higher percentage of bone.9•45 Surprisingly, this could 
not be confirmed by meta-analysis of the four selected papers.19-22 
Particulated and block grafting 
After statistical analysis, particulation of the bone graft seems to lead to a signifi-
cant lower amount ofTBV, where there was no such evidence for bone blocks. In 
literature it is reported that up to 33% of the autologous bone graft can resorb 
during the initial six months after sinus floor augmentation surgery.23·26•38•39 The-
se processes of bone resorption and remodeling have a major influence on the 
clinical outcome and are described to be a continuous problem as this effect of 
significant initial bone resorption may persist for years. 3 1.4°·4 1 Zerbo et al. 
performed sinus augmentation surgery using monocortical blocks of autolo-
gous chin bone in order to allow dental implant placement.19 As a result from 
biopsies taken at 2.5 and 7 months, the amount of non-vital bone decreased 
significantly with the time of healing, as it was progressively remodelled into 
new bone.19 Zijderveld et al. observed predominantly lamellar bone after a 
healing period of six months.33 Lorenzetti et al. performed unilateral 
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augmentation with bone blocks or particulated bone originating from the chin. 
In the particulated subgroup the healing period had been reduced since the 
original compact bone structure had been removed by the particulation pro-
cess.27 Chin bone blocks prevailed more over fibrous tissue ingrowth and 
showed to be more compact than particulated grafts. However, vitality within 
the cortical component varied to a great extent.27 The chin bone blocks exhibit-
ed an increased bone quantity unlike the particulated chin bone and iliac bone 
blocks.27 A remarkable higher number of blood vessels was noted within the 
particulated bone graft than in block bone grafts.27 In a study of Consolo et al. 
biopsies were obtained after four, five, six and seven months after iliac bone 
grafting. The amount of bone decreased over time, thus resorption was 
observed.23 Also these authors state that graft volume resorption seemed to 
occur during the early phase of healing.27 Pejrone et al. described that the 
amount of mineralized tissue was increased after 12 months compared to at 
baseline and measurements after six months, concluding that bone growth and 
remodeling has taken place.26 Furthermore, histomorphometric results from 
Tadjoedin et al. showed that trabecular bone was present after four months in 
autologous iliac bone grafts. This bone contained viable osteocytes, was of a 
mature lamellar type and showed a mature histological appearance.28 In 
addition, bone volume continued to increase slightly at five and six months.28ln 
a study of Van den Bergh et al. autogenous iliac crest grafts were used for sinus 
floor augmentation, from which after six months of healing core biopsies were 
obtained. In all five autogenous grafted sinuses bone appearance was observed 
similar to normal maxillary bone, clinically as well as histologically.42 Gerressen 
et al. performed sinus floor augmentation procedures using grafts from the iliac 
crest consisting of purely cancellous bone or a composite of cancellous and 
cortical bone. Both resulted in reliably good bone quality suitable to allow 
osteointegration of dental implants.43 The purely cancellous bone graft however 
seemed to be superior to the mixture, although an average healing time of six 
months until implant insertion seems to be appropriate for both.43 Surprisingly, 
after statistical analysis of the literature, there was no significant evidence of 
resorption or differences in TBV in time. Szabo et al. stressed that, although 
bone formation in the surgical area can be influenced by several factors, mainly 
individual patient factors strongly influence the fate of the various graft materi-
als in the organism.44 
Histological section thickness 
Histomorphometry is the most frequently used method to evaluate the structur-
al properties and the amount ofTBV in biopsy samples, as obtained for example, 
after maxillary sinus floor augmentations. Assessment is traditionally in two di-
mensions, which offers high spatial resolution and high image contrast. 
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 Section thickness, however, seemed to be a significant variable to total bone 
volume in histomorphometric coupes. In most studies 5-10 micron thick histo-
logical sections were used, while in others 10-30 micron or even 50 micron thick 
sections were prepared. Furthermore, no information was described about the 
quality or the staining of the histological sections which potentially could also 
influence the histomorphometric outcome. 
Summary 
In literature no proof is available for an improved implant survival for the various 
donor sites.51 However, there are indications that bone harvested from an intra 
oral donor site will lead to a higher mineralization rate and increased incorpora-
tion compared to iliac bone grafting.17•31 The choice for selecting intra oral or 
iliac crest is made on a pure clinical basis. If smaller amount of bone is 
requested, the intra oral region will be selected. As an extra advantage such 
procedure can be performed under local anesthetics. Are larger bone volumes 
needed, for example in the case of bilateral sinus augmentation procedures, the 
iliac crest will be selected as donor site. Application of iliac bone grafts, however, 
will result in a significant lower TBV as compared to bone grafts harvested from 
intra oral donor sites. No significant evidence was present, that 'biopsy time', 
'immediate or delayed implant placement', 'block grafting' or the 'usage of a 
resorbable barrier membrane' had a positive or negative influence on the 
amount ofTBV. However, it was reported that membrane utilization will increase 
implant survival due to the higher percentage of bone.9.45 Surprisingly, this 
could not be confirmed by meta analysis of the 4 selected papers.19-22 Further 
more patient age and histomorphometric slice thickness were significant 
variables on total bone volume. 
CONCLUSION 
'Age',' intra oral chin grafts', 'intra oral miscellaneous grafts', 'particulate' and 
'histological section thickness' were determined as significant variables on the 
histomorphometric outcome of TBV after sinus floor augmentation surgery 
using autologous bone. Only particulation of the bone graft leads to a signifi-
cant lower amount of the TBV, as the others will lead to a significant higher 
amount of total bone volume. No correlation between TBV and time of graft 
healing could be found. Bone grafting from the iliac crest resulted in a signifi-
cantly lower TBV compared to intra oral bone grafting. Although of clinical rele-
vance, in case a considerable amount of bone is needed, such as in augmenting 
the severely atrophic maxilla, the iliac crest, has still to be considered the gold 
standard. 
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 8 INTRODUCTION 
lo.... 
Q) 
........ 
0. Sinus floor augmentation surgery has become a routine procedure to generate 
ro 
....c primary implant placement and stability in the lateral part of the maxilla, result-
U ing in an implant survival rate of 90 percent for 3 to 5 years.1-7 Autologous bone 
is the most common used graft material and, as such, still considered to be the 
gold standard.8'9 Unfortunately, harvesting an autologous bone graft is associat-
ed with several disadvantages. Donor site surgery requires prolonged 
operating time and may cause morbidity.10-14 To avoid serious advents of taking 
iliac crest bone transplants, such as hypersensitivity, 15 pelvic instability, infec-
tion,1 4'16 and paraesthesia,17 the mandibular symphysis has been advocated as an 
alternative donor site,13'18-20 however, grafting chin bone may induce complica-
tions as well, such as paraesthesia21 and apical root damage.12•22 In contrast to 
intra-oral donor sites, a relative larger amount of bone is available in the iliac 
crest that can be harvested in multiple forms (particles, strips and blocks). 
To overcome the disadvantages of autologous bone grafting in sinus augmenta-
tion surgery, various allogenic, xenogenic and alloplastic graft materials or 
combination of these materials have been tested, followed by variable results.23 
Demineralized Freeze Dried Bone Allograft (DFDBA) and also Mineralized Freeze 
Dried Bone Allograft (MFDBA) are obtained from cadaver bone which is cleaned 
and chemically treated.24 Both have been proven to be biocompatible and 
osteoconductive25 and are harvested in the same matter, with the only differ-
ence that the DFDBA material undergoes the additional step of decalcification. 
This also accounts for Anorganic Deproteinized Bovine Bone (ADBB),26 which is a 
xenogenic bone graft from which all organic components have been removed,27 
although still small amounts of proteins may be present, including growth 
factors such as TGF-~ and BMP-2.28 Furthermore alloplastic materials have been 
investigated. As such, promising results for bioactive glass (BG) composites were 
reported.29 Their bioactivity stimulates the reparative process,30 resulting in a 
relatively fast bone ingrowth compared to for example hydroxyapatite (HA).31 
HA, either hydrothermally converted from coral or synthetically manufactured, 
shows a crystalline spatial structure close to that of cortical bone matrix32 and it 
is considered to be osteoconductive.27'33 The degradation of HA is relatively slow 
and is related to the amount of porosity of the material; it may dissolute at the 
surface or resorb by the activity of macrophages and multinucleated giant 
cells.34'35 Pure-phase beta-tricalcium phosphate (~-TCP), as a derivate of HA, has 
been shown to be completely resorbable and, in addition, is simultaneously 
replaced by new bone formation.36'37 For the sake of completeness, also calcium 
sulfate, calcium carbonate, hydrogels, (biodegradable) polymers and tissue 
engineered constructs, either combined with growth factors or cultured cells, 
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are described in the literature as graft material in human sinus floor augmenta-
tion. Except for the selected biomaterial, other variables may also influence the 
final outcome.38 For example, some authors advise to apply a resorbable or non-
resorbable barrier membrane over the sinus graft osteotomy site,39-42 or propa-
gate immediate or delayed placement of dental implants. Others recommend a 
prolonged graft healing time? 
lt is reported that a higher percentage of bone volume results in a higher 
implant-bone contact, thereby resulting in a higher implant survival.38 Further-
more, the percentage of total bone volume (TBV) formed is an important 
parameter of the performance of a bone graft or bone replacement graft in an 
augmented sinus.24;43-45 Till now, no studies have been published which evaluat-
ed histological and histomorphometric data related to different biomaterials 
and their variables from a large group of patients. Therefore, to answer which 
graft material results in the highest TBV in human sinus floor augmentation 
surgery and which graft healing time is the most optimal, a meta-analysis was 
conducted. 
(n)
"Sinus Augmentation" OR "Sinus Lift" 428 hits
AND (Human OR Patient OR Clinical) 401 hits
AND (Histology OR Histomorphometric 147 hitsOR Histomorphometry
Included 64 Articles
Randomized Clinical Trails 8 Articles
Prospective Clinical Trials 48 Articles
Case Series 8 Articles
Table 1: Literature overview 
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 8 MATERIALS AND METHODS 
lo.... 
~ Search Protocol and Selection of Articles 
a. 
ro An on line and manual search was conducted of the Medii ne database from Jan-
....C 
U uary 1993 till April 2009 using the PubMed search machine entering the 
following search terms: "(maxillary) sinus augmentation or (maxillary) sinus lift" 
and "human or clinical or patient" and "histology or histomorphometry or 
histomorphometric". A hand search was performed in the following journals: 
Clinical Oral Implant Research, International Journal of Oral and Maxillofacial 
Implants, International Journal of Periodontics and Restorative Dentistry, and 
the Journal of Periodontology. As well, the references of the retrieved articles 
were searched. The results were limited to humans and to articles published in 
the English literature. Articles were only regarded eligible if they included lateral 
sinus augmentation surgery in which an autogenic, allogenic, xenogenic or 
alloplastic graft material, solely or in combination, was placed. Furthermore, 
histomorphometric data about TBV needed to be present. Effects elucidated by 
a graft mixture with more than 90% volume of one biomaterial was fully 
accounted to that specific biomaterial, except if Platelet Rich Plasma (PRP) was 
added. Each retrieved citation was reviewed by two independently working 
reviewers. Most articles were excluded on the basis of information provided by 
the title or abstract. If the citation could not be excluded unequivocally, any 
disagreement was resolved by consensus. To ensure consistency of the results 
for the included studies clear definitions of outcome were defined. For example, 
TBV was based on histomorphometric data as a percentage of the whole field of 
view. Subsequently, the included studies were carefully analyzed concerning 
data on 'graft material', 'biopsy time', 'block grafting technique', 'particulated 
grafting technique', the usage of a '(non)-resorbable membrane' over the lateral 
window, 'immediate or delayed' implant placement and TBV. Where adequate 
data were available, subgroups of similar interventions were identified. At least 
five subgroups, including at least two sinus floor augmentations per group, 
describing a graft material or combination of graft materials, had to be reported 
in the literature to include their data in this analysis. 
Meta-Analysis 
Linear regression, a form of meta analysis, was performed to determine the ef-
fect of the independent variables: 'graft material', 'biopsy time', 'block grafting 
technique', 'particulated grafting technique', the usage of a '(non)-resorbable 
membrane' over the lateral window, and 'immediate or delayed' implant 
placement on the histomorphometric outcome after maxillary sinus floor aug-
mentation. The amount ofTBV was used as the dependent variable. To evaluate 
the general influence of 'biopsy time' on the histomorphometric data outcome, 
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all data were equally divided into three different groups of time: 0-4.5 months, 
4.5-9 months and longer than 9 months. The reference group comprised the use 
of an autologous bone graft with a biopsy time between 4.5 and 9 months, 
immediate implant placement and no membrane use. The overall averages 
were controlled for study characteristics and weighted by study size. 
A second linear regression was performed to correct the found TBV for each 
graft material or combination of graft materials, for 'biopsy time'. All subgroups 
were divided into three subgroups based on biopsy time: 0-4.5 months, 4.5-9 
months and longer than 9 months. The amount of TBV was used as the depend-
ent variable. Independent variables were 'block grafting technique', 
'particulated grafting technique', the usage of a '(non)-resorbable membrane' 
over the lateral window, and 'immediate or delayed implant placement'. The 
reference group was identical. All effects have been corrected for different 
parameters inside the model by linear regression and group size. The outcome, 
among corresponding p-values, had to be summed and recalculated for the 
groups with combined use of different graft materials in sinus augmentation 
surgery. 
Material Subgroups (n) Sinusses (n) 
Autologous bone graft 47 438
PRP 7 35
MFDBA 7 96
ADBB 29 319
ADBB +autologous bone 29 261 
ADBB+DFDBA 9 113
Synthetic HA 10 108
Phycogenic HA 9 52
~-TCP 8 116
~-TCP +autologous bone 7 62
Bioactive glass + autologous bone 8 72
TOTAL I 170 1672
Table 2: Overview grafting materials. PRP, platelet-rich plasma; MFDBA. mineralized freeze-dried 
bone allograft; ADBB, anorganic deproteinized bovine bone; DFDBA, demineralized freeze-dried 
bone allograft; HA, hydroxyapatite; ~-TCP, beta-tricalcium phosphate. 
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RESULTS 
The basis search provided 147 titles for consideration. As result 64 articles met 
our inclusion criteria. Describing autologous bone/ 9;36;37;39;41;42;46-64, addition of 
PRP (Platelet Rich Plasma),47;52;55 DFDBA (Demineralized Freeze Dried Bone 
Allograft),65-69 MFDBA (Mineralized Freeze Dried Bone Allograft),24;25;68;7o-73 ADBB 
(Anorganic Deproteinized Bovine Bone),24;26A8;53;60;62;69;74-85 BG (Bioactive 
Glass)/9;56;86;87 synthetic HA (Hydroxyapatite),53;64;81;82;88-90 coral derived HA 
(Hydroxyapatite),91;92 ~-TCP (beta-tricalcium phosphate)36:37;54;58-60:85:93-95 and 
combinations of these materials.24;42A8A9;60;62;67;69;78;87;95-98 The majority of these 64 
articles were prospective controlled studies (48). Only eight prospective 
randomized clinical trials met the inclusion criteria, followed by eight case series 
(Table 1 ). In total, histomorphometric data were obtained from 1677 grafted 
sinuses divided in 172 subgroups. As a result, 11 material groups were recog-
nized of similar bone graft or combination of bone graft materials (Table 2). A 
specific overview of these subgroups is provided in Table 3-13. Graft materials 
were used as blocks, particulated grafts or as combination of both. The topic of 
using (non)-resorbable barrier membranes over the lateral wall was addressed in 
24 out of the 64 articles. 
Statistical analysis 
In total 17 variables entered into the regression model as depicted in Table 14 
along with their p-values and confidence intervals. The R-square for the full 
model was 0.460, the adjusted R-square 0.403. 
Graft material 
After linear regression a reference value for TBV of 63% was calculated. Most 
graft materials showed significant differences in TBV compared to this reference 
value (Table 14) (Figure 1). The addition of PRP to an autologous bone graft 
reduced the TBV with -18.0%. Usage of a xenogenic bone graft decreased the 
TBV with -13%, while usage of a xenogenic bone graft combined with autolo-
gous bone resulted in a less decrease of -8%. The confidence intervals showed a 
significant overlap, indicating that the addition of autologous bone made no 
statistically significant difference. Combining DFDBA with a xenogenic bone 
graft, however, resulted in a significant lower TBV, as a decrease of -25% 
compared to the reference was found. Combining BG with autologous bone 
resulted in a -17% decrease and combining ~-TCP with autologous bone 
resulted in a reduction of -9% in TBV. Sinus floor augmentation with synthetical-
ly manufactured HA or hydrothermally converted coral reduced TBV with 
-11% or -12% respectively. Furthermore, almost significant, MFDBA and ~-TCP 
resulted both in a TBV decrease of -7%. Thus, most bone substitutes, even mixed 
with autologous bone, resulted in a significant lower TBV compared to the refer-
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 ence value of 63% for autologous bone. On the other hand, taken into account 
that the confidence intervals of most substitutes had a significant overlap, the 
difference between them regarding amount of TBV was not statistically signifi-
cant. This, however, did not account for DFDBA with a xenogenic bone graft. 
Biopsy time 
There is significant evidence that the TBV was influenced by graft healing time 
in general, thus the 'biopsy time' of all samples. Overall TBV was 8% or 6% high-
er if a biopsy was respectively taken before 4.5 months or after 9.0 months after 
the sinus augmentation surgery. After performing the second linear regression, 
(Table 15) correcting each bone graft material for 'biopsy time', a 
summation had to be made for the combined use of graft materials with their 
corresponding p-values (Table 16). 
Only in case of autologous bone grafting and the combined use of autologous 
bone with a xenogenic bone graft, 'biopsy time' had a significant influence on 
the TBV: a biopsy time of less than 4.5 months resulted in an increase in TBV of 
11% compared to a biopsy taken between 4.5 and 9.0 months. Additionally, a 
biopsy time of 9.0 months or longer increased the TBV with 1 0% compared to 
the centered group. Furthermore, the combined use of autologous bone and a 
xenogenic bone graft started with a plus of 26% of TBV compared to the period 
between 4.5 and 9 months. Surprisingly, no further significant difference could 
be detected between the various graft materials in time. 
Variables 
Compared to the reference value of TBV, usage of a particulated graft signifi-
cantly decreased the TBV with -18%, while usage of a block resulted in an de-
crease of -6% TBV, although not to a significant level. In addition, 'delayed' 
implant placement, significantly resulted in a lower TBV of -7% compared to 
'immediate' implant placement. Further, no evidence was found that the use of 
a resorbable membrane over the lateral window had any effect, positive or neg-
ative, on the amount ofTBV. 
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Chapter 03 
Author Year Graft name Particulated N (sinusses) Membrane Immediate or Delayed Biopsy time TBV(%)
or Block implant placement (months)
Thor 2007 ABG + PRP Particulate 11 None Delayed 3.0 22.00
Raghoebar 2005 ABG + PRP Both 5 None Delayed 3.0 38.40
Consolo 2007 ABG + PRP Particulate 2 None Delayed 4.0 43.30
Consolo 2007 ABG + PRP Particulate 2 None Delayed 5.0 39.30
Thor 2007 ABG + PRP Particulate 11 None Delayed 6.0 14.00
Consolo 2007 ABG + PRP Particulate 2 None Delayed 6.0 29.00
Consolo 2007 ABG + PRP Particulate 2 None Delayed 7.0 20.00
Table 4: Overview addition of PRP 
-~- ~ 
---
Author Year Graft name Particulated N (sinusses) Membrane Immediate or Delayed Biopsy time TBV(%)
or Block implant placement (months)
Choukroun 2006 FDBA Particulate 3 None Delayed 4.0 20.31 
Stacchi 2008 FFB Particulate 10 Collagen Delayed 5.0 48.15
Kassolis 2005 FDBA Particulate 10 Collagen Delayed 5.3 26.50
Froum 2006 Puros Particulate 13 Collagen Delayed 6.6 28.25
Kolerman 2008 FDBA Particulate 23 Collagen Delayed 9.0 29.09
Noumbissi 2005 Puros Particulate 6 None Delayed 9.0 40.33
Cammack 2005 FDBA Particulate 31 (non)- resorbable Delayed 11.2 41 .07
Table 5: Overview MFDBA 
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Wheeler 1996 lnterpore 200 + ABG Particulate 2 None Delayed 7.0 15.60
Froum 1998 Osteograft/ n + ABG Particulate 7 None Delayed 7.5 18.50
Froum 1998 Osteograft/ n + ABG Particulate 31 None Delayed 7.5 29.00
Wallace 2005 Bio Oss + ABG 5:1 Particulate 6 None Delayed 8.0 12.10
Wallace 2005 Bio Oss + ABG 5:1 Particulate 21 e-PTFE Delayed 8.0 16.90
Wallace 2005 Bio Oss + ABG 5:1 Particulate 37 Collagen Delayed 8.0 17.60
Moy 1993 lnterpore 200 + ABG 1:1 Both 4 None Delayed 8.0 44.40
Wheeler 1996 lnterpore 200 + ABG Particulate 2 None Delayed 9.0 12.60
Yildirim 2001 BioOss+ABG Particulate 2 Collagen Delayed 9.0 18.88
Simunek 2008 Bio Oss + ABG 85:15 Particulate 10 None Delayed 9.0 24.40
Lorenzetti 1998 lnterpore 200 + ABG 1:1 Particulate 3 None Delayed 12.0 43.60
Artzi 2005 BioOss+ABG Particulate 2 Collagen Delayed 12.0 45.60
Artzi 2005 BioOss+ABG Particulate 10 Collagen Immediate 12.0 45.60
Hall man 2002 ABG + Bio Oss 1 :4 Particulate 11 None Delayed 12.5 39.90
Hall man 2001 ABG + Bio Oss 18:82 Particulate 20 None Delayed 36.0 51.50
Table 7: Overview ADBB grafting and autologous bone 
60  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6
3
  
  
 
   
    
       
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
Unstandardized Coefficients Si g. 95% Confidence Interval for B 
Model
B Std. Error p Lower Bound Upper Bound
1 (Constant) 62.66 8.28 0.00 52.77 85.48
Particulated graft -17.89 5.64 0.00 -29.02 -6.76
Block graft -5.85 4.79 0.22 -15.31 3.62
Membrane -13.14 8.05 0.10 -29.04 2.75
Resorbable membrane 11.47 8.18 0.16 -4.68 27.62
Delayed implantology -6.46 2.91 0.03 -12.20 -0.72
Biopsy t<4.5 months 8.41 2.56 0.00 3.35 13.47
Biopsy t>9.0 months 5.57 2.13 0.01 1.35 9.78
PRP -17.96 6.27 0.01 -30.33 -5.59
MFDBA -7.30 4.52 0.11 -16.23 1.63
ADBB -12.74 3.02 0.00 -18.71 -6.77
ADBB +Autologous -8.26 3.13 0.01 -14.44 -2.09
ADBB+ DFDBA -25.31 3.97 0.00 -33.16 -17.47
Synthetic HA -11.30 4.10 0.01 -19.40 -3.20
Coral derived HA -11.50 5.48 0.04 -22.32 -0.67
~-TCP -6.53 4.04 0.11 -14.50 1.45
~-TCP +autologous -9.19 5.00 0.07 -19.06 0.69
Bioactive glass+ autologous -16.82 4.79 0.00 -26.28 -7.35
Table 14: Regression analysis 1. Dependent Variable: TBV. 
(Example: Calculation of expected TBV for: "Particulated synthetic HA with a resorbable membrane and Immediate implantology 
and a biopsy time of <4.5 months"= 62.66- (17.89- 11.3 + 11.47 + 8.41) = 53.35% ). 
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Chapter 03 
Unstandardized Coefficients Si g. 95% Confidence Interval for B 
Model p 
B Std. Error Lower Bound Upper Bound
2 (Constant) 62.20 8.41 0.00 52.29 85.52
Particulated graft -1 8.91 5.54 0.00 -29.86 -7.95
Block graft -7.52 4.73 0.11 -16.87 1.82
Membrane -8.16 7.96 0.31 -23.90 7.57
Resorbable membrane 7.31 8.08 0.37 -8.65 23.27
Delayed implantology -6.70 2.99 O.D3 -12.60 -0.80
PRP t <4.5 months 4.18 12.28 0.73 -20.09 28.46
PRP t=4.5-9.0 months -19.79 9.22 0.03 -38.01 -1.57
Autologous t <4.5 months 10.86 3.79 0.00 3.37 18.34
Autologous t >9 months 9.52 4.31 0.03 0.99 18.05
MFDBA t <4.5 months 6.74 11.78 0.57 -16.55 30.03
MFDBA t=4.5-9.0 months -7.49 10.11 0.46 -27.48 12.50
MFDBA t >9 months 8.07 10.39 0.44 -12.46 28.60
ADBB t <4.5 months 1.17 6.29 0.85 -11.27 13.61 
ADBB t=4.5-9.0 months -10.82 3.96 0.01 -18.65 -3.00
ADBB t>9 months 6.19 4.24 0.15 -2.19 14.57
ADBB +autologous t <4.5 months 14.83 7.55 0.05 -0.10 29.76
ADBB +autologous t=4.5-9.0 months -11 .53 4.06 0.01 -19.54 -3.51 
ADBB +autologous t>9 months 5.40 6.79 0.43 -8.03 18.82
ADBB + DFDBA t=4.5-9.0 months -24.09 5.10 0.00 -34.17 -14.00
ADBB + DFDBA t >9 months 6.77 6.45 0.30 -5.97 19.51 
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Synthetic HA t<4.5 months -13.56 8.56 0.12 -30.47 3.36
Synthetic HA t=4.5-9.0 months -0.91 5.49 0.87 -11 .78 9.95
Synthetic HA t>9 months -9.35 8.20 0.26 -25.55 6.85
Coral derived HA t=4.5-9.0 months -9.81 6.70 0.15 -23.05 3.42
Coral derived HA t >9 months 4.11 10.33 0.69 -16.30 24.52
~-TCP t=4.5-9.0 months -3.35 4.40 0.45 -12.06 5.35
~-TCP t>9 months -11 .84 11.24 0.29 -34.06 10.39
~-TCP +autologous t=4.5-9.0 months -3.04 6.08 0.62 -15.06 8.98
~-TCP +autologous t >9 months -16.98 10.13 0.10 -37.01 3.05
Bioactive glass+ autologous t<4.5 months -8.19 15.91 0.61 -39.65 23.26
Bioactive glass+ autologous t=4.5-9.0 months -7.76 7.38 0.29 -22.34 6.83
Bioactive glass+ autologous t >9 months -16.72 9.82 0.09 -36.13 2.69
Table 15: Regression analysis 2. (Reference group is Autologous bone grafting and biopsy time between t =4.5-9.0 months) 
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Chapter 03 
Augmentation Material t <4.5 compared to t=4.5-9.0 t >9.0 compared to t=4.5-9.0
Effect 95o/o Cl p-value Effect 95o/o Cl p-value
Autologous 1 0.86o/o [2.41' 19.3] 0.02 9.52o/o [-0.1, 19.14] 0.05
PRP 15.04o/o [-13.62, 43.71] 0.27
MFDBA 6.74o/o [-19.53, 33.02] 0.58 8.07o/o [-15.1, 31.23] 0.46
ADBB 1.17o/o [-12.87, 15.2] 0.86 6.19o/o [-3.27, 15.65] 0.18
ADBB +Autologous 25.69o/o [6.84, 44.53] 0.01 5.40o/o [-9.75, 20.54] 0.45
ADBB+ DFDBA 6.77o/o [-7.6, 21.15] 0.32
Synthetic HA -13.56% [-32.64, 5.53] 0.14 -9.35o/o [-27.63, 8.93] 0.28
Phycogenic HA 4.11 o/o [-18.92, 27.14] 0.70
~-TCP -11.84% [-36.91, 13.24] 0.32
~-TCP +Autologous -16.98% [-39.58, 5.62] 0.12
Bioactive glass+ Autologous -7.20o/o [-31.12, 16.72] 0.52
Table 16: Summation of regression analysis 2 
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 DISCUSSION 
Maxillary sinus floor augmentations are ideal test sites to histomorphometrically 
assess a grafted material. Before preparing the implant bed to install dental im-
plants, a biopsy of the reconstructed area can be easily taken, implicating no 
extra burden for the patient. As an additional advantage this procedure can be 
performed under local anesthesia. In the selected studies various bone substi-
tutes were used, or solely or as a bone graft extender in combination with autol-
ogous bone. Till now, autologous bone grafts are considered to be the gold 
standard.8;9 This postulation, however, is only based on implant survival, while 
bone quality in the grafted area is often left out of consideration.7;27 Further-
more, implant survival and bone quality may be confounded by factors other 
than the graft material.7;38 The aim of this study was to give a powerful estimate 
of the true effect of the various variables: 'graft material', 'biopsy time', 'block 
grafting technique', 'particulated grafting technique', the usage of a '(non)-
resorbable membrane' over the lateral window, and 'immediate or delayed' im-
plant placement, on the histomorphometric outcome after sinus floor augmen-
tation surgery. Because of the general absence or differences of other histomor-
phometric indices in the studies, TBV was solely used as dependent variable. 
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Figure 1. Overview of the effect of type of grafting material on total bone volume compared to the 
reference (Table 14). 
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Autologous bone 
Compared to autologous bone, for each biomaterial or combination of graft 
materials in sinus augmentation surgery a significant lower TBV was found . 
Evidently, autologous bone grafting resulted in the highest percentage of 
mineralized bone. lt should, however, be emphasized that when evaluating 
biopsies from autologous bone grafted areas, not only the new bone formation, 
but also the transplanted bone volume is scored. This in contrast to examining 
biopsies from sites reconstructed with bone substitutes, from which only the 
new formed bone can be measured. 
PRP 
Platelets are a natural source of growth factors. Some authors state that the 
combined use of growth factors and graft material will introduce osteogenesis 
and improve bone healing,99 while others reject the adjunctive use Platelet-Rich 
Plasma (PRP) in sinus augmentation because of disappointing results.100:101 In 
this study, the addition of PRP to a autologous bone graft generally resulted in a 
significant lower TBV. In the literature, the regenerative potential of PRP seemed 
to be restricted to shorter treatment times.47 However, in this meta-analysis, no 
significance evidence was found that PRP has a positive effect on TBV during 
graft healing time. To date, none of the studies, describing the use of growth 
factors, for example BMP-2, BMP-7 or TGF-!3, fulfilled the inclusion criteria. 
Allogenic bone 
DFDBA was always used in combination with a xenogenic bone graft and 
resulted in the lowest TBV as compared to autologous bone and all other mate-
rials. Grafting with MFDBA has a tendency to result in a slightly lower TBV com-
pared to autologous bone, but not to a significant level. Also in case of MFDBA, 
it must be noted that particles of non-resorbed MFDBA are described to be 
difficult to distinguish as graft material from new vital bone in the calculation of 
TBV.24 
Xenogenetic bone 
The addition of autologous bone to a xenograft resulted in a slight increase in 
TBV compared to its single use, but not to a significant level. This increase in TBV 
varied between 15% till 50%.42;60 As the ratio of xenogenic bone mineral versus 
autologous bone graft increases, resorption of the bone additive decreases 
exponentially, because less osteoclasts can be recruited from the autogenous 
bone.27;102 A reduced resorption may have negative consequences on the 
mechanical properties of the augmented bone and its capacity to support an 
implant, since the augmented bone will be a composite rather than a homoge-
nous bone structure.27;103 Obviously, this is the case for all bone substitutes. 
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 Allop/astic bone substitutes 
A variety of alloplastic bone substitutes, single or in combination with 
autologous bone, was used in sinus augmentation surgery. In this study the 
effect of BG, synthetic HA, coral derived HA and P-TCP on the amount of TBV 
was investigated. Although alternative materials were described in the litera-
ture, they did not met the inclusion criteria stated for this meta-analysis. To add 
the osteogenic and osteoinductive components that are necessary to achieve 
complete bone formation, the bone substitutes were occasionally mixed with 
autogenous bone.24;42;48;49;60:62;67;69;7s;s7;95-98 Furthermore, in larger defects the bone 
additive reduces the required autologous bone needed. 
BG was used in combination with autologous bone in ratios of 1:1 and 1:4. BG is 
a resorbable particulate synthetic bioactive glass from which the granules are 
supposed to function as small bone regenerative chambers.104 Unexpectedly, 
after linear regression, sinus augmentation with BG, resulted in the lowest TBV 
of all alloplastic materials. Sinus augmentation with synthetic or coral derived 
HA also resulted in a decrease of TBV. As HA was grafted without the addition of 
autologous bone, TBV was only influenced by new bone formation from the 
local sinus environment. For P-TCP with or without the addition of autologous 
bone, TBV differed not significantly. While others stated that, along with the 
replacement of solely P-TCP, the TBV will consequently increase,58 this postula-
tion, however, could not be confirmed by this meta-analytical study. Also the 
influence of adding autologous bone to P-TCP appeared to be negligible, 
although supplemented in 1 Oo/o to SOo/o of the total graft volume.60;93;95 
All bone graft substitutes, alone or in combination with an autologous bone 
graft, resulted in a analogous significant lower TBV compared to autologous 
bone grafting. On the other hand, taken into account that the confidence inter-
vals of most substitutes had a significant overlap, the differences between them 
regarding amount ofTBV were not significant. 
In a recent review by Nkenke et al., the current literature was analyzed in order 
to determine whether there are advantages of using autogenous bone over 
bone substitutes in sinus floor augmentation with respect to implant survival. 
They concluded that no evidence was present that neither supports nor refutes 
the superiority of autologous bone grafts over other graft materials with regard 
to implant survival? In our study, there is a significant difference between autol-
ogous bone and their alternatives with respect to the TBV. However, the higher 
TBV apparently does not result in a higher implant survival.7 Therefore, when 
using bone substitutes, it is still unclear what the minimal TBV is for a grafted 
sinus to guarantee implant survival. 
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 8 Biopsy time 
lo.... QJ In literature it is reported that up to 33% of the autologous bone graft may 
........ a. resorb during the initial six months after sinus floor augmentation 
~ surgery.47;51;105:106 This decrease in TBV affects the primary implant stability and 
U therefore, as this effect of significant initial bone resorption may persist for 
years,107•109 is a serious problem. In this meta-analysis, autologous graft resorp-
tion resulted in a significant lower TBV between 4.5 and 9.0 months. Hereafter, 
the TBV raised to same level ofTBV, as scored in the first 4.5 months. 
For the combination ADBB and autologous bone, biopsies taken in the first 4.5 
months after initial surgery resulted in a significant higher TBV compared to 
biopsies taken at a later time point. Surprisingly, addition of autologous bone to 
the other bone substitutes did not result into this boost effect; the TBV did not 
significantly alter in time. Recently, Nkenke et al. concluded in a review that 
implant survival seemed not to be influenced by the healing period of the graft 
material.7 This is in analogue with our finding that in case of using bone 
substitutes, the TBV is constant in time. Because of the wide variation and 
absence of other (cellular) histomorphometric indices in studies, no further 
conclusion could be drawn about resorption, bone apposition of remodeling in 
time in our study. 
Variables 
After statistical analysis, particulation of the graft resulted in a significant lower 
amount of TBV, but there was no such evidence for block grafting. Almost all 
grafted materials were used in a particulated structure. Occasionally, autologous 
bone was used as block graft, but only a few articles compared block versus 
particu late grafting. 26;39;49-52;56;67;88 
Placement of endosseous dental implants is done either simultaneously or after 
a certain time period to allow for consolidation of the grafted material. Simulta-
neous implant placement is less invasive and more effective.110 Also, 'delayed' 
implant placement resulted in a significant decrease of TBV compared to 
'immediate' implant placement. However, residual alveolar ridge height and 
implant stability should be the decisive argument for the decision of staged 
implant placement.111 
Another examined variable was the use of a membrane over the lateral window 
of the sinus. Tarnow et al. reported that the placement of a e-PTFE (expanded 
polytetrafluoroethylene) barrier membrane tends to increase vital bone 
formation.112 Others suggested that this effect also can be achieved using a poly 
(lactic acid) membrane.113 In a meta-analysis on the survival of endosseous 
dental implants, Wallace et al., concluded that membrane utilization is a useful 
adjunctive therapy that results in an increased survival rate of implant in the 
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 grafted maxillary sinus.38 This increase in implant survival could be explained by 
a higher percentage of bone volume.38'11 2 However, our study shows no 
significant effect, positive or negative, of the use of a (non)-resorbable 
membrane over the lateral window on the amount ofTBV. 
CONCLUSION 
In conclusion, 'particulate grafting' 'immediate and delayed implant placement,' 
and 'biopsy time' were determined as general significant variables on the 
histomorphometric outcome of TBV after sinus floor augmentation surgery 
using various biomaterials. Allogenic, xenogenic and alloplastic graft materials 
or combinations will result in a significant lower TBV compared to autologous 
bone grafting. The addition of PRP to an autologous bone graft in sinus 
augmentation has a negative effect on the TBV. In the second analysis, invento-
rying the effect of 'biopsy time' for autologous bone, the TBV was significantly 
higher before 4.5 and after 9.0 months of healing time compared to period in 
between. For bone substitutes only ADBB in combination with autologous bone 
performed significant higher in the first 4.5 months. Surprisingly, for all other 
bone substitutes no significant effect on TBV in time could be proven. Based on 
this histomorphometric meta-analysis autologous bone grafting results in the 
highest TBV and has still to be considered to be the gold standard. All described 
bone graft substitutes showed less TBV. However, it must be emphasized that 
the consequence of the TBV for implant survival is still unraveled yet. 
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INTRODUCTION 
After loss of a single tooth or multiple teeth, the morphology of the alveolar 
crest changes. Bone reduction in both corona-apical and bucca-lingual direction 
has been observedY which significantly limits the insertion of implants of 
desired length and diameter.3:4 Reduced residual bone dimensions combined 
with pneumatization of the maxillary sinus is considered to be an indication for 
augmentation procedures.5:6 Previous studies estimated these dimensional 
changes of the alveolar crest after tooth loss as well as their relationship to the 
maxillary sinus, but these evaluations were based on panoramic radiographs.5:7•9 
Panoramic radiographs only allow a two-dimensional evaluation and distances 
may be affected by magnification or distortion.10 Recently, Pramstraller et al. 
published the first study evaluating three-dimensional morphology of the alveo-
lar ridge based on Computerized Tomography (CT) scans.6 To date, convention-
al CT protocols are generally associated with relatively high radiation dose levels 
compared to two-dimensional imaging.11 The last decade, Cone Beam Comput-
erized Tomography (CBCT) gained more popularity as CBCT provides a lower 
cost alternative and easy accessibility compared to conventional CT, and can 
therefore be used in a wider range of oral and maxillofacial patients.12;13 
Although it was also described that CBCT provides a lower radiation dose, a 
recent systematic review by de V os et al. showed that there is a lack of evidence-
based data to validate this statement.12 
Several augmentation techniques have been developed to increase the amount 
of bone to allow functional dental implant placement in an atrophic posterior 
maxilla.14 Currently, sinus floor augmentation is the most-common and widely 
accepted augmentation method.15;16 With respect to the augmentation material, 
although a broad range of bone substitutes is used in sinus floor augmentation 
procedures, autologous bone grafts are still considered the gold standard.17;18 
Nevertheless, resorption and remodeling of an autologous bone graft is still a 
concern, as an imbalance between these processes may lead to insufficient bone 
volume thereby frustrating implant installation.19 Previous reports have clearly 
indicated that volume reduction of the transplanted bone results in an increased 
implant loss in one-stage procedures or could affect the positioning of implants 
in two-stage procedures in cases, in which an insufficient amount of transplant-
ed bone remains.19-21 Furthermore, bone volume resorption around 
implants is described to be a continuous problem, as the processes of resorption 
and remodeling of transplanted bone may persist for years.23;24 
Besides ridge dimensions, also bone graft resorption was quantified using two 
dimensional panoramic images.9:25 However, with the introduction of (CB)CT 
imaging, calculation of the absolute quantity of bone grafted within the maxi I-
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 lary sinus as well as the dimensions of the alveolar ridge is nowadays possi-
ble.21'26'27 Volumetric reduction of grafting material was observed using both 
autologous bone graft as well as synthetic bone substitute materials. Johansson 
et al. evaluated volume change of autologous bone grafts, for which an average 
volume loss of approximately 50% was foundP Wanschitz et al. evaluated 
algae-derived hydroxyapatite for sinus floor augmentation which resulted in an 
average volume loss of around 14%.21 Kirmeier et al. used mainly Bio Oss and 
found a overall reduction in the order of 25%.26 
Besides bone volume, also bone quality appears important for primary implant 
stability and clinical outcome.20 Adequate primary implant stability is often 
difficult to achieve in low quality bone, resulting in a significant decrease of 
implant success rate over time.28'29 Bone graft quality is mostly expressed in 
terms of bone density. However, factors such as bone metabolism, cell turn over, 
mineralization, maturization, intercellular matrix and vascularity are also im-
portant in the definition of bone quality and also may influence clinical out-
come.22 As an additional advantage of using CBCT imaging over panoramic radi-
ographs, bone density can also be determined, however not in Hounsfield Unit 
{HU}, as is the case in conventional CT.3° These HU units are based on density 
values for air {-1 ,000 HU} and pure water (0 HU). A decrease in density results 
from decalcification and reduction of cortical and trabecular bone. Therefore, 
bone density has been correlated to the quality of the bone graft.31 
Although resorption of bone grafts after maxillary sinus augmentation has been 
described radiographically, no studies are available providing predictive 
parameters about the expected amount of resorption of transplanted bone 
grafts. Therefore, the aim of this study was to determine which parameters 
influence the outcome of autologous bone graft resorption. The hypothesis was 
that especially the original dimensions of the surrounding bone (i.e. the alveolar 
crest and maxillary sinus} in which an autologous bone graft is placed can 
predict the outcome of the process of bone resorption and remodeling. 
Furthermore, patients' gender and age as well as graft healing time interval may 
also influence volume changes. The experimental set-up consisted of a retro-
spective three dimensional analysis of alveolar ridge dimensions and bone graft 
volume change in the atrophic posterior maxilla performed by CBCT imaging, 
follow by multi-level analysis of variables found in 20 patients. 
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~ MATERIALS AND METHODS 
lo.... 
Q) 
......., Patients and surgical procedure 
a. 
~ A retrospective cohort design (trohoc) was used for this study. All maxillary sinus 
U augmentation surgeries and CBCT data acquisition in the study population took 
place between 2006 and 2009. The study criteria were a CBCT scan directly 
before and within 2 weeks after maxillary sinus floor augmentation surgery, and 
one before implant placement. Furthermore, patients should have been at least 
ten years edentulous. A total of 20 consecutive edentulous Caucasian patients 
fulfilling these criteria (12 females with a mean age of 56 year (SD=8 year) and 8 
males with a mean age of 56 year (SD=14 year) were included in this study. Of 
these 20 patients, 18 patients received bilateral and 2 received a unilateral sinus 
augmentation, resulting in a total of 38 augmented sinuses. Autologous bone 
blocks and granulates harvested from the iliac crest were used without any 
additive. In some cases, additional screw fixed onlay bone blocks were used to 
increase the alveolar crest width. 
CBCT imaging 
For each patient, CBCT imaging was performed before maxillary sinus augmen-
tation surgery (t=O), within 2 weeks after maxillary sinus floor augmentation 
surgery (t=1 ), and after a graft healing interval of several months (median=4 
months; t=2). The pre-operative and post-operative scans were acquired using 
the i-CAT® 3D lmaging System (lmaging Sciences lnternationallnc, Hatfield, PA, 
USA) with a field of view of 22x16 cm and 0.4 mm voxel size. For further CBCT 
imaging specification see Table 1. 
X-ray source
High frequency, constant potential, fixed anode 120 kVp, 
3-8 mA (pulse mode)
X-ray beam Cone-beam
Focal spot O.Smm
Field of view 16 cm (diameter) * 22 cm (height)
Image detector Amorphous silicon flat panel20 cm * 25 cm
Voxel size 0.4 mm3 
Gray scale 16 bit
Scan time 20 seconds (or 40 seconds for extended height)
Radiation dose Maximal 136 !JSV for extended height
Table 1: i-CAT"' 3D imaging system specifications 
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Figure 1: Alveolar ridge dimension measurement. A) On a panoramic slice of a preoperative CBCT 
scan (t=O) of an edentulous patients, a section of interest (SOl) was selected at both sites at 21, 28, 
36 and 43 mm, and 22, 29, 37 and 44 mm from the incisive foramen, respectively in females and 
males. SOis allocated the area of the first premolar (PM1), second premolar (PM2), first molar (M1) 
and second molar (M2). B) Example of bone height (BH) measurement between the most coronal 
point of the alveolar crest(~) and the most coronal point of the sinus floor (+).Bone width (BW) was 
evaluated at a height of 1, 3, and 7 mm apically of(*). 
Alveolar crest dimension analysis 
Pre-operative CBCT scans (t=O) were assessed in 1-Cat Vision" software (lmaging 
Sciences International, Inc. Hatfield, PA, USA). Alveolar crest dimensions before 
sinus floor augmentation were evaluated at four regions (i.e. first and second 
molars and premolars regions) per edentulous site according the method of 
Pramstraller et al..6 Shortly, the mean distance from the incisive fora men to the 
CT cross-section of the first premolar, second premolar, first molar and second 
molar was 21.2. 28.2, 36.1 and 44.0 mm, respectively in females and 22.0, 29.0, 
37.1 an 45.0, respectively, in males (Figure 1 a). The CT cross-section for each 
premolar and molar region was regarded as the section of interest (SOl). At the 
SOl, the alveolar bone height (BH) was measured between the most coronal 
point of the alveolar crest (hcr•srl and the most coronal point of the sinus floor 
(hsinusl (Figure 1 b). At a height of exact 1.0, 3.0, and 7.0 mm apically of hcr<?w bone 
width (BW) was measured as the width of the alveolar crest (Figure 1 b). 
Bone graft volume analysis 
Post-operative CBCT scans (t=1 and t=2) were processed according to the meth-
od described by Cuijpers et al. to evaluate calcified bone graft volume chang-
esY Shortly, i-CAT images were converted into a stack of Digital lmaging and 
Communications in Medicine (DICOM) format image files and converted from 16 
-bit gray scale to 8-bit gray scale images using 3D-Doctor software V4 (Able Soft-
ware Corp, Lexiton, MA, USA). The files were imported in CT-Analyzer V1.10 
(Skyscan; Kontich, Belgium) and re-sliced into coronal sections. Section thickness 
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was 0.265 mm between resliced images. The three dimensional 
volume of interest (VOI), consisting of the bone graft located inside the maxillary 
sinus, was manually drawn and interpolated through consecutive coronal 
sections (Figure 2a). Grafted bone could be distinguished from original bone by 
density and shape of the maxillary sinus. Care was taken not to include local 
original bone. After selection of the VOI, calcified grafted bone was differentiat-
ed from closely related soft tissues and fluids by gray value selection (Figure 2b). 
By setting the threshold relatively high (i.e. at least a gray value of 11 0), only 
dense calcified bone suggestive for a high quality was selected. Moreover, 
comparison between local original bone and grafted bone was performed to set 
the band width. CT-Analyzer was used to calculate the absolute amount of 
selected bone within the VOl. Calcified bone graft volume differences between 
t=1 and t=2 were denoted as 'bone volume change' and expressed in terms of 
percentage. 
Statistical data analysis 
Mean and standard deviation (SD) were calculated for comparable measure-
ments to reduce the number of possible variables for further analysis. Pearson 
correlation testing (IBM® SPSS 16.0) was performed to assess if it was statistically 
acceptable to cluster these measurements. By this method, the number of 
variables was reduced with only marginal loss of information by using the mean 
premolar BW (BWpml' mean molar BW (BWml and mean BH. 
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> 2,5% 
.. 
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Figure 2: Graft selection and gray value. A) The volume of interest (VOI), consisting of the bone graft 
located inside the maxillary sinus, was manually drawn and interpolated through consecutive coro-
nal sections. The selected area is shown in red. B) Example of gray value distribution within the VOl. 
A lower threshold of at least 110 gray value was used including only dense calcified bone. 
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 To analyze the relation between 'bone volume change' with the independent 
variables 'gender', 'age', 'healing time interval' 'mean BH', 'mean BWJ>m' and 
mean BW,0 ', a linear regression model was build. Since 38 observations in 20 
patients were available, the data were clustered. Therefore, the multi-level 
extension of linear regression was applied. To further decrease the amount of 
variables, first each variable was univariately assessed by multi-level analysis. 
Only variables with a p-value below 0,5 were considered for further analysis. 
Using these selected variables, a model was created and backward elimination 
of variables was performed with a threshold for the p-value of above 0.1 for 
removing a variable from the model. The package R, version 2.1 0.1 was used for 
statistical analysis. 
Figure 3: 3D i 11 ustration of bone graft change. A) CBCT three dimensional illustration of selected 
grafted bone inside the right maxillary sinus (green) within two weeks of maxillary sinus augmenta-
tion surgery (t=l). B) CBCT three dimensional illustration of selected grafted bone inside the right 
maxillary sinus (red) within a mean healing time of around five months after maxillary sinus augmen-
tation surgery (t=2). C) Three dimensional overlay of both selected bone grafts (lateral view). The 
green (t=l) is shown with a lower transparency than red (t=2). indicating volume reduction over 
time. 
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Figure 4: Bone graft volume change per site. Absolute bone graft volume change at the left and right 
maxillary sinus between sinus augmentation (t= 1) and after 4.7 ± 2.7 months of healing time (t=2) 
(range: 2-13 months). Sample size: left side 18 sinuses, right side 20 sinuses. 
Value(%) Std.Error {%) p-value 
Constant -49.3 25.9 0.07 
Age 0.9 0.3 O.o2 
Mean bone height -2.1 0.8 0.03 
Mean bone width premolar 1.4 1.4 0.31 
Mean bone width molar -2,5 1.4 0.09 
Table 3: Multilevel analysis model. First multilevel analysis model. Dependent variable was percentile 
bone volume change between t=1 and t=2. 
Statistical data analysis 
Independent variables 'gender', 'age', 'healing time interval' 'mean BH', 'mean 
BWrm' and mean BWm' were analyzed by multi-level analysis to decrease the 
number of variables to a acceptable level for the amount of patients. The 
variables 'gender' and 'healing time interval' resulted in a p-value of 0.83 and 
0.87 respectively, indicating no significant contribution to the model. The 
resulting variables were then further assessed by backward regression (Table 3). 
The variables 'age' and 'mean BH' remained in the model with a p--value of 0.01 
and 0.04, respectively, indicating a significant influence on bone graft resorption 
(Table 4). A constant of 69.0% (SE=20.9%) was found for this backwards model. A 
1.0% (SE=0.3%) decrease of bone graft resorption was found for each year the 
patient gets older. An increase in bone graft resorption of 1.8% (SE=0.8%) was 
found for each mm of original bone height before sinus floor augmentation. 
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DISCUSSION 
This study aimed to determine parameters that have a predictive value on autol-
ogous bone graft volume resorption after maxillary sinus floor augmentation. In 
a retrospective cohort of 20 patients, autologous bone graft volumes decreased 
with an average of 25% after 5 months of healing time. Assessment of potential 
predictive parameters resulted in a significant positive influence of initial alveo-
lar bone height and a significant negative influence of patients age on bone 
graft resorption. This means that, if autologous bone grafts are placed in a maxil-
lary sinus with relatively high alveolar bone height, graft resorption is increased. 
On the other hand, the resorption of autologous bone grafts 
decreases with patient age. 
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Figure 5 : Bone graft volume change in time. Scatter plot of bone graft volume change over time 
(range 2 to 13 months). Line indicated a non significant linear trend line. Dots indicated bone graft 
volume change(%) of a single maxillary sinus graft related to the initial bone graft volume (1 00%). 
-
Value(%) Std.Error (%) p-value 
Constant -69.0 20.9 0.004 
Age 1.0 0.3 0.01 
Mean bone height -1.8 0.8 0.04 
Table 4: Multilevel analysis after backward regression analysis. Dependent variable was percentile 
bone volume change between t=1 and t=2. A threshold for the p-value of above 0.1 for removing a 
variable from the model. 
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 Alveolar crest dimensions 
CBCT has been shown to represent an imaging technique that can provide 
adequate information about alveolar ridge dimensions.6 To obtain a basis for 
statistical analysis, ridge dimensions were determined by CBCT imaging only 
prior to sinus augmentation surgery. it has to be emphasized, that the study 
set-up excludes potential factors that might have contributed to earlier dimen-
sional changes of alveolar ridge. A major factor in this respect is the time 
between tooth extraction and the first CBCT. Although dimensional changes in 
the alveolar ridge occur predominantly within the first 3 months after tooth 
extraction,9 the changing of the alveolar ridge dimensions might persist for 
several years. In the present study, however, patients were at least ten years 
edentulous, thus, no further extensive resorption pattern was expected. 
Pramstraller et al. concluded in a recent study, using three dimensional CT analy-
sis, that the dimensions of the alveolar crest in the premolar and molar regions 
might require bone augmentation procedures in a substantial number of eden-
tulous patients.6 Farina et al. used the same method to compare alveolar ridge 
morphology between edentulous and dentulous sites, and concluded that a 
reduced alveolar height and bucca-lingual width was present at the edentulous 
sites.2 Sinus pneumatization was found to be the cause of reduced vertical 
dimensions in 46% of the cases.21n both CT studies, alveolar bone height showed 
a significant decrease from the first premolar to the molar sites. In the present 
study, however, bone height at all four SOis (i.e. two premolar and two molar 
sites) showed high correlation and consequently expressed as one variable for 
multilevel analysis. In contrast, bone width, showed a lower correlation between 
premolar and molar site and hence was included as two different variables 
Bone graft volume 
In staged maxillary sinus augmentation surgery, an autologous bone graft is 
allowed to heal before dental implant placement. Remodeling and resorption 
rates of autologous bone grafts are significantly higher compared to the local 
original bone.33 Long term implant survival after maxillary sinus augmentation is 
related to sufficient bone volume, which facilitates a reduction of intrabony 
stresses and stress on dental implants.19 Monitoring the effects of sinus augmen-
tation by volumetric measurements using CBCT has been described as an 
accurate method.34 Volumetric data observed by CBCT showed high accuracy of 
measurement with a relative error below 1 Ofo with respect to the same measure-
ments performed during surgery.34 However, the selection of the ROI in separate 
CBCT sections remains sensitive to bias. The software used in the present study 
interpolated the marked areas between different consecutive slides, thereby 
increasing the reliability of the measurements. Furthermore, detection of bony 
structures might have been compromised due to the limited spatial resolution of 
CBCT (voxel size: 0.4 mm). 
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Resorption of bone grafts causes not only bone volume reduction but also decal-
cification and reduction of trabecular bone. Both phenomena can be analyzed 
and quantified using CBCT.31'36 In this study, bone graft volume was determined 
by gray value selection within the VOl. By setting the threshold relatively high 
(i.e. at least a gray value of 11 0), only dense calcified bone suggestive for a high 
quality was selected. Furthermore, bone selected within the grafted area was 
compared with original bone present in the excluded surrounding area to 
achieve a consistent selection of calcified bone. Unfortunately, CBCT imaging 
and the used software package did not allow to express the selected bone graft 
in HU to compare these findings with earlier publications using CT. Compared to 
the use of CT, scatter levels and image artifacts produced by CBCT scanners are 
higher, and consequently the accuracy of CBCT intensity values can be 
affected.36'37 However, in a recent study of Nackaerts et al. it was concluded that 
the intensity values derived by CBCT images are mostly influenced by the used 
device, imaging parameters and positioning of the patient.37 These issues were 
not changed during the present study. Furthermore, a limitation for gray value 
selection in several patients was distortion by highly radiodense osteosynthesis 
material used for the buccal onlay bone blocks. Osteosynthesis material, when 
present within the maxillary sinus, was included in both scans resulting in an 
overestimation of the graft volume at both time points. 
Although it seems that the mean volume of the bone graft in the right maxillary 
sinus was higher compared to the left site, this difference was not significant and 
could be explained by the fact that all surgeons were right-handed and likely 
graft the right maxillary sinus first. This observation was already earlier described 
by Johansson et al..27 Overall measurements showed that bone graft volumes 
decreased by 25% within 2 to 13 months after sinus augmentation. In the past, 
several other studies evaluated bone graft resorption after maxillary sinus aug-
mentation using autologous bone graft as well as synthetic bone substitute ma-
terials, and all showed volumetric reductions of the graft material.21'26' 27 Johans-
son et al. evaluated volume change of autologous bone grafts used for onlay or 
inlay purposes, for which an average volume loss of -50% was found using a 
threshold of 150 HU to determine the bone graft volume changesP Wanschitz et 
al. used algae-derived hydroxyapatite for sinus floor augmentation, but failed to 
differentiate bone from bone substitute material.21 Kirmeier et al. assessed the 
dimensional stability of Bio-Oss or Bio-Oss combined with autologous bone after 
maxillary sinus augmentation.26 A mean volume reduction of 26% was observed 
with a threshold of above 400 HU.26 The present study corroborates with these 
reports, as a mean resorption rate of 25% was found. 
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 Statistical data analysis 
Volumetric measurements has been described as a highly accurate method, but 
freehand drawings for analysis could be sensitive to analysis bias. Therefore in 
this study measurement of bone height and weight and also selection of the 
volume of interest was performed blinded by one observer. Furthermore, there 
is a possibility that small areas of preexisting bone were incorporated in the re-
gion of interest by selection of the volume of interest. However, the use of an 
experienced, blinded observer minimizes errors regarding this issue as well as 
bias. A multi-level analysis was performed to determine which parameters (i.e. 
patient gender and age, healing time interval and alveolar crest dimensions} 
influenced the outcome of autologous bone graft resorption. However, in this 
retrospective cohort study the number of patients was limited, which restricted 
the possibility to evaluate a large number of independent variables. As a rule of 
thumb 10 observations are required per variable in a regression model. To allow 
for multiple regression with at least three independent variables to explain loss 
of volume 30 observations were needed. Generally one patient will contribute 
two observation: left and right. This would call for a study size of 15 patients. 
Since in this study observations were clustered within patients, the study size 
was increased to 20 patients to compensate for the loss of power by clustering. 
Furthermore, by calculating a mean bone height over all four SOis and a mean 
bone width for (pre)molar sites, the amount of parameters was substantially 
reduced. Then, by performing a first analysis per variable (i.e. 'gender', 'age', 
'healing time interval', 'mean BH', 'mean BWpm' and 'mean BWm'}, a selection was 
made based on expected significant contribution to the model. After backward 
analysis, only 'mean bone height' and 'age' remained in the model as significant 
variables influencing the amount of bone graft resorption, whereas no influence 
of 'gender', 'alveolar bone width' at premolar of molar sites or 'graft healing 
time' was found. 
Thus, an increase in patient age is associated with a reduction in bone graft re-
sorption. Therefore, it can be hypothesized that, when a higher alveolar ridge is 
pre-operatively present, more extensive bone augmentation is necessary to ob-
tain sufficient bone volume after time. Or, that a lesser amount of donor bone 
can be harvested in a elderly patient compared to a young one. Furthermore, it 
can be suggested that sinus augmentation procedures in the already atrophic 
maxilla should preferably be performed after the majority of dimensional alveo-
lar ridge alterations has occurred. lt also can be stated that the remodeling turn-
over of bone transplants, both in elderly patients, as in patients in whom the 
residual ridge is limited, caused by whatever reason, is slowed down, implicating 
that more graft resorption is still to come, thus pleading for bone augmentation 
in time. 
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In addition to the parameters found in this study, a recent meta-analysis showed 
that total bone volumes after sinus augmentation were significantly influenced 
by donor site of the harvested graft, the mode of delivery of the bone graft (e.g . 
particulate or block), and patient age.18 Bone grafts derived from intraoral donor 
sites resulted in a significant 10% higher total bone volume compared to iliac 
grafts, while particulation of a bone graft resulted in a significant lower amount 
of bone volume compared to block grafting. Thus, especially patient or graft 
characteristics, which are statistically proven to influence significantly the bone 
graft resorption process should be given full consideration when performing 
sinus augmentation surgery in an individual patient. Further, it can be 
recommended that the occurrence of continued bone graft resorption on 
continuated resorption after dental implant placement should be investigated 
further using three dimensional analyses by CBCT. 
CONCLUSION 
The present study evaluated the influence of patient characteristics and alveolar 
ridge dimensions on changes in autologous bone graft volume after sinus 
augmentation based on CBCT imaging. A overall mean volume reduction of 
25% was found after -4 months of healing time. Alveolar ridge height and 
patient age were identified as parameters that significantly influence the 
decrease of bone graft volume. Thus, if autologous bone grafts are placed in a 
maxillary sinus with relatively high alveolar bone height, graft resorption is 
increased. On the other hand, the resorption of autologous bone grafts 
decreases with patient age. Consequently, patient characteristics that affect the 
process of bone graft resorption should be given full consideration when 
performing sinus augmentation surgery. 
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INTRODUCTION 
Preprosthetic surgery has become a routine procedure to obtain sufficient bone 
quantity and quality for dental implant installation in patients with an initial 
inadequate bone volume.1 Various approaches are used to augment bone at the 
implantation site. The most frequently applied methods include distraction oste-
ogenesis, guided bone regeneration and onlay bone grafting.1 Although these 
procedures result in comparable levels of long-term dental implant survival/ a 
high complication rate has been reported for distraction osteogenesis and guid-
ed bone regeneration, which includes basal bone fractures, non-union of the 
alveolar bone, and secondary infections.3'4 In view of these drawbacks, autolo-
gous bone onlay or inlay grafting is still the preferred bone augmentation tech-
nique.5 Unfortunately, harvesting of an autologous bone graft is associated with 
serious drawbacks, such as donor site morbidity and prolonged operation time. 
Various synthetic bone substitutes have been developed to overcome these 
problems. Mostly, they are composed of calcium phosphate (CaP) 
ceramics.6-1° Clinically relevant advantages of these bone substitutes compared 
to autologous bone are their reduced costs, safety and off the shelf availability. 
Bone substitutes are mostly applied as blocks or granules.6 Main disadvantages 
regarding blocks and granulated grafts include lack of shaping, difficult to 
handle and potential soft tissue damage.11 As a solution for this problem, Brown 
and Chow introduced calcium phosphate cement (CPC) for non load bearing 
applications.12 Such a CPC consists of a CaP-powder component and a liquid 
phase, which upon mixing allows injection of the material in combination with 
optimal defect filling and shaping. 
lnjectability, cohesion, and setting time are critical characteristics for the reliable 
application of CPCs.13 In view of biological performance, important CPC proper-
ties include biocompatibility, osteoconductivity and interconnected porosity. 
The latter property is not only important for ingrowth of bone tissue, but is also 
related to the CPC degradation process.14 Ideally for clinical applications, CPC 
degradation is in optimal balance with bone formation, which means that the 
space as becomes available during CPC degradation is directly filled up with 
newly-formed bone tissue. CPC degradation can take place by passive physico-
chemical dissolution and active cellular degradation.15-18 Substantial efforts have 
been dedicated to control CPC degradation by introducing porosity within CPCs 
using porogens, hydrogels and hydrophobic liquids.B A promising method is 
also the introduction of interconnected porosity by inducing C02 bubbles dur-
ing setting of CPC.19'20 When entrapped during cement setting, these bubbles 
result in instantaneously porous CPC (CPC-IP). In vivo results of such CPC-IP, as 
applied in critical size bone defects, showed substantial bone formation and CPC 
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 degradation already after 2 weeks.20 Nevertheless, it has to be noticed that this 
method does not allow a good control of the pore size. A method, which can 
solve this issue, is the incorporation of degradable polymeric (e.g. poly(lactic-co-
glycolic acid), PLGA) microspheres.21•25 Degradation of the PLGA microspheres 
results in a so-called delayed porous CPC. In addition to their morphological 
contribution to create porosity, the released acidic by-products during degrada-
tion of the PLGA microspheres stimulate further the passive degradation of the 
CPC mass.26 lt can even be hypothesized that the use of dense PLGA 
microspheres (dPLGA) vs. hollow ones (hPLGA) will result in an additional 
increase of acidic by-products due to the increased amount of PLGA, which in 
turn will enhance the passive degradation of the CPC. 
In view of the above mentioned, the aim of the present study was to compare 
the degradation and bone conductive capacity of CPCs with instantaneous 
porosity generated by C02 bubbles or delayed porosity generated by PLGA-
microsphere incorporation (either hPLGA or dPLGA) as bone substitute materials 
for augmentation purposes using a rat skull bone augmentation model. 
Figure 1: Surgery and histological sectioning. (a) Schematic illumation of augmentation procedure 
on the skull of rats using a PTFE ring filled with CPC. Red lines indicate the plane of sectioning; area 
bordered by dashed line indicates the region of interest {ROI). {b) Per operative illustration of two 
PTF E rings filled with two different CPCs augmented on top of the rat sku 11. 
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 ~ MATERIALS AND METHODS 
lo.... 
~ Materials 
a. 
~ Calcium phosphate cement (CPC) consisted of 85% alpha-tricalcium phosphate 
U (Cam Bioceramics BV, Leiden, the Netherlands), 10% dicalcium phosphate dehy-
drate (Baker, Griesheim, Germany), and 5% precipitated hydroxyapatite (Merck, 
Darmstadt, Germany). For CPC-IP, 10 wt.% NaHC03 (Merck) was added. The 
applied liquid component was a filter-sterilized (0.2-f.lm) aqueous solution of 
Na2HP04 (Merck). 
Purasorb® PDLG 5002A (Purac, Gorinchem, The Netherlands) with an acid termi-
nated end-group functionalization, a lactic to glycolic acid ratio of 50:50 and an 
average molecular weight of 17 kDa was used for the preparation of both 
hollow and dense poly(DL-Iactic-co-glycolic acid) (PLGA) microspheres. 
CPC-IP and CPC-PLGA composite powders were sterilized using gamma 
irradiation (25 kGy; lsotron B.V., Ede, The Netherlands). Polytetrafluorethylene 
(PTFE) rings (Polyfluor, Ede, the Netherlands) with an outer diameter (OD) of 7.0 
mm, an inner diameter (ID) of 6.0 mm and a height of 2.3 mm were sterilized by 
autoclavation. 
Preparation of PLGA microspheres 
Hollow PLGA (hPLGA) microspheres were prepared following a previously 
described double-emulsion solvent-extraction technique ([water in oil] in wa-
ter).21 Briefly, hPLGA microspheres were produced by injecting 500 ml of ddH20 
into a tube containing a solution of 1.0 g of PLGA in 4 ml of dichloromethane. 
The mixture was emulsified for 90 s at 8000 rpm with an ultra turrax (IKA, Stau-
fen, Germany). Thereafter, 6 ml of 0.3% aqueous poly (vinyl alcohol) (Acros Or-
ganics, Geel, Belgium) solution was added and emulsified for another 90 s to 
produce the second emulsion. This mixture was added to 394 ml of 0.3% poly 
(vinyl alcohol) solution and 400 ml of 2% isopropyl alcohol solution and was 
stirred for 2 h. The evaporation of the solvent resulted in precipitation of the 
dissolved polymer and hPLGA microspheres were subsequently formed. The 
hPLGA microspheres were allowed to settle for 1.5 h, and the solution was 
decanted. Then the hPLGA microspheres were collected through centrifugation 
at 1500 rpm for 5 m in and freeze dried for 24 h. 
Dense PLGA (dPLGA) microspheres were produced by MicrosieverM emulsifica-
tion technology as described previously 27 and kindly provided by Nanomi 
(Oidenzaal, the Netherlands). 
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Preparation of CPC-hPLGA and CPC-dPLGA 
Density calculations of hPLGA and dPLGA microspheres indicated a 1.94-fold 
weight difference for dPLGA microspheres. The preparation of CPC-hPLGA was 
performed using 20 wt.% hPLGA; for CPC-dPLGA, similar microsphere volume 
was obtained using 38.8 wt.% dPLGA. Before application, the CPC containing 
(hPLGA or dPLGA) microspheres was created by adding 350 f-ll 2% Na2HP04 in a 
2-ml syringe (BD Plastipak, Becton Dickinson S.A., Madrid, Spain) with a closed 
tip and 30 s mixing using a mixing apparatus (Silamat, Vivadent, Schaan, Liech-
tenstein). 
Preparation of CPC-IP 
CPC-IP was prepared as described by del Real et a/ .. 19 Shortly, 10 wt.% NaHC03 
was added to the standard CPC powder. Before application, CPC-IP was created 
by adding 200 f-ll 2% Na2HP04 to the powder mixture using a 2-ml syringe (BD 
Plastipak) with a closed tip and mixing these components for 15 s using a 
mixing apparatus (Silamat). The plunger was removed to add 150 f-ll 8% 
NaH2P04 to decrease the pH necessary to produce C02 from NaHC03 • The sy-
ringe was mixed for another 15 seconds. 
Morphological analysis 
Microsphere size distribution was assessed by morphometrical analysis using a 
light microscope (Leica Microsystems AG, Wetzlar, Germany) and computer-
based image analysis techniques (Leica"' Qwin Pro-Image Analysis System, Wetz-
lar, Germany). Morphological appearance of both types of PLGA 
microspheres and pre-set CPCs (dimensions: 0 7.8 mm; height 1.8 mm; created 
using a Teflon mold) was observed using scanning electron microscopy (SEM) 
(JEOL 6310 microscope at 10 kV). Additionally, interconnectivity and pore 
distribution were assessed for pre-set CPCs using microcomputed tomography 
(f-!CT). Pre-set CPCs (n=4) were digitally equal divided in a mid transversal 
direction into 2 volumes of interest (VOI), a VOI-top and VOI-bottom. Within 
those 2 volumes, macroporosity was determined and expressed as a percentage 
of the VOI by grey value selection. Samples were scanned at an energy of 100 kV 
and intensity of 98 f-!A with a resolution of 7.54 f-!m using an 1 mm aluminum 
filter (Skyscan-1 072 X-ray microtomograph, TomoNT version 3N.5, Skyscan", 
Belgium). Cone beam reconstruction (version 2.15, Skyscan"') was performed. 
f-!CT data were assessed using CT Analyser (version 1.4, Skyscan"'). All scan and 
recon struction parameters applied were identical for the three different CPC 
formulas. 
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1.{) o Setting time and Cohesion 
lo.... QJ Initial and final setting time of CPCs was assessed using custom available 
........ a. Gillmore needles (ASTM C266). For this, a bronze block containing six holes (6 
~ mm in diameter, 12 mm in height) was used as a mould and placed in a water 
U bath at 37"C. Samples were mixed and injected into the mould in a retrograde 
fashion, after which the initial and final setting time was determined. Tests were 
done in fourfold. For the determination of cohesive properties, CPCs were 
injected in ddH20 at 37°C. During setting of CPCs it was inspected whether the 
CPCs retained their original configuration. Any anomalies were recorded. 
Porosity 
Total and macroporosity of pre-set samples was determined as described by 
Ha bra ken et a/ .. 26 Macro porosity is regarded as the porosity of CPCs, in which the 
pores are generated by the (i) degradation of PLGA microspheres, or (ii) 
entrapped C02 bubbles. Total porosity is the macroporosity plus the intrinsic 
microporosity of the cement. For the determination of porosity characteristics, 
CPC-IP and both CPC-PLGA pre-set samples of known volume were placed in an 
oven at 650 oc for 2 h (n=4). Subsequently, total porosity and macroporosity 
could be calculated using mass determinations of pre-set CPCs following 
equations described by Ha bra ken et a/ .. 26 
In vitro degradation studies 
For the in vitro degradation studies, pre-set CPC-IP and both types of CPC-PLGA 
discs were incubated in 1.5 ml phosphate-buffered saline (PBS) at 37 oc on a 
shaking apparatus for 12 weeks (n=4) with refreshment of the incubation 
medium at 1, 2, 3, 4, 5, 6, 9 and 12 weeks. At these time points, CPCs were 
retrieved for morphological analysis (SEM) and samples (volume: 200 ul) were 
taken from the incubation media for analysis of pH (PHM210, Standard pH 
meter, MeterlabTM Radiometer, Copenhagen), calcium amount and PLGA-
degradation products. After each incubation medium sampling, the volume of 
the incubation medium was increased to 1.5 ml by adding 200 ul fresh PBS. All 
results were corrected for dilution of the incubation media over time. 
The absolute amounts of Ca2+ in the incubation media were analyzed by the 
orthocresolphtalein complexone (OCPC) method (Sigma-Aidrich Chemie B.V., 
Zwijndrecht, the Netherlands) as a measure of CPC mass degradation. In brief, 
0.5 M acetic acid was added to the incubation medium sample. After overnight 
incubation on a shaking apparatus, 300 iJI working solution was added to 10 iJI 
sample in a 96-wells plate. Working solution consisted of (a) OCPC solution (80 
mg OCPC in 75 ml milliQ + 0.5 ml1 M KOH + 0.5 ml 0.5 N acetic acid), (b) 14.8 M 
ethanolamine/boric acid buffer (pH = 11 ), (c) 8-hydroxyquinoline (1 g in 20 ml 
95% ethanol), and milliQ, in a ration of 5:5:2:88 (a,b,c,d). A standard curve was 
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 generated by preparing serial dilutions of CaCI2 (0-1 00 1-19/ml). 
The amounts of glycolic and lactic acid in the incubation media were analyzed 
by reverse-phase high performance liquid chromatography (RP-HPLC) as a 
measure of PLGA degradation. The system consisted of a Hitachi L2130 HPLC 
pump, a Hitachi L-2400UV detector, a Hitachi L-2200 autosampler and an 
Atlantis dC18 column (Waters), 250 mm x 4.6 mm, 5 11m. Two mobile phases 
were used: 1% acetonitrile in 20 mM NaH2P04, pH 2.2 (mobile phase A), and 
100% acetonitrile (mobile phase B). The flow was 1 ml min·1, the injection 
volume was 20 111 and the ultraviolet detection wavelength was 210 nm. 
Design of the in vivo experiment 
A total of 12 adult male Wistar rats with an average weight of 275 g were used, 
observing national guidelines for the care and use of laboratory animals. The 
research protocol was approved by the Experimental Animal Committee of the 
Radboud University, Nijmegen, The Netherlands (DEC201 0-027). A total of 24 
augmentation sites (i.e. 8 for CPC-IP, 8 for CPC-hPLGA and 8 for CPC-dPLGA) 
were randomly distributed over the 12 animals, which each received two differ-
ent CPCs injected within a PTFE ring on the parietal bone. 
The animals were pre-medicated by an intramuscular injection of fentanyl (2.7 
ml/kg) to reduce operative pain. General anesthesia was initiated by 4% 
isoflurane. Subsequently, rats were placed in a ventral position, intubated, and 
connected to an inhalation ventilator with a constant volume of a mixture of 2% 
isoflurane, 0.4% N20 and 0.4% 0 2. The skull was shaved and disinfected with 
povidone-iodine. Lidocaine HCL 1 o/o/epinephrine was subcutaneously injected 
to minimize pain and reduce bleeding. A longitudinal incision was made from 
the nasal bone to the occipital protuberance to visualize the parietal perioste-
um. Subsequently, the periosteum was undermined and the skin flap was re-
flected, exposing the parietal bone. A hollow trephine drill (outer diameter: 7 
mm, inner diameter 6 mm; ACE Dental Systems, Brockton, MA, USA) in a dental 
hand piece (WS-75E/KM, W&H Dentalwerk Burmoos GmbH, Austria) was used to 
drill two circular slits in the parietal skull. Drilling was performed only in the 
upper part of the cortical plate to create a circular slit with a depth of approxi-
mately O.Smm. The bony surface was cleaned with a gauze. PTFE rings were 
positioned into the slits and checked on their immobility. Hereafter, CPCs were 
injected inside the rings (n=8 for each implantation material). In this way, 
implants in the shape of discs were created, with a diameter of 6 mm and a 
height of -2 mm augmented on top of the parietal bone (Figure 1 a,b). After the 
initial setting of CPC, the overlying skin flaps were closed in separate layers. 
Buprenorphine (1 SO 1-19/kgl was applied for three days to reduce postoperative 
pain. 
106  
 
    
    
    
    
    
    
    
 
   
107  
 
 
 
RESULTS 
Material characteristics: morphological analysis, handling and porosity 
Morphological analysis on the size and distribution of pores in CPC-IP created by 
C02 foaming demonstrated lack of pore uniformity, irregular shape (Figure 2c,f), 
and pore sizes ranging from 0.1 J.lm up to 500 J.lm. The hPLGA and dPLGA micro-
spheres showed a spherical shape with a size of 33.4±7.4 J.lm and 39.8±3.9 J.lm, 
respectively. However, the surface of dPLGA microspheres was less smooth and 
irregular compared to the surface of hPLGA microspheres (Figure 2a,b). CPC-
hPLGA and CPC-dPLGA demonstrated to contain microspheres that maintained 
their integrity and shape (Figure 2d,e). Besides macroporosity, as created by C02 
bubbles and PLGA microspheres, all CPCs showed also a characteristics 
additional intrinsic microporosity (Figure 2c,d,e). 
Results of the Gillmore test assessing the setting time of the CPC composites are 
listed in Table 1. CPC-hPLGA and CPC-dPLGA showed similar initial setting times 
of approximately 4.5 minutes. Initial setting of CPC-IP was significantly faster in 
3.7 minutes (p<O.OS). However, final setting time of CPC-IP (17.5 minutes) was 
significantly slower compared to the final setting times of both CPC-hPLGA and 
CPC-dPLGA (-10 minutes; p <0.001). Cohesion tests revealed no disintegration 
for any of the CPCs upon injection in an aqueous environment during setting. 
Figure 2: Material morphology. Morphological analysis of materials. (a-e) Scanning electron micro-
scopic evaluation of (a) hollow PLGA microspheres, (b) dense PLGA microspheres, (c) pre-set CPC-IP, 
(d) pre-set CPC-hPLGA , and (e) pre-set CPC-dPLGA. (f-h) Representation of four binary sagittal sec-
tions (left) subtracted from the 30 model obtained by IJ(T (right) of (f) CPC-IP, (g) CPC-hPLGA and (h) 
CPC-dPLGA (CPC is represented in white; created porosity is indicated in black). 
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Figure 3: Scanning electron microscopic imaging of CPC degradation. SEM micrographs of 
CPC-IP (a,d,g), CPC-hPLGA (b,e,h) and CPC-dPLGA (c,f,i) after 2 (a-c), 4 (d-f) and 12 (g-i) weeks 
of incubation, respectively. 
The total porosity, originating from the micro- and macroporosity calculations, 
of all three CPCs is presented in Table 1. The macroporosity in CPC-hPLGA and 
CPC-dPLGA was 44.5±1.9% and 42.0±0.2%, respectively. The macroporosity of 
the CPC-IP was 53.2±0.4%. 
~-tCT analysis of CPC-hPLGA and CPC-dPLGA samples showed a homogenous 
distribution of porosity throughout the specimens, as presented by an equal 
porosity measured in the top and bottom volumes of the pre-set CPCs (Table 1 ). 
In contrast, CPC-IP samples showed a higher porosity in the top volume 
compared to the bottom volume (57±% vs. 43±%; p<0.001; Table 1 ). ~-tCT 
sections demonstrated substantial interconnectivity of micro- and macropores 
in all CPCs (Figure 2f,g,h). 
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 In vitro degradation studies 
SEM images of the CPCs after 2, 4 and 12 weeks of incubation time are shown in 
Figure 3. No obvious CPC-matrix degradation was observed for CPC-IP at any 
time point (Figure 3a,d,g). Both CPCs containing PLGA microspheres showed 
initial microsphere degradation after 2 weeks of incubation (Figure 3b,c). 
Remnants of shells of hPLGA microspheres were observed within the CPC-matrix 
(Figure 3b). In contrast, the initial internal compact structure of dPLGA micro-
spheres became porous, indicating an intermediate stage in the degradation 
process (Figure 3c). After 4 weeks, both types of microspheres had degraded to 
a large extent (Figure 3e,f). After 12 weeks of incubation, no PLGA remnants 
were visible in PLGA containing CPCs and the CPC-matrix partially lost its struc-
ture after retrieval. In contrast, the macroporous structure of CPC -lP was still 
maintained (Figure 3h,i). 
CPC-IP showed a gradual decrease in pH of the incubation media in the first 4 
weeks, after which pH stabilized at 6.3±0.4 after 6 weeks (Figure 4a). pH 
measurements of delayed porous CPC showed already after 2 weeks of incuba-
tion a significant larger decrease in pH to 4.4±0.3 and 3.4±0. 1 for CPC-hPLGA 
and CPC-dPLGA, respectively (p<O.OOl ). Furthermore, CPC-dPLGA showed a 
significantly lower pH at all time points compared to CPC-hPLGA (p<0.001). The-
se results revealed a higher release of acidic monomers in the incubation media 
using CPC-dPLGA. 
The cumulative CPC-matrix degradation determined by Ca2+-release in the 
incubation media for CPC-IP was limited and increased from around 20 to 130 
11g Ca2+/g CPC-matrix at 12 weeks (Figure 4b). In contrast, both PLGA containing 
CPCs showed substantial degradation of the CPC-matrix according to a signifi-
cant increase of Ca2+ into the incubation media (p<0.001) over time to reach 
-5000 and 11000 11g Ca2+/g CPC-matrix for CPC-hPLGA and CPC-dPLGA, respec-
tively. Moreover, CPC-dPLGA showed a significant higher CPC-matrix degrada-
tion compared to CPC-hPLGA at all time points (p<0.001; Figure 4b). 
Both acidic monomers were released at a comparable rate from CPC-hPLGA and 
CPC-dPLGA and the glycolic acid release data are shown in Figure 4c. The data 
show a gradual increase in concentration of glycolic acid in the incubation 
media from 2 to 12 weeks, after which the release reaches 100% for both CPC-
hPLGA and CPC-dPLGA. Significantly accelerated release of glycolic acid 
(p<0.001) was observed for CPC-dPLGA compared to CPC-hPLGA in the period 
between 3 to 9 weeks of incubation time. 
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Figure 4: In vitro degradation studies. (a) pH measurements of the incubation media after CPC degra-
dation. (b) Absolute amount (ug) of dissolved Ca 2+/ gram CPC-matrix. (c) Glycolic acid detection by 
RP-HPLC. Significant differences in time and between material groups: CPC-IP, CPC-hPLGA and CPC-
dPLGA were found in pH and dissolved Ca2+ measurements. RP-HPLC results showed significant 
differences between CPC-dPLGA and CPC-hPLGA in the period from 3 to 9 weeks of incubation. 
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 In vivo follow-up and sample retrieval 
The number of augmentation sites per group that were created, retrieved, and 
used for analysis are presented in Table 2. One animal died during surgery as a 
result of skull bone penetration, followed by intracranial bleeding. The 12 week 
follow-up period was uneventful for the remaining 11 animals. At sacrifice, a 
total of 22 augmentation areas were retrieved, of which macroscopic observa-
tion showed rigidly immobilized PTFE rings in which residual CPC material was 
present and overgrown with (layers of) soft tissue. During histological pro-
cessing, one specimen was lost. 
Descriptive histology 
In the histological sections, PTFE borders and residual CPC-matrix within the 
ring were lost during decalcification, sectioning and staining of the histological 
sections. Nevertheless, the location of the PTFE borders could be clearly identi-
fied and no adverse tissue reaction or inflammatory response to the PTFE could 
be observed. 
All experimental groups displayed new bone formation originating from the 
skull bone both centrally and at the borders of the PTFE ring boundaries (Figure 
Sa,b,c}. No bone formation was seen originating from the soft tissue layer above 
the implants. Between CPCs and newly formed bone direct contact could be 
observed. CPC-IP showed bone and soft tissue ingrowth into the macropores. 
Augmentation with CPCs containing hPLGA or dPLGA microspheres showed 
limited bone formation and soft tissue ingrowth. The morphological appearance 
of newly formed bone showed similarity with the pore sizes and shapes (Figure 
Sa,b,c}. Occasionally, at the outside the borders of the PTFE ring, limited bone 
formation was observed extending from the existing bony surface (Figure Sb). 
At a higher magnification, newly formed bone appeared as vital bone tissue 
containing osteoblasts, osteoid, osteocytes and blood vessels in all CPCs (Figure 
6a,b). Furthermore, soft tissue was apparent between bone voids including 
blood vessels and osteoblasts lining the surface (Figure 6a,b}. In addition, multi-
nucleated cells were found at the boundaries of the remaining CPC (Figure 6c). 
Histomorphometry 
The amount of newly formed bone was significantly higher in the CPC-IP group 
(1 0.8±1.8%} compared to both PLGA containing CPCs (CPC-hPLGA: 7.0±2.4%, 
CPC-dPLGA: 6.8±2.6%; p<O.OS; Figure 7). The maximum augmented bone height 
(Figure 8) was significantly higher for CPC-IP (947±175 1Jm) compared to CPC-
dPLGA (364±178 IJm; p<O.OS}, but not in comparison to CPC-hPLGA (601±493 
IJm). No significant differences were observed between CPC-hPLGA and CPC-
dPLGA for either bone area or appositional bone height. 
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Figure 5: Histology. Hematoxylin-eosin staining of coronal histological sections after 12 weeks. PTFE 
borders together with some residual CPC contained by the ring was lost during sectioning and stain-
ing of the histological sections. (a-c) Whole images of the representative slices of the three groups: 
CPC-IP, CPC-hPLGA, CPC-dPLGA respectively (bar= 1 mm). At the right side, a higher magnification 
of the selected square from the three groups: CPC-IP, CPC-hPLGA, CPC-dPLGA respectively (bar = 
250 IJm). At a higher magnification, note the similarity of the morphology of newly formed bone 
showed with the pore sizes and shapes. 
Group No. of implants placed
No. of implants retrieved No. of implants used for 
after 12 weeks histomorphometric analysis
CPC-hPLGA 8 7 6
CPC-dPLGA 8 7 7
CPC-IP 8 8 8
Table 2: Sample overview. Number of samples placed, retrieved and used for histological and histo-
morphometric analysis per experimental group (deviation from number of samples retrieved due to 
dead of 1 rat and histological processing). 
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Figure 6: Histology. High magnification of hematoxylin-eosin staining of coronal histological sec-
tions after 12 weeks. (a-b) Newly formed bone in close contact to remaining CPC appeared as vital 
bone tissue containing lining osteoblasts (0Bl. osteoid, osteocytes and blood vessels (VE). (c) Multi-
nucleated cells (MNC) at the boundaries of remaining CPC. (bar= 50 !Jm). 
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DISCUSSION 
The aim of the present study was to compare the in vitro degradation and in vivo 
bone conductive capacity of CPCs that follow fundamentally different strategies 
to become porous. Instantaneous porosity was obtained by the formation and 
entrapment of gas bubbles during CPC setting, while incorporation of PLGA 
microparticles into CPC was used to obtain a delayed porosity after PLGA degra-
dation. An additional aspect was the use of two different types of PLGA 
microparticles (i.e. hollow vs. dense), for which it was hypothesized that an 
increased amount of acidic by-products might improve CPC degradation and 
hence create more space for bone formation. 
Instantaneously porous CPC directly allows penetration of (body) fluids and 
ingrowth of cells, whereas the main drawback has been described as the lack of 
control on pore size and distribution.19;20;28 Morphological analysis of instantane-
ously created pores in the present study confirmed this irregularity in size and 
distribution, of which the latter is related to the upward migration of gas bub-
bles during setting. lt is likely that this effect becomes even more apparent with 
increasing dimensions of the material. Alternatively, delayed porosity within 
CPC after PLGA microsphere degradation allows excellent control of pore sizes 
and a gradual replacement of CPC by newly formed bone. Additionally, it is pos-
sible to induce a slow and constant release of biological factors incorporated in 
PLGA microspheres.23 Nevertheless, the main drawback of the inclusion of PLGA 
microspheres within CPC is the delay in the creation of porosity and this process 
depends largely on the degradation characteristics of the used PLGA.24;26;29;30 In 
this study, one type of PLGA was used to produce hollow and dense micro-
spheres. Morphological analysis confirmed that incorporation of either of these 
microspheres results in a homogeneous distribution of microspheres through-
out the CPC-matrix. 
In vitro, CPC-matrix degradation was observed morphologically by SEM and 
chemically by Ca2+ and PLGA-degradation product measurements in the incuba-
tion media. Limited instantaneously porous CPC degradation was observed, 
while CPCs containing PLGA microspheres showed morphological and chemical 
dissolution in time. This enhanced passive degradation was most likely caused 
by the release of acidic by-products from PLGA hydrolysis and subsequent de-
crease of pH in the incubation media. In line with these findings, CPC with dense 
PLGA microparticles degraded significantly more than CPC with hollow PLGA 
microspheres. Although the volumetric amount of PLGA microspheres was simi-
lar for CPC incorporating hollow or dense PLGA microspheres, the difference in 
PLGA mass (i.e. ~2-fold higher for dense PLGA microspheres) resulted in an 
increased amount of acidic by-products in the incubation media. The associated 
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pH decrease can have an accelerating effect on the degradation of PLGA micro-
spheres and CPC-matrix.29'31 This accelerated degradation is the result of an au-
tocatalytic effect due to the low pH of the surrounding environment generated 
by the previously released acidic by-products. The presence of an earlier and 
higher concentration of acidic by-products in the incubation media for CPC con-
taining dense microspheres confirmed the occurrence of such an autocatalytic 
effect. Resulting from the above-mentioned acidification of the environment, 
the creation of porosity was enhanced by CPC dissolution in the direct vicinity of 
dense microspheres. Thus, while porosity was already present after injection of 
instantaneously porous CPC, gradual formation of pores or further in vitro CPC-
matrix dissolution was only observed for CPCs containing PLGA microspheres 
(dense > hollow). 
Several preclinical augmentation models have been developed in various 
animals to evaluate bone substitute materialsY However, in smaller animals, 
bone augmentation surgery is limited to flat bone surfaces such as the mandible 
or parietal bone. Two of the most relevant parameters that influence the out-
come of on lay grafts are rigid immobilization and a high degree of graft contact 
to the recipient surface.33'34 Earlier studies described the use of titanium domes 
or rings with or without screws to ensure immobilization.35-37 This study showed 
that also PTFE rings can be successfully fixed to the parietal bone by a circular 
drilled slit allowing rigid immobilization. Furthermore, CPCs completely filled 
the PTFE ring and were already initially set on the bony surface after three to 
four minutes resulting in a high degree of graft contact. Nevertheless, sufficient 
time was available for handling in order to achieve precise adjustment to the 
augmentation site within the PTFE ring. Thus, CPCs showed an uncomplicated 
injection and setting times within a clinical acceptable range. Furthermore, the 
in vivo model allowed rigid immobilization of these CPCs within a PTFE barrier 
for biological or even radiographic evaluation. 
In this study the bone conductive capacity of CPCs with an instantaneously 
versus delayed porosity were compared. The in vivo part of the study showed 
bone apposition reaching volumetric amounts of only up to 10% of the aug-
mentation area and a maximum augmentation height of -1 mm after 12 weeks 
of implantation. Histomorphometric analysis demonstrated that the use of 
instantaneously porous CPC resulted in the significantly largest amount of bone 
formation and the highest augmentation height compared to delayed porous 
CPCs. Although a significant difference was observed in the in vitro part, no 
statistically significant differences in bone apposition were found between CPCs 
with dense or hollow PLGA microspheres in vivo. 
Although no temporal information was obtained in vivo in the present study, it 
is likely that the instantaneously porous CPC allowed direct influx of body fluid, 
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 proteins and cells into the porous CPC after application. This advantage resulted 
in a jump-start in bone formation compared to CPCs with a delayed porosity. 
Ruhe et al. confirmed by fluorochrome labeling that bone formation started at 
the cement surface of instantaneously porous CPC and proceeded into the 
macro pores already after 1 week after implantation.22 In contrast, the possibility 
of tissue ingrowth in delayed porous CPC increases gradually during implanta-
tion time with PLGA degradation.38 Previous reports have shown that the 
amount of PLGA in CPC containing hollow PLGA microspheres decreased 
-3.5-fold during 4 weeks after in vivo implantation, resulting in a porous struc-
ture to allow tissue ingrowth.38 However, such information was not yet available 
for CPC containing dense PLGA microspheres. 
While most of the delayed porous CPC was lost during histological processing, 
the CPC-matrix of instantaneously porous CPC remained in place and was infil-
trated for the major part of the porosity with soft tissue. Only limited ingrowth 
of soft and hard tissue was observed in delayed porous CPC. In view of these 
findings, pore size dimension and interconnectivity of porosity has been 
described as a main prerequisite for tissue ingrowth.14'39'40 In a recent review of 
Bohner, it was concluded that the diameter and pore interconnections in CPC 
must be larger than 50 1-1m to allow fluid flow and cell penetration.13 Instantane-
ously porous CPC allowed the formation of porosity that equals (or exceeds) 
these dimensions. Moreover, previous reports described a pore size distribution 
of instantaneously porous CPC in the range 0.003-300 1Jm.2° Furthermore, Ruhe 
et al. concluded that the pores of instantaneously porous CPC could be regarded 
as completely interconnectedP Quite the opposite accounts for delayed porous 
CPC which has a theoretical pore size of only around 40 1-1m after PLGA hydroly-
sis. A contributing factor is that, as a consequence of the standardized produc-
tion process of dense PLGA microspheres, their size distribution becomes signifi-
cantly smaller compared to that of hollow equivalents. In view of this, Ha bra ken 
et al. concluded that microspheres of different sizes can create a closer packing 
in which little spheres serve as interstitials between the larger ones inducing a 
higher CPC porosity.25 Nevertheless, an (potential} open porous structure was 
observed by SEM and ~-tCT for all three types of CPC. In contrast with the recent 
findings, previous in vivo studies indicated that hollow PLGA microspheres of 
even 20 11m appeared large enough for bone ingrowth.24'41 
In view of the above mentioned, we suppose that the lack of bone and soft tis-
sue ingrowth into both dPLGA hPLGA CPC can be due to: (1) a difference 
between the in vitro and in vivo degradation behavior of PLGA particles resulting 
in a delayed in vivo degradation, (2) a negative effect of the acid released from 
dense PLGA microspheres on the biological process of new bone formation, or 
(3} the buffering capacity of the body, which diminishes the effects of acid 
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release to induce porosity by PLGA degradation. This latter effect can perhaps 
be enhanced by the used implantation sites where the CPC is mainly 
surrounded and in contact with well-vascularized soft tissue instead of bony 
tissue as in condylar defects. Currently, no final answer can be given, which of 
these three explanations is most valid. Therefore, further research is necessary to 
elucidate the effect of the temporal degradation of PLGA microspheres incorpo-
rated in CPC (and PLGA degradation products) on the biological performance in 
vivo in bone augmentation models. 
While previous CPC studies using critical size defects showed substantial bone 
formation, bone augmentation procedures rely on the complex biological 
process of appositional bone growth. In view of this, only a limited amount of 
bone formation was observed using either instantaneously or both delayed 
porous CPC in this study. The bone implant contact surface is limited to the 
surface and a longer implantation time might be required to achieve complete 
filling of the porosity within CPCs by bone. Enhancement of this process is 
possible by the inclusion of growth factors stimulating bone growth (such as 
bone morphogenetic proteins). In view of this, delayed porous CPC has the 
advantage of adsorption and release of growth factors from PLGA microspheres 
incorporated into CPC compared to instantaneously CPC. Therefore, further 
research is necessary to enhance the amount and bone apposition speed of 
CPCs for complicated bone augmentation procedures. 
CONCLUSION 
This study compared CPCs for bone substitution with instantaneous porosity 
generated by C02 bubbles or delayed porosity generated by incorporation of 
PLGA microspheres (either hollow or dense). All CPCs showed appropriate clini-
cal handling and an interconnected porous structure with a final total porosity 
above 70% (v/v). In vitro degradation studies showed direct porosity in instanta-
neously porous CPC. However, gradual in vitro formation of pores and further in 
vitro CPC-matrix dissolution was only observed for CPCs containing PLGA micro-
spheres. In vivo data demonstrated limited bone formation reaching only up to 
1 Oo/o of the augmented area. A significantly higher amount of appositional bone 
formation in combination with a higher augmentation height for augmentation 
with instantaneously porous CPC was found compared to delayed porous CPC. 
No significant differences in bone apposition were observed between the incor-
poration of hollow or dense PLGA microspheres into CPC. Further research is 
necessary to enhance the amount and bone apposition speed of CPCs for bone 
augmentation procedures before used in a clinical setting. 
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Maxillary sinus floor augmentation with 
injectable calcium phosphate cements: 
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INTRODUCTION 
Throughout the history of dentistry, dentists and oral-maxillofacial surgeons 
have thought of ways to replace missing teeth. Loss of teeth can be caused by 
trauma or disease and is known to be related to age, ethnicity, health condition, 
poverty and educational status.1 Despite increased oral healthcare and 
prevention over the last decades, full edentulism is still observed for around 4% 
of people in the age of 20 to 64 in the United States of America.1 
Treatment options for tooth loss have evolved from traditional fixed or remova-
ble (partial) dentures to implant dentistry in the last few decades. Treatment with 
dental implants has the ability to maintain the alveolar ridge over time, which is 
known to resorb in height and width after extraction of teeth.2-4 Furthermore, in 
the maxillary (pre)molar region the presence of the maxillary sinus may even 
further compromise the possibility for primary implant placement.5 
Therefore, it is a major challenge in implant dentistry to provide treatment mo-
dalities that regain or maintain original alveolar ridge dimensions that enable 
implant placement, especially in the maxillary (pre)molar region. 
To regenerate bone of sufficient quality and quantity for the installation of dental 
implants in the region of the maxillary (pre)molars, maxillary sinus floor elevation 
procedures can be performed.5 Autologous bone is considered to be the gold 
standard grafting material in these procedures.6-8 However, the disadvantages 
involved with harvesting autologous bone (e.g. an additional surgery site, extra 
time, and extra morbidity) and the general limited availability, emphasize the 
need for synthetic bone substitution materials. 
Calcium phosphate (CaP) based materials are widely used as synthetic bone 
substitutes in the field of dentistry, orthopedics and reconstructive surgery.6;8 
From a clinical perspective, CaP based materials in an injectable formulation 
have several advantages over pre-fabricated CaPs, including ease of handling, 
application through minimally invasive surgical techniques, and the ability to be 
fully adapted to the dimensions of the bone defect. Nevertheless, the most im-
portant disadvantage of these calcium phosphate cements (CPCs) remains their 
lack of controlled degradation to allow replacement by newly formed bone.9 
To increase the degradation of CPCs and hence allow bone regeneration, efforts 
have focused on various methods to introduce macroporosity within CPCs.9 An 
appealing approach is the incorporation of biodegradable polymeric micro-
spheres within CPCs, which after hydrolytic or enzymatic degradation generate 
pores within the CPC matrix.10 Polymeric microspheres based on poly(D,L-Iactic-
co-glycolic)acid (PLGA) have gained most interest for this purpose, as PLGA has a 
long clinical history and such CPC-PLGA composites have demonstrated to be 
biocompatible in several animal experiments.11 In a CPC-PLGA composite, PLGA 
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 microspheres degrade in a relatively short time period by hydrolysis resulting in 
porosity that increases the surface area of the CPC matrix and as such accelerates 
degradation of the CPC.12 Control over CPC-PLGA composite degradation can be 
obtained by varying the type and chemical characteristics of the PLGA used for 
the preparation of microspheres.B-15 Low molecular weight PLGA (LMW; <20 
kDa) in CPC-PLGA composites has been shown to accelerate composite degrada-
tion as well as new bone formation compared to high molecular weight (HMW; 
>40 kDa) equivalents.B-15 In addition to variations in molecular weight, recent 
studies have shown that chemical modification of PLGA end-groups (Le. acid-
terminated or end-capped) affects CPC-PLGA composite degradation to a larger 
extent.14 
In an effort to combine the molecular weight and chemical modification modali-
ties and to test it in a large animal study comparable to the human situation, the 
aim of this study was to evaluate the biological performance of injectable 
CPC-PLGA composite materials in a maxillary sinus floor elevation model in 
sheep. In order to maximize the difference in PLGA degradation properties, PLGA 
microspheres were made of either LMW acid-terminated PLGA (CPC -PLGAL-Ar) or 
HMW end-capped PLGA (CPC-PLGAH-Ecl- lt was hypothesized that composite 
degradation and bone formation would be enhanced for CPC-PLGAL-Ar compared 
to CPC-PLGAH-Ec composites. 
MATERIALS AND METHODS 
Materials 
CaP-based cement powder consisted of 85% alpha tri-calcium phosphate (CAM 
Bioceramics BV, Leiden, the Netherlands), 1 Oo/o di-calcium phosphate anhydrous 
(Baker, Griesheim, Germany) and 5% precipitated hydroxyapatite (Merck, Darm-
stadt, Germany). PLGA was obtained from Purac Biomaterials BV (Gorinchem, the 
Netherlands) in two variations: Purasorb" PDLG 5002A (MW ~ 17 kDa, acid termi-
nated end-group functionalization) and Purasorb· PDLG 5002 (MW ~44 kDa, end 
capped end-group functionalization). Both PLGA types had a lactic-to-glycolic 
ratio of 50:50. A 0.2 1-1m filter-sterilized aqueous solution of 2% Na2HP04 (Merck, 
Darmstadt, Germany) was used as the liquid phase for CPC preparation. 
Preparation of PLGA microspheres 
Microspheres were prepared by an established water-in oil-in water (w/o/w) 
double emulsion solvent evaporation technique as described previously.14 Brief-
ly, 1.0 g of P.LGA was dissolved in 4 ml of dichloromethane (Merck, Darmstadt, 
Germany). After dissolution of the polymer, 500 ml of demineralized H20 was 
added while emulsified vigorously with an Ultra-Turrax· (IKA, Staufen, Germany) 
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at 8000 rpm. After 90s of emulsifying, 6 ml of a 0.3% poly vinyl alcohol (PVA) 
solution (Acros Organics, Geel, Belgium) was added and emulsifying was contin-
ued for another 90s. Then, this content was transferred to a 1000 ml beaker and 
another 394 ml of 0.3% PVA solution was added slowly under continuous stir-
ring. This was directly followed by adding 400 ml of a 2% isopropylic alcohol 
solution (Merck, Darmstadt, Germany). PLGA microspheres were allowed to settle 
for 1.5 h, after which the solution was decanted and PLGA microspheres were 
collected by centrifugation at 1500 rpm for 5 min. The microspheres were freeze 
dried for 24 hand finally stored at -20°C. 
Preparation of CPC-PLGA composites 
All material samples were prepared in 10 ml syringes with closed tip (BD Plasti-
pakTM, Becton Dickinson S.A., Madrid, Spain) by mixing PLGA microspheres with 
CaP cement powder in a 20:80 wt% ratio to a total 5.0 g of CPC-PLGA composite 
per syringe. All material samples were sterilized by y-radiation with a minimum 
dose of 25 kGy (lsotron B.V., Ede, the Netherlands). Before adding the liquid 
phase, the powder component was mixed for 15 s with a standard amalgam mix-
er (Silamat·, Vivadent, Schaan, Liechtenstein) to distribute PLGA microspheres 
homogeneously throughout the CaP powder. Subsequently, 1.95 ml of 2% 
Na2HP04 solution was added to the powder component (liquid/powder ratio: 
0.39 mllg) and immediately mixed for 30 s again just before injection. This pro-
cedure was used to generate two different CPC -PLGA composites: 
CPC-PLGAL-AT (containing microspheres of LMW PLGA with acid-terminated 
end-groups); and 
CPC-PLGAH-Ec (containing microspheres of HMW PLGA with end-capped end-
groups). 
Material characterisation 
Microsphere size distribution of PLGA microspheres was assesed by image analy-
sis. The microspheres were suspended in water and images were taken with an 
optical microscope (Leica/Leitz DM RBE Microscope system, Leica Microsystems 
AG, Wetzlar, Germany). Subsequently, the diameter of microspheres was 
determined (n>250 for each type of PLGA) with image analysis software (Leica 
Qwin·, Leica Microsystems AG, Wetzlar, Germany). 
Total porosity of CPC-PLGA composites (PLGA-induced macroporosity plus 
intrinsic CaP microporosity) was assesed as described before.10 Briefly, CPC-PLGA 
composites were injected in Teflon molds (0 7 mm, height 3 mm) and allowed to 
set for 24 h (n=5). Mass determinations of pre-set and heat-treated CPC-PLGA 
composites (furnace at 650°C for 2 h) were used to calculate total porosity 
according to the equation in Figure 1. 
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( mburnt) Etot = 1- V X 100°;0 
X PHA 
Figure 1: Equation to calculate CPC porosity. E,01 =total porosity(%), m,,.,,= average sample mass 
after burning out the polymer (g), V= theoretical volume of the sample (cm') and p111, = theoretical 
density of pure hydroxy apatite (g/cm'). 
Animals 
A total of eight female Swifter sheep in healthy condition (average weight: 65 
kg) were used in this study. The experimental protocol was reviewed and 
approved by the Experimental Animal Ethical Committee of the Radboud 
University Nijmegen, the Netherlands (RU-DEC 2008-194). National guidelines 
for the care and use of laboratory animals were observed. 
Surgical procedure 
Preoperatively, a single dose of amoxicilline 10 mg/kg i.v. (Aibipen·, lntervet BV, 
Boxmeer, the Netherlands) was administered as profylaxis to reduce infection 
risk. Surgery was performed under general inhalation anesthesia, initiated by 
intravenous administration of pentobarbital (AUV Wholesale, Cuijk, the Nether-
lands}. Thereafter, the animals were intubated and connected to an inhalation 
ventilator with a constant volume mixture of nitrous oxide, isoflurane and oxy-
gen (Rhodia Organique Fine Limited, Avonmouth, Bristol, UK}. Each animal was 
ventrally immobilized and the skin overlying the lateral wall of the maxillary 
sinus was shaved, washed and disinfected with povidone-iodine. Each sheep 
underwent a bilateral sinus floor elevation procedure under sterile conditions by 
means of an extra-oral approach. A split mouth design was used in which each 
animal received both material samples, alternately installed in the left or right 
maxillary sinus. The facial bony sinus wall was exposed over a 4 cm long 
paramedial sagittal skin incision, thereby avoiding to cut the facial artery. The 
masseter muscle was partially detached and a bony window with a diameter of 
-1 0 mm was created in the lateral maxillary sinus wall under constant saline 
cooling with a dental burr (Eicomed· 100, W&H Dentalwerk Burmoos GmbH, 
Burmoos, Austria). The resultant bone plate was carefully removed from the 
Schneiderian membrane. The Schneiderian membrane was elevated from the 
buccal, caudal and medial bony wall and displaced cranially with bent, blunt 
dissectors. Care was taken during this procedure to avoid tearing or damaging 
the Schneiderian membrane. A gauze was inserted in the maxillary sinus cavity 
to optimally dry the cavity and to keep the Schneiderian membrane in its 
elevated position. CPC-PLGA was injected into the maxillary sinus immediately 
after removal of the gauze. After setting of the CPC-PLGA composite, the 
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removed bony window was placed back into position. Soft tissues were closed 
in separate layers using resorbable sutures (Vicryl™ 3-0, Ethicon, Inc., Somerset 
County, NJ, USA). Directly after the surgical procedure, a conventional 
radiograph was taken of the grafted sinuses to verify augmentation location. 
Flunixide 2 mg/kg/24h i.m., 3 doses, (Finadyne·, AUV Wholesale, Cuijk, the 
Netherlands) and amoxicilline 15 mg/kg/48h, 2 doses, (Aibipen-LA·, lntervet BV, 
Boxmeer, the Netherlands) were administered to reduce post-operative pain 
and infection risk, respectively. Directly following sinus augmentation surgery 
and after 6 weeks of healing time, a radiograph was obtained of the maxillary 
sinus area to verify graft localization and surgery. 
Sequential fluorochrome labeling 
To visualize the dynamics of bone growth, fluorochrome markers were 
administered subcutaneously to seven sheep (to analyze auto-fluorescence after 
histological processing, the eighth sheep was used as a control). Sequential fluo-
rochrome labels were administered at 1 week (oxytetracycline, blue; 25 mg/kg), 
3 weeks (alizarin complexon, red; 25 mg/kg), 6 weeks (calcein, green; 25 mg/kg) 
and 9 weeks (oxytetracycline, blue; 25 mg/kg) post-surgery. 
Sample retrieval and histological processing 
All eight animals were sacrificed using an overdose of pentobarbital after 12 
weeks. A total of 16 maxillary sinuses could be retrieved and were excised. 
Subsequently, the retrieved specimens were fixed in a 4% phosphate-buffered 
formalin solution for 72 h. Specimens were dehydrated in a graded series of eth-
anol (70-1 00%) and embedded in poly(methylmethacrylate). After polymeriza-
tion, -10 11m thick bucca-palatal sections (5 sections of each specimen) were 
prepared using a sawing microtome technique with a diamond blade (SP 1600, 
Leica Microsystems AG, Wetzlar, Germany). Three histological sections per speci-
men were stained with methylene blue and basic fuchsin for histological and 
histomorphometrical analysis. Two sections per specimen were left unstained 
for fluorochrome labeling analysis. 
Histological, histomorphometrical and fluorochrome labeling analysis 
Digital images of all histological sections were made using a light microscope 
(Axio lmager.Z1, Carl Zeiss AG Light Microscopy, Gottingen, Germany). Histologi-
cal analysis consisted of a concise morphological and histological description of 
all sections. Computer-based quantitative image analysis techniques (Leica 
QWin Pro", Leica Microsystems AG, Wetzlar, Germany) were used for histomor-
phometrical analysis of all digital images of the stained sections. 
129  
 
 
 
Figure 2 shows the different areas that were identified in the sections. The 
region of interest {ROI) was defined as the total grafted area {without the 
original maxillary sinus wall). The ROI was manually set using Leica QWin Pro· 
software and consisted of both areas C {CPC) and NB {newly formed bone, due 
to CPC-PLGA composite degradation and subsequent bone-ingrowth) as shown 
in Figure 2. Newly formed bone was discriminated from the original maxillary 
sinus bone wall {represented by SW in Figure 2) by difference in staining intensi-
ty and cellular orientation. The following parameters were evaluated: 
-Bone-CPC contact {expressed as a percentage of the total cement perimeter) 
-Bone area {percentage of bone within the ROI) 
-Cement area {percentage of CPC within the ROI) 
-Degradation distance {the maximal distance in !Jm between the original 
maxillary sinus wall and CPC surface, perpendicular to the newly formed bone-
original maxillary sinus wall interface). The degradation distance was measured 
at three different visually maximal degradation locations per histological sec-
tion, the largest distance of which was thereafter considered to be the maximal 
degradation distance. 
Buccal Medial 
Figure 2; Schematic illustration of the grafted maxillary sinus after 12 weeks of implantation time. SW 
= pre-existent sinus wall; NB = newly formed bone; C = cement. The Schneiderian membrane is 
ind ic<~ted by the red line on top of the grafted are<~. The region of interest (ROll was set as both are<~s 
NB and C. 
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Analysis of sequential fluorochrome labeling was performed using a fluores-
cence microscope (Axio lmager.Z1, Carl Zeiss AG Light Microscopy, Gottingen, 
Germany). Excitation wavelengths for each of the fluorochrome labels were 365-
490 nm I 520-570 nm (blue), 530-580 nm I 600-645 nm (red) and 436-495 nm I 
517-540 nm (green). Four images of the same area in each unstained section 
were taken: one for each fluorochrome marker (oxytetracycline blue, alizarin 
complexon red and calcein green), the fluorescence images were thereafter 
merged with one regular image using transmission light microscopy to assess 
the dynamics of bone formation over time. 
Statistical Analysis 
Statistical analysis of data was performed using lnstat" 2000 software (version 
3.05, GraphPad Software Inc., San Diego, USA). Histomorphometrical data were 
collected based on three sections per sample and combined to one value per 
sample. All values were expressed as mean ± standard deviation (SD) and 
median and analyzed by means of a Student's t-test. To test if data were 
normally distributed, the method of Kolmogorov and Smirnov was used. The 
level of significance was set at p<0.05. 
RESULTS 
Material characterization 
Analysis of the microsphere size distribution revealed similar sizes for micro-
spheres generated from PLGAL-AT (37 11m ± 11 IJm) or PLGAH-Ec (41 11m ± 10 IJm). 
The total porosity of CPC-PLGAL-AT (67.0% ± 0.41 %) was statistically significantly 
lower (p=0.0018) compared to that of CPC-PLGAH-Ec (69.3% ± 1.04%). 
General observations of the animals 
The surgical procedure was uneventful for all animals, none of the Schneiderian 
membranes were damaged or torn and injection of CPCs went uneventful. 
Directly following sinus augmentation and after 6 weeks of healing time, no 
dislocations or adverse effects were observed on radiographs (data not shown). 
Moreover, the post-operative period elapsed without any clinical signs of 
discomfort. All animals remained in good health during the entire implantation 
period. During sample retrieval after the 12 week implantation period, no 
macroscopically visual adverse tissue reaction or clinical signs of inflammation 
could be detected and all16 maxillary sinuses could be retrieved. 
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 Histological analysis 
All injected CPC-PLGA composite grafts remained at the original defect site 
during the entire implantation period. Light microscopy showed newly formed 
bone from the original bone surface and Schneiderian membrane in both CPC-
PLGA composite groups (Figure 3). Occasional cracks and voids in the grafts 
were filled with newly formed bone tissue. A direct contact between CPC-matrix 
and newly formed bone was observed. The Schneiderian membrane was in 
close contact with the CPC -PLGA composites and/or newly formed bone tissue 
(Figure 3a and 4a). At a higher magnification, newly formed bone appeared as 
vital bone tissue, containing osteoclasts, osteoid, and osteocytes inside bone 
lacunae (Figure 4c). Newly formed bone could be identified in close vicinity to 
the cement surface. At a greater distance from the cement surface, bone-
marrow like tissue was observed, including osteoid and osteoblasts (Figure 4b). 
CPC-PLGAL-AT showed more apparent material degradation and an irregular 
cement perimeter compared to samples containing CPC-PLGAH-Ec (Figure 3). 
Degradation of both types of CPC-PLGA composites was characterized by the 
occurrence of occasional free cement particles in bone marrow cavities and 
frequent presence of multi-nucleated cells at the cement surface (Figure 4c). 
I ..... ,. ..._;..}. ~; .. 
2mm -2mm 
Figure 3: Histological overview of the sinus area (hematoxylin-eosin staining of coronal hisrological 
sections after 12 weeks). CPC-PLGA composite (black) embedded in newly formed bone within rhe 
maxillary sinus of sheep. (a) CPC-PLGA11 Le (b) CPC-PLGAL 111 • 
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lo.... QJ The method of Kolmogorov and Smirnov showed that all presented data of the 
........ a. histomorphometrical analysis were normally distributed. CPC-PLGAL-AT showed a 
~ significantly higher (p=0.0009) amount of newly formed bone within the ROI 
U compared to CPC-PLGAH-Ec (26.4% ± 10.5% [median: 27.8%] versus 8.6% ± 3.9% 
[median: 8.1 %], respectively; Figure Sa). Additionally, CPC -PLGAL-AT showed 
significantly less (p=0.0192) remaining CPC in the ROI than CPC-PLGAH-Ec (61.2% 
± 17.7% [median: 61.2%] versus 81.9% ± 10.9% [median: 82.3%], respectively; 
Figure Sa). Moreover, a significantly increased (p=0.01 07) degradation distance 
was found for CPC-PLGAL-AT (Figure Sb) with a degradation distance from the 
original maxillary sinus wall of 1949 11m ± 129S 11m (median: 1706 11m) 
compared to 4S911m ± 2671-lm (median: 3891-lm) for CPC-PLGAH-Ec· Similar bone-
cement contact values (p=0.7S27) were determined for CPC -PLGAL-AT (61.3% ± 
21.0% [median: S3.6%]) and CPC-PLGAH-Ec (64.9% ± 21.7% [median: 61.1%]). 
Fluorochrome labeling analysis 
Analysis of the fluorochrome labeling showed a regular distribution of calor 
bands following the order of administration. Bone formation occurred from the 
original sinus wall and Schneiderian membrane in direction of the degrading 
CPC-PLGA composite (Figure 6). All fluorescent markers could be identified, 
although alizarin complexon showed a relative reduced intensity. 
Figure 4: High magnification of methylene blue-
basic fuchsin staining of coronal histological 
sections after 12 weeks (CPC -PLGAL-AT). Newly 
formed bone (NB) in close contact to remaining 
CPC-PLGA composite (C) appeared as vital bone 
tissue containing lining osteoblasts (OB), osteoid 
(OS) and osteocytes inside bone lacunae. (a) New 
bone formation from the Schneiderian mem-
brane (SM). (b) Lining osteoblasts and osteoid 
formation. (c) Multinucleated cell (MNC) at the 
boundaries of remaining CPC-PLGA composite. 
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 DISCUSSION 
The aim of this pre-clinical study was to evaluate the biological performance of 
two types of injectable CPC-PLGA composite materials with either rapidly or 
slowly degrading PLGA microspheres in a maxillary sinus floor elevation model 
in sheep. Since this study focused solely on evaluating these materials for the 
first time in a large animal model comparable to a human application, no dental 
implants were placed. Biocompatibility of both materials was evidenced by the 
absence of adverse tissue responses and signs of inflammation. Instead, both 
types of CPC-PLGA showed direct contact to bone without intervening soft 
tissue layers and degraded CPC-PLGA was gradually replaced by newly-formed 
bone. Interestingly, CPC-PLGA with rapidly degrading PLGA microspheres 
showed significantly faster CPC degradation and more bone formation com-
pared to CPC-PLGA with slowly degrading PLGA microspheres, demonstrating 
the ability to control CPC-PLGA degradation by changing the properties of PLGA 
m icrospheres. 
A large variety of CPC materials for maxillary sinus augmentation have been 
described in literature.6;8 To allow application in a clinical situation, these CPCs 
need to fulfill a number of criteria amongst which the most important are bio-
compatibility, biodegradability and easy handling.9 In previous studies using 
CPC -PLGA composites in either a pre-set or injectable form in small animal 
models, excellent biocompatibility has been demonstrated while the material 
degraded and bone tissue was formed.13-16 The results of the present study, 
using a large animal model, corroborate those findings regarding handling, 
biocompatibility and bone formation. 
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Figure 5: Histomorphometry. (a) Percentage (mean± SD) of bone and remaining CPC-PLGA compo-
site in the ROI after 12 weeks of implantation time (b) Degradation distance (mean± SD) of CPC after 
12 weeks of implantation time, measured as the maximal distance in 1-1m between the pre-existent 
maxillary sinus wall and cement, perpendicula r to the newly fo rmed bone - pre-existent maxi llary 
sinus wall interface. (* indicates significant difference; p <O.OS) (*** indicates significant difference; 
p <0.001 ). 
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Figure 6: Polychrome sequential fluorochrome labeling. Sequential fluorochrome labels were admin-
istered at 1 week (oxytetracycline, blue), 3 weeks (alizarin complexon, red}, 6 weeks (calcein, green) 
and at 9 weeks (oxytetracycline, blue). SW = pre-existent sinus wall; NB = newly formed bone; C = 
cement. 
Degradation of PLGA microspheres is critical for the degradation of CPC-PLGA 
composites.14 As control over CPC-PLGA degradation has apparent clinical 
significance, exploiting variations in PLGA properties has been considered in 
terms of molecular weight_B·ls In view of that, Bodde et aL indeed showed that 
relatively LMW PLGA microspheres evoke an accelerated CPC-PLGA degradation 
in combination with increased bone formation compared to relatively HMW 
PLGA equivalents.13 More recently, the type of PLGA polymer end-group 
appeared to be a more powerful parameter regarding PLGA degradation and 
subsequent CaP scaffold degradation.14 In vitro degradation assays by Felix La-
nao et aL revealed that acid-terminated PLGA degrades much more rapidly com-
pared to end-capped PLGA.14 The present study maximized the difference in 
these PLGA degradation properties by incorporating either microspheres made 
of LMW and acid-terminated PLGA or HMW and end-capped PLGA into CPC. lt 
was confirmed in this study that rapidly degrading CPC-PLGA allows an 
increased amount of bone formation compared to the slow degrading 
equivalent in vivo. Solidity and close adaptation to the bony maxillary sinus floor 
of the CPC-PLGA graft during surgery was confirmed by X-ray images directly 
post-operative. However, both CPC-PLGA composites showed an irregular 
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 surface at the end of the implantation period with bone formation into the CPC 
matrix, indicating substantial CPC matrix degradation. The statistically 
significant difference in porosity between rapidly and slowly degrading CPC-
PLGA composites in this study (i.e. 67o/o vs. 69%) is not likely to be of clinical 
significance. Van de Watering et al. demonstrated that a higher volumetric PLGA 
amount in CPC has significant though minimal effects on CPC degradation, and 
showed similar bone formation for CPC-PLGA composites with a porosity from 
64 to 72%.15 Furthermore, analysis of fluorochrome markers revealed that bone 
ingrowth occurred in the same direction as CPC degradation took place, i.e. 
from the original sinus wall towards the center of the grafted area. 
The sheep model used in the present study represents analogy with human 
maxillary sinus floor elevation procedures. Both the required graft volume and 
shape of the sheep maxillary sinus is comparable to the human situationY 
However, two major differences exist regarding the maxillary sinus floor eleva-
tion procedure in humans versus sheep: the limitation to an extra-oral approach 
in sheep due to the limited mouth opening and the relatively thick Schneiderian 
membrane in sheep.18-20 The latter, however, can be seen as an advantage, since 
lifting the Schneiderian membrane is less complicated and reduces the risk of 
damaging or tearing the membrane. In addition, sheep models are a valuable 
model for human bone turnover and remodeling activity.21 In support of this 
theory, Pearce et al. reported that sheep and humans have a similar pattern of 
bone-ingrowth into porous implants over time.21 Consequently, the perfor-
mance of both types of CPC -PLGA composites in the present study is likely to be 
predictable for the performance in maxillary sinus floor augmentation proce-
dures in humans. 
The ultimate goal for the development of a bone substitute material to be used 
in a clinical setting, is to obtain a material that degrades over time with the same 
speed as new bone is formed. This process results in a constantly solid grafted 
area which is replaced from material to natural bone over time. In human cases, 
the desired pace of bone graft degradation and subsequent replacement by 
newly formed bone is dependent on the bone forming capacity and moment of 
implant placement. When commercially available synthetic bone grafts are used 
in maxillary sinus floor augmentation procedures, usually a broad graft healing 
period of 4 to 9 months is considered to be required before implants can be 
installed.6:8 Therefore, in the present study only one time point was chosen at 12 
weeks to assess bone formation after a clinical acceptable healing period. 
Regarding healing time, the histological results of the present study showed 
that both types of CPC-PLGA composites are competitive to commercially 
available synthetic materials,8 although rapidly degrading CPC-PLGA is the 
preferred material because already after 12 weeks it showed significantly 
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enhanced material degradation and a significantly higher amount of bone 
ingrowth compared to the slow degrading equivalent. Nevertheless, the actual 
amount of bone formation is still at a clinically insignificant level. Further, the 
brittleness of CPC-PLGA composite material impedes the (simultaneous) instal-
lation of dental implants without jeopardizing the structural integrity of the 
graft material and implant stability. In previous small animal studies, CPC-PLGA 
composites demonstrated to be eventually completely degraded and replaced 
by bone after an implantation period of 12 weeks in rats.B However in the 
present animal model this would require a clinically unacceptable healing 
period. Therefore, the material characteristics of CPC-PLGA composites need to 
be optimized further, since the present composition seems to degrade too slow 
and therefore hinder new bone formation. 
Further enhancement of bone growth and speed has been described by the 
inclusion of several biological active factors to bone graft substitute materials in 
animal models.22 In view of this, PLGA microspheres within CPC have the advan-
tageous possibility to function as a drug-delivery vehicle. Several reports have 
demonstrated the beneficial influence of rhBMP-2 on new bone formation in 
CPC-PLGA composites.23-25 Furthermore, a significant increase of bone material 
contact was observed for injectable CPC-PLGA composites enriched with 
TGF-~1. 1 6 However, both recombinant growth factors represent expensive treat-
ment modalities. In addition, this financial aspect becomes even more evident 
with increasing graft dimensions compared to the use of bare CPC-PLGA com-
posites. Therefore, future research should aim at optimization of CPC-PLGA 
degradation properties in order to fully control material degradation and 
replacement by bone tissue. 
CONCLUSION 
Both CPC-PLGAL-ATand CPC-PLGAH-Ec demonstrated to be safe materials for sinus 
floor augmentation procedures in a large animal model, presenting biocompati-
bility and direct bone contact. In view of material performance, CPC-PLGAL-AT 
showed significantly faster degradation and a significantly higher amount of 
newly formed bone compared to CPC-PLGAH-EC· However, the degradation rate 
of CPC-PLGAL-ATneeds to be improved to allow faster and more bone formation 
in a clinically acceptable time period. 
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INTRODUCTION 
Placement of dental implants requires the presence of adequate alveolar bone 
quantity and quality. In case the amount of alveolar bone or its quality are insuffi-
cient, additional surgical techniques are needed to achieve primary implant 
stability.1 For extensive alveolar defects, onlay or inlay grafting procedures have 
been advised.1·5 To allow implant placement in the posterior part of the maxilla, 
sinus floor augmentation surgery has become a routine procedure6·9 that results 
in an implant survival rate of over 90 percent for 3 to 5 years.10;11 
Autologous bone grafts are considered the gold standard in sinus floor augmen-
tation.1 2;13 However, harvesting an autologous bone graft, especially from extra-
oral sources, is associated with several disadvantages. Especially, reservations 
must be made regarding the prolonged operating time and donor site morbidi-
ty,14-17 which may include hypersensitivity,18 pelvic instability, infection,19;20 and 
paraesthesia.21 Consequently, various allogenic, xenogenic and synthetic graft 
materials or combinations thereof have been used as an alternative to autologous 
bone grafts with variable clinical results.11;13;22 
Meta-analysis of augmented maxillary sinuses demonstrated comparable newly 
formed bone volumes for different types of biocompatible, osteoconductive bone 
substitutes, mostly calcium phosphate (CaP) ceramics.13 In an advanced set-up, 
such synthetic CaP-based bone substitutes have been combined with autologous 
bone, growth factors or even as a fully tissue engineered cellular construct to 
establish osteoinductive capacity.12;13 These composites combine the advantages 
of each element alone, i.e. osteoconductive properties from the synthetic material 
and osteoinductive capacity from biological components. Nevertheless, the 
disadvantage of harvesting bone or the expenses for using growth factors are still 
present using this approach. Furthermore, the efficacy of cell-based constructs 
remains unclear as evidenced by conflicting experimental results reported using 
various cell types of animal or human origin.23;24 
In view of safety, regulatory and application issues, the ideal synthetic bone sub-
stitute should be available off-the-shelf and have intrinsic osteoinductive capaci-
ty. Winter and Simpson were the first to report ectopic bone formation induced 
by a biomaterial.25 Since then, several authors reported material-induced osteo-
genesis in soft tissues in different animal models.26;27 A recent study of Yuan et al. 
showed an excellent osteoinductive capacity of microstructured tricalcium phos-
phate (MSTCP) particles after 12 and 52 weeks of intramuscular implantation in 
dogs and sheep.28;29 Consequently, it was hypothesized that MSCTP particles rep-
resent a suitable bone substitute in maxillary sinus floor augmentation surgery. 
In view of this, the present study aimed to evaluate the biological performance of 
MSTCP particles with osteoinductive capacity28 in maxillary sinus floor augmenta-
tion procedures in sheep. 
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 MATERIALS AND METHODS 
Material 
MSTCP particles were kindly provided by RevisiOs BV (Bilthoven, The 
Netherlands). Production of the particles was described before.28 In brief, calcium 
phosphate powders (with a Ca/P ratio 1.5) were mixed with a H20 2 solution and 
naphthalene particles to produce slurries. After foaming, drying and evaporation 
of the naphthalene, the material was sintered for 8 hrs at 1100°C. X-ray diffraction 
analysis of MSTCP showed more than 90% ~TCP phase and a trace of hydroxyap-
atite (<1 Owt%).28 After milling, ceramic particles with a size of 150 to 500 11m were 
sieved, cleaned and sterilized using gamma irradiation (lsotron Nederland BV, 
Ede, the Netherlands). 
Animals 
In total, eight female Swifter sheep in healthy condition (average weight: 65 kg) 
were used in this study. The experimental protocol was reviewed and approved 
by the Experimental Animal Ethical Committee of the Radboud University Medical 
Center, The Netherlands (RU DEC 2008-194). National guidelines for the care and 
use of laboratory animals were observed. 
Surgical procedure 
To reduce the perioperative infection risk, prophylactic antibiotics were adminis-
tered subcutaneously (Aibipen· 15%, 3ml/50 kg preoperative and Albipen· LA, 
?.Sml/50 kg for 3 days post-operative, lntervet BV, Boxmeer, the Netherlands). 
General anesthesia was initiated by an intravenous injection of pentobarbital 
(AUV Wholesale, Cuijk, the Netherlands). Subsequently, the sheep were intubated 
and connected to an inhalation ventilator with a constant volume of a mixture of 
nitrous oxide, isoflurane, and oxygen. The animals were immobilized in a ventral 
position and the operation site was shaved, washed and disinfected with 
povidone-iodine. Access to the maxillary sinus was obtained by first exposing the 
facial antral wall over a 4 cm long paramedian sagittal skin incision, taking care to 
avoid the facial artery. After reflecting the skin flap, a bony window with a diame-
ter around 10 mm was created rostrally with a dental burr (Eicomed· 100, W&H 
Dentalwerk GmbH, Bi.irmoos, Austria) under continuous external cooling, fol-
lowed by careful removal of the resultant bone plate from the Schneiderian mem-
brane. The membrane was then elevated from the buccal and caudal bony wall 
and displaced cranially with bent blunt dissectors. In total eight maxillary sinuses 
were unilaterally grafted with 2 ml of the MSTCP particles. The grafted defect was 
covered by the bone plate. Thereafter, the soft tissues were closed in separate 
layers. To reduce pain after surgery, all sheep received Finadyne· (AUV Wholesale, 
Cuijk, the Netherlands) for 3 days postoperatively. Directly after sinus 
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0 augmentation surgery and after 6 weeks of healing time a radiograph was 
1o.... obtained of the maxillary sinus area to verify graft localization and surgery. 
Q) 
........ a. Sequential fluorescent labeling 
ro 
....c A polychrome sequential fluorescent labeling method was carried out in seven 
U sheep to visualize the dynamics of bone growth, one sheep was used as control 
to exclude auto fluorescence of the specimens and implanted MSTCP after 
histological processing. Fluorescent labels oxytetracycline (blue), alizarin 
complexon (red), calcein (green) and tetracycline (blue) were administered 
subcutaneously (25 mg/kg body weight) at 1, 3, 6, and 9 weeks post surgery, 
respectively. 
Sample retrieval and histological processing 
Animals were sacrificed using a overdose of Pentobarbital after 12 weeks post 
surgery. The maxilla with surrounding tissue was retrieved. Subsequently, the 
sinus region was excised and excess tissue was removed. By using a diamond 
saw, the tissues were sawed into smaller blocks suitable for histological pro-
cessing. Specimens were fixed in phosphate-buffered formaldehyde solution 
(pH 7.4), dehydrated in a graded series of ethanol (70-1 00%) and finally embed-
ded in polymethymetacrylate (PMMA). Multiple histological sections (n:?:3; -20 
IJm) were prepared in a buccal palatinal direction at consecutive levels through 
the grafted area using a microtome with diamond blade (Leica Microsystems SP 
1600, Nussloch, Germany). Histological sections were stained with methylene 
blue and basic fuchsin. Two unstained sections (-20 IJm) were prepared for 
fluorescent microscopy of each block. Furthermore, MSTCP granules were 
embedded in PMMA, after which sections (-20 IJm) were prepared of the 
as-received granules before implantation. 
Radiological evaluation 
After sacrifice, cone beam computed tomograms (CBcn (i-CArM 3-D lmaging 
System, lmaging Sciences lnternationallnc, Hatfield, PA, USA) were made of the 
maxillae, during which grafts were localized and the maximum augmentation 
height was measured at three levels with 1-Cat Vision· software (lmaging 
Sciences International, Inc. Hatfield, PA, USA). 
Histological and histomorphometrical analysis 
The histological evaluation consisted of a morphological description of at least 
three sections of each grafted area using a light microscope (Leica Microsystems 
AG, Wetzlar, Germany). Fluorescent labeling was observed with unstained 
sections using a fluorescent microscope (Leica Microsystems AG, Wetzlar, 
Germany). Excitation wavelengths for each of the fluorescent labels were as 
follows: 365-490nm/520-570nm (blue), 530-580nm/600-645nm (red) and 436-
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 495nm/517-540nm (green). The fluorescence images were merged with one 
regular image using transmission light microscopy to assess the dynamics of 
bone formation over time. 
In addition, the stained sections were quantitatively scored using computer-
based image analysis techniques (Leica Qwin Pro-image analysis system). Three 
randomly selected standardized areas (1.4 mm2) within the boundaries of the 
grafted area of at least three histological sections were analyzed of each speci-
men (Figure 1 & 2b). The area of newly formed bone, residual MSTCP and 
connective tissue were determined and expressed as a percentage within this 
region of interest by manual selection based on pixel value detection. Further-
more, the perimeter of the granules in direct contact with bone was measured 
and expressed as a percentage of the total perimeter for -500 randomly chosen 
particles from different histological sections. Additionally, the surface, perime-
ter, and longest axis of these granules in the histological sections were 
compared with sections of the granules before implantation. 
Statistical analysis 
Quantitative measurements were expressed as median and mean ± standard 
deviation (mean± SO). The differences in particle surface, perimeter and longest 
axis were analyzed by Mann Whitney test. Statistical analysis was performed 
using SPSS statistical software package (IBM' SPSS 16.0). Data were considered 
significant at p<O.OS. 
Medial wa ll 
Figure 1: Schematic overview of three randomly selected standardized areas (1.4 mm2) within the 
boundaries of the grafted area for histomorphometric analysis. 
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RESULTS 
General observations of the animals 
The surgical procedure was uneventful for all animals. At sacrifice, a total of 8 
maxillary sinuses including surrounding tissue could be retrieved. Macroscopi-
cally, no signs of infection or adverse tissue reaction were observed. 
Radiological evaluation 
Directly after sinus augmentation and after 6 weeks of healing time, an x-ray was 
obtained of the maxillary sinus area. The location of the surgical site and graft 
location were examined by comparison. No dislocations or adverse effects were 
observed (data not shown). A mean augmented height of 6.0±2.2mm was found 
in CBCT scans after 12 weeks of implantation time. 
Histology 
No signs of inflammation or adverse tissue reactions were observed. Bony 
structures were preserved and the maxillary sinus did not change in shape. New-
ly formed woven bone was observed bridging the space between the 
original bone of the buccal wall and sinus floor (Figure 2a). This bone appeared 
as vital bone tissue containing osteoblasts, osteoid covering the border, and 
osteocytes inside bone lacunae. Furthermore, bone marrow like tissue was 
observed in between the bone voids, including blood vessels. The Schneiderian 
membrane was completely covering the augmented sinus floor (Figure 2a). 
Remaining MSTCP granules could be easily identified in the newly formed bone 
by its size, shape, and dark calor (Figure 2b). The bone was in close contact with 
the surface of MSTCP granules without the presence of an intervening fibrous 
tissue layer. In areas, where the remaining MSTCP particles were in contact with 
bone marrow, occasionally multinucleated cells were observed at the surface of 
the particles, suggesting the occurrence of cell-mediated resorption (Figure 2c). 
Overall, MSTCP particles appeared to be reduced in size compared to their 
original size. 
N"'500 Area (mm2) Perimeter (~m) Longest axis (~m) Bone particle contact(%)
T=O 0.059 ± 0.047 1487 ± 803 386± 159
T= 12 weeks 0.027 ± 0.025 851 ±490 258 ± 126 82.3 ± 7.5
Mann Whitney p<0.001 p<0.001 p<0.001 
Table 1: MSTCP particle degradation. MSTCP particle characteristics before and after 12 weeks 
implantation time in maxillary sinuses of sheep. 
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Figure 2: Hi~tology 12 weeks after maxillary sinus augmentation in ~heep. Histological overview of the 
sinus area (A}. Higher magnification ofthe MSTCP particles embedded in bone and direct bone bonding 
(B); occasionally, multinucleated cells were observed in contact with MSTCP particles (C). Haematoxylin-
eo~in staining. Green square specify an example of randomly selected area (1.4 mm2} within the bound-
arie~ of the grafted area for histomorphometry; • indicates MSTCP particle; arrow indicates multinucle-
ated cell. 
Fluorochrome labeling 
Fluorescent labels were systemically administered to allow the visualization of 
dynamic bone formation at one, three. six and nine weeks. All sequential fluoro-
chrome markers could be identified at a low magnification within the total graft-
ed area in the experimental site (Figure 3). Consecutive fluorochrome markers 
appearance, laid down in the form of bands, was observed around the MSTCP 
granules. No clear sequence of fluorescent bands could be observed within the 
grafted area_ In contrast to the labels tetracycline (blue; administered in week 1 
and 9) and calcein (green; administered in week 6). the presence of the alizarin 
complexon label (red; administered in week 3) could not as sharply be identified 
in the sections. 
Histomorphometry 
Tissue formation 
Figure 4 demonstrates the results of the histomorphometric analysis of the 
MSTCP-augmented specimens_ The area fraction of the newly formed bone 
ranged from 25.0% to 65.4%. Randomly selected areas of the histological sec-
tions revealed a mean newly formed bone area of 42.9 ± 9.7% (median: 42.3%). 
Furthermore, a mean area of 33.1±10.9% (median: 23.8%) was occupied by fi-
brous connective tissue_ 
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r--... o Particle degradation 
lo.... QJ Particle surface, perimeter and longest axis were measured before and after im-
....., 
a. plantation to assess particle degradation (Figure 5 & Table 1 ). A significant 
~ (p<0.001) decrease of all parameters was measured between the starting 
U material and the MSTCP particles 12 week after implantation (Table 1 ). The 
mean residual particle area recorded for MSTCP was 24.0±7.0% (median: 34.0%) 
after 12 weeks (Figure 4). Furthermore, the percentage of bone in contact with 
the graft particles was measured to determine the actual bone to particle 
contact percentage. A mean bone particle contact of 82.3±7.5% (median: 81.7%) 
was found (Table 1 ). 
Figure 3: A polychrome sequential fluorescent labeling. Fluorescent labels oxytetracycline (blue), 
alizarin complexon (red), calcein (green) and tetracycline (blue) after 12 weeks implantation time of 
the MSTCP group (* indicates MSTCP particle). 
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 DISCUSSION 
This pre-clinical study aimed to evaluate the biological performance of MSTCP 
particles applied in maxillary sinus augmentation surgery in sheep with an 
implantation period of 12 weeks. Histology, histomorphometric analysis, 
sequential fluorescent labeling and maxillofacial CBCT were employed to 
systematically evaluate new bone formation and bone remodeling in the graft-
ed area. Substantial new bone formation and incorporation of the MSTCP parti-
cles in the newly formed bone was observed. These observations indicate a suc-
cessful performance of MSTCP particles. Additionally, MSTCP particles showed 
signs of degradation. 
Experimental studies on maxillary sinus floor augmentation have been reported 
using different animal species and various grafting materials. The sheep model 
is considered one of the suitable larger animal models for maxillary sinus aug-
mentation surgery, due to its similarity in size, bone physiology and structure 
with the human maxillary sinus.30 lt was, however, not possible to perform the 
procedure using an intra-oral approach like in humans, due to the limited open-
ing of the mouth of a sheep. Consequently, this model only allows sinus aug-
mentation using an extra-oral approach, as already several authors stated 
before.31-34 In contrast to the finding that Schneiderian membrane perforation is 
a common technical problem in humans,35 the thickness of the sheep 
Schneiderian membrane showed enough consistency to perform sinus floor 
augmentation without tearing the membrane in any case. 
Autologous bone grafting is considered the gold standard in sinus floor aug-
mentation surgery.13 However, a variety of alloplastic bone substitutes, single or 
in combination with autologous bone, have been used in sinus augmentation 
surgery in human with various results.11'13 TCP was already used in the 1970s to 
heal bone defects.36 Nkenke et al. analyzed the present literature to determine 
whether there are advantages of using autologous bone over bone substitutes 
in sinus floor augmentation procedures with respect to dental implant survival.11 
They concluded that no evidence exists that either supports or refutes the 
superiority of autologous bone grafts over TCP with regard to dental implant 
survival.11 Furthermore, a recent meta-analysis by Klijn et al. demonstrated that 
histomorphometrically determined bone volumes did not significantly differ 
from using an autologous bone graft or using TCP in maxillary sinus augmenta-
tion.B Also, the addition of autologous bone to TCP appeared to have a negligi-
ble effect regarding total new bone formation.13 According to these findings, the 
MSTCP particles that were used in this preclinical study showed a substantial 
amount of new bone formation. 
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The ultimate bone substitute in implant dentistry should eventually be resorbed 
and replaced by functional newly formed bone. Therefore, the use of resorbable 
TCP particles for sinus floor elevation has received increasing attention in 
implant dentistry.37'38 Resorption of MSTCP particles was demonstrated both 
histological and histomorphometrically one year after intramuscular implanta-
tion in dogs.28 ln the present study, resorption could be confirmed by comparing 
particle size, perimeter and longest axis before and after implantation in the 
bony maxillary sinus environment. Yuan et al. demonstrated both chemical 
dissolution and cell-mediated resorption over time.28 Considering the occasional 
presence of multi-nucleated cells in contact with remaining MSTCP particles, the 
present study corroborates with these findings. 
In the past years, several authors described the use of osteoconductive ~TCP in 
human maxillary sinus floor augmentation procedures.37'39-44 Histomorphometri-
cally obtained bone volumes of 17 to 52% were found in patients after 6 to 12 
months of healing time. Besides, the use of TCP has been evaluated in maxillary 
sinus augmentation in various animal species. In a recent study of Wang et al., 
TCP was used as grafting material for maxillary sinus augmentation in dogs.46 A 
mean newly formed bone area of 34% was found after 24 weeks of healing time. 
In another study of Jiang et al., TCP was used in sinus augmentation in rabbits, 
after 8 weeks of healing time a mean newly formed bone area of 16% was 
found.47 TCP was also used in a miniature pig study, as described by Gruber,48 
60 
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Mean newly formed bone Mean residual material Mean connective tissue 
Figure 4: Histomorphometry. Mean percentage of newly formed bone, residual material and 
connective tissue area after 12 weeks implantation time in maxillary sinuses of sheep. 
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 who installed, in contrast to the current study, a dental implant simultaneously 
with sinus floor augmentation. A mean bone volume up to 19% was found after 
12 weeks.48 The MSTCP particles evaluated in this study in sheep, resulted in 
43% of newly formed bone after 12 weeks after implantation within the grafted 
area. 
Zerbo et al. concluded that due to the absence of osteoinductive properties of 
the TCP they investigated, the rate of bone formation was delayed in compari-
son to autologous bone grafting.42 lt would be beneficial for the patient to 
reduce the interval between maxillary sinus augmentation and implant 
placement by accelerating the process of integration of the grafted material. 
Some authors state that the application of osteoinductive substances, such as 
platelet-rich plasma or growth factors are promising options.49'50 However, PRP 
seemed not to be beneficial for new bone formation in sinus augmentation and 
the use of recombinant growth factors is an expensive option. 51 With the ability 
to form bone in soft tissue,28 the osteoinductive MSTCP particles used in this 
study will be useful to speed up the process of appositional bone growth. 
Sequential fluorochrome markers were observed within the total grafted area 
implicating bone growth through the hole specimen already at least 3 weeks 
after implantation. However, the question remains what healing period is 
necessary to provide adequate bone formation for successful dental implant 
placement. Furthermore, MSTCP particles were not evaluated at an ectopic site 
in this study. Therefore, no conclusions regarding the osteoinductive properties 
could be drawn. Follow-up studies with prolonged evaluation periods and the 
application of a combined approach with both sinus floor augmentation and 
one or two staged implant placement will give an insight in bone to dental 
implant contact and mechanical stability of the augmented bone. 
CONCLUSION 
Based on the histological and histomorphometrical results of this preclinical 
study, MSTCP particles showed to represent a suitable bone substitute material 
for maxillary sinus augmentation. The MSTCP demonstrated to provide a 
scaffold for cell ingrowth and substantial bone formation. Additionally, MSTCP 
particles showed significant signs of degradation after 12 weeks of implantation 
in the sheep maxillary sinus. 
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Figure 5: Box plot of MSTCP particle degradation. MSTCP particle characteristics before and after 12 
weeks implantation time in maxillary sinuses of sheep. (A) MSTCP particle area (median: 43153 1Jm2) 
(B) MSTCP particle perimeter (median: 1300 !Jm) (C) MSTCP particle longest axis (median: 358 !Jm). 
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 SUMMARY AND ADDRESS TO THE AIMS 
The general aim of the research described in this thesis was to assess the value 
of bone substitute materials for maxillofacial bone augmentation procedures as 
well as to evaluate innovative synthetic bone substitute materials in preclinical 
bone augmentation models. The general conclusion on the use of bone 
substitutes for oral and maxillofacial applications is that their performance is 
predominantly related to bone substitute material properties, recipient site 
characteristics, and patient conditions. 
In bone augmentation procedures for the oral and maxillofacial skeleton, the 
use of autologous onlay and inlay grafting is still considered the gold standard. 
Unfortunately, harvesting of such an autologous bone graft is associated with 
serious drawbacks. The major disadvantage is that donor site surgery requires a 
prolonged operating time and may cause severe donor site morbidity. 
Consequently, a broad variety of (synthetic) bone substitute materials have been 
developed. Clinically relevant advantages of these materials compared to autol-
ogous bone include their cost, safety and off-the-shelf availability. In order to 
improve decision making regarding the augmentation material to be 
recommended for oral and maxillofacial procedures in individual patients, two 
meta-analytical studies were performed. Furthermore, patient specific 
conditions were evaluated for their potential influence on the clinical outcome. 
Although a large number of bone substitute materials have been described, 
research and development in this area is still progressing in order to improve the 
performance of candidate materials. Three of the most important prerequisites 
for the clinical acceptance of a novel bone substitute material are excellent peri-
operative handling properties, degradation over time and replacement by bone 
tissue in a controlled manner. In view of this, research in this thesis specifically 
focused on the improvement of clinical handling properties, degradation 
characteristics and osteoinduction capacity of such materials. The investigated 
calcium phosphate cements (CPCs) allowed optimal defect filling and easy 
shaping. Porosity was introduced to enhance material degradation and bone 
conduction via both a foaming agent (C02) that forms gas bubbles during CPC 
setting and several different degradable poly(lactic-co-glycolic acid) (PLGA) 
microspheres that degrade hydrolytically within the CPC-matrix. CPCs were eval-
uated in small and large animal models to assess their biological 
performance and potential for future clinical use. In view of osteoinduction, a 
novel osteoinductive microstructured calcium phosphate material was assessed 
in a large animal model. 
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 Autologous bone grafts and maxillary sinus floor augmentation. 
No studies have been published before that evaluated histomorphometric data 
from a large number of patients comparing different sites and methods of autol-
ogous bone grafting in maxillary sinus floor augmentation procedures. In the 
second chapter of this thesis, a meta-analysis was performed on earlier 
published data. Pubmed search engine and the following journals were 
explored: Clinical Oral Implant Research, International Journal of Oral and Maxil-
lofacial Implants, International Journal of Periodontics and Restorative Dentistry, 
and the Journal of Periodontology. According to the inclusion criteria for this 
study, 25 out of 147 articles were selected for analysis. The majority were 
prospective clinical studies, followed by two randomized clinical trials, one pilot 
and one case series. After statistical analysis, a reference value for Total Bone 
Volume (TBV) of 47% was found using iliac bone grafting as standard group. The 
use of intra-oral bone grafts for sinus augmentation increases the TBV; with 11 o/o 
for chin bone and 14 o/o for bone grafted from other intra-oral sites. Particulation 
of a bone graft had a negative effect on TBV of 18%. Surprisingly, no correlation 
between TBV and the time of graft healing was found. Histological section 
thickness seemed to be a significant variable, as every micron increase of section 
thickness lead to an increase of 0.4% of TBV. From the meta-analysis in chapter 
2, it was concluded that bone grafting from the iliac crest resulted in a 
significantly lower TBV compared to intra-oral bone grafting. However, due to 
the limited availability of intra-oral bone to be harvested, iliac grafts still have to 
be considered as the gold standard in augmenting the severely atrophic maxilla. 
Bone substitute materials and maxillary sinus floor augmentation. 
In addition to the lack of studies comparing the use of autologous bone grafts, 
no extensive studies have been published before in which histomorphometric 
data from a large group of patients using various biomaterials for sinus floor 
augmentation procedures were evaluated. Therefore, in the third chapter of 
this thesis, another meta-analysis was performed. Pubmed and the same 
journals as in the previous chapter were used for the inclusion of data. Accord-
ing to the inclusion criteria for this study, a total of 64 out of 147 articles were 
integrated for analysis. Based on autologous bone grafting as gold standard, a 
reference value for TBV of 63% was found in this study. Particulation of the bone 
graft also resulted in a general reduction of 18% of TBV. Furthermore, delayed 
implant placement was found to reduce the TBV with 7%. TBV was 8% or 6% 
higher, if a biopsy was respectively taken before 4.5 months or after 9.0 months 
after initial maxillary sinus augmentation surgery. The application of allogenic, 
xenogenic, or alloplastic bone substitute materials (or combinations thereof) 
mainly resulted in a significant lower amount of TBV, varying between 7% and 
26%, as compared to autologous bone grafting. Inventorying the effect of 
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 'biopsy time' for only autologous bone grafts, showed a TBV which was 
significantly higher before 4.5 and after 9.0 months of healing time compared to 
period in between. This effect was not found in the previous meta-analysis. 
Surprisingly, with respect to 'biopsy time' for bone substitutes other than autol-
ogous bone, no significant differences in TBV were found. lt was concluded that 
autologous bone still has to be considered as the gold standard because of 
higher TBV after maxillary sinus augmentation procedures. However, the 
consequence of the TBV for dental implant survival still needs to be unraveled. 
Predictive value patient specific characteristics on bone graft resorption. 
As the outcome of a maxillary sinus floor augmentation procedure is based on 
multiple factors, individual patient characteristics as well as material properties 
need to be taken in consideration. In the fourth chapter of this thesis, it was 
attempted to identify patient specific parameters to predict maxillary sinus floor 
augmentation outcome regarding autologous bone graft volume by 
maxillofacial CT. No studies are available providing predictive radiographic pa-
rameters regarding the expected amount of resorption after maxillary sinus 
augmentation surgery using autologous bone grafts. Therefore, the aim of this 
study was to determine parameters influencing the outcome of the bone graft 
resorption process. In 20 patients, three dimensional analysis of alveolar ridge 
dimensions and bone graft volume change in the atrophic posterior maxilla was 
performed by Cone Beam Computerized Tomography (CBCT) imaging at several 
chronological time points. Ridge dimensions were assessed before maxillary 
sinus augmentation surgery. Bone graft volumes were compared directly after 
maxillary sinus floor augmentation surgery and after a variable graft healing 
interval. To analyze the relation between bone volume change with the 
independent variables patients gender, age, alveolar crest height and width, 
and graft healing time interval, a multi-level extension of linear regression was 
applied. A residual bone height of 6.0 mm (50=3.6 mm) and 6.2 mm (50=3.6 
mm) was found for the left and right sides, respectively. Moreover, alveolar bone 
widths of 6.5 mm (50=2.2 mm) and 7.0 mm (50=2.3 mm) at the premolars and 
8.8 mm (50=2.2 mm) and 8.9 mm {50=2.5 mm) at the molars regions were 
found for the left and right side, respectively. Bone graft volume decreased on 
average 25.0% (50=21.0%) after an average healing interval of 4.7 months 
(50=2.7, median=4.0 months). The variables 'age' (p=0.009) and mean alveolar 
crest 'bone height' (p=0.043), were identified as significant regarding bone graft 
resorption. A decrease of 1.0% (5E=0.3%) bone graft resorption was found for 
each year the patient gets older and an increase in bone graft resorption of 1.8% 
(5E=0.8%) was found for each mm of original bone height before maxillary sinus 
floor augmentation. lt was concluded that graft resorption occurs when using 
autologous bone grafts for maxillary sinus augmentation and that alveolar crest 
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 bone height and patient age have a significant effect on graft resorption, with 
increased resorption for higher alveolar crest bone height and decreased 
resorption for older patients. Consequently, patient characteristics that affect 
the process of bone graft resorption should be given full consideration when 
performing maxillary sinus augmentation surgery. 
Three porous calcium phosphate cements for bone augmentation. 
Pre-implant surgery has become a routine procedure to obtain sufficient bone 
quantity and quality for dental implant installation in patients with initially 
inadequate bone volumes. Although autologous bone onlay or inlay grafting is 
still the preferred bone augmentation technique, a broad range of synthetic 
bone substitutes have been developed, such as calcium phosphate cement 
(CPC). The introduction of porosity within CPC can be used to increase CPC 
degradation and bone ingrowth. Therefore, in chapter S three different strate-
gies to obtain porous CPCs and their performance were evaluated in a preclini-
cal augmentation model. Instantaneously porous CPC (CPC-IP) was compared to 
delayed porous CPC in vitro and in vivo. CPC -I P was obtained by creation of C02 
bubbles during setting, whereas delayed porous CPC was obtained after 
degradation of incorporated PLGA microspheres. As an additional aspect, 
delayed porous CPC was created by the incorporation of either hollow or dense 
degradable PLGA microspheres (CPC-hPLGA and CPC-dPLGA). All CPC composi-
tions showed appropriate clinical handling properties and an interconnected 
porous structure with a final porosity above 70o/o. In vitro degradation studies 
showed gradual formation of pores and further CPC-matrix dissolution for CPCs 
containing PLGA microspheres (dense PLGA microspheres > hollow PLGA micro-
spheres), whereas hardly any degradation was observed for CPC-IP. For in vivo 
evaluation of the CPCs, an augmentation model was used, allowing CPC 
injection into a rigidly immobilized Teflon ring on the rat skull. Histological eval-
uation after 12 weeks of implantation showed bone formation using all three 
CPCs. Bone apposition reached volumetric amounts of up to 1 Oo/o of the aug-
mentation area and a maximum augmentation height of -1 mm. CPC-IP showed 
significantly more bone formation and resulted in a superior bone 
apposition height compared to both CPCs containing PLGA microspheres. No 
differences in biological performance were observed between CPCs containing 
hollow or dense PLGA microspheres. 
Maxillary sinus floor augmentation with CPC-PLGA composites in sheep. 
The aim of the preclinical study described in chapter 6 was to evaluate the 
biological performance of two injectable CPC composite materials containing 
PLGA microspheres with different properties in a maxillary sinus floor elevation 
model in sheep. PLGA microspheres were made of either low molecular weight 
(LMW; -17 kDa) acid-terminated PLGA (PLGAL-Arl or high molecular weight 
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 (HMW; -44 kDa) end-capped PLGA (PLGAH·Ecl and incorporated in CPC. Eight 
female Swifter sheep underwent a bilateral maxillary sinus floor elevation 
procedure via an extra-oral approach. All animals received both materials, 
alternately injected in the left and right sinus cavity (split-mouth model) and a 
healing period of 12 weeks was used. Analysis of biological performance was 
based on histology, histomorphometry and evaluation of sequential 
fluorochrome labeling. Both types of CPC-PLGA composites showed 
biocompatibility and direct bone-cement contact. CPC-PLGAL-Arshowed a signif-
icantly higher degradation distance compared to CPC-PLGAH-Ec (1949 IJm ± 1295 
flm versus 459 1-1m ± 267 1-1m; p<0.05). Further, CPC-PLGAL·ATshowed significantly 
more bone in the region of interest (26.4% ± 10.5% versus 8.6% ± 3.9%; p<0.001) 
and significantly less remaining CPC material (61.2% ± 17.7% versus 81.9% ± 
1 0.9%; p<0.05). lt was concluded that both CPC-PLGAL·ATand CPC-PLGAH·Ecare 
safe materials for sinus floor elevation procedures in a large animal model, pre-
senting biocompatibility and direct bone contact. In view of material 
performance, CPC-PLGAL-Arshowed significantly faster degradation and a 
significantly higher amount of newly formed bone compared to CPC-PLGAH-Ec· 
Maxillary sinus floor augmentation with osteoinductive ceramic in sheep. 
The objective of the study described in chapter 7, was to evaluate the biological 
performance of novel osteoinductive micro-structured tricalcium phosphate 
(MSTCP) particles in maxillary sinus floor augmentation surgery in sheep. For 
this purpose, maxillary sinus floor augmentation with MSTCP particles was 
unilaterally performed in eight Swifter sheep. Radiological imaging and 
histological analyses were performed after 12 weeks of implantation. 
Maxillofacial CT, histology, histomorphometrical analysis, and sequential 
polychrome fluorescent labeling indicated that MSTCP particles provided an 
excellent scaffold for cell ingrowth and bone formation. After a 12 week 
implantation period, the augmented sinuses showed an increased bone height 
of -6 mm and a mean total bone volume of 43% with significant degradation of 
the implanted MSTCP particles. Consequently, it was concluded that MSTCP 
particles represent a suitable bone substitute material for maxillary sinus floor 
augmentation surgery. 
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 CLOSING REMARKS 
In this thesis, research efforts focused on the use of autologous bone and bone 
substitute materials for maxillofacial bone augmentation procedures. Two 
meta-analytical studies and a trohoc study provided an overview of the current 
concepts in the development of these augmentation materials and their 
biological performance. lt could be concluded that in reconstructive bone 
augmentation procedures of the maxillofacial skeleton, autologous bone grafts 
must still be considered the gold standard. Furthermore, it was concluded that 
the biological outcome of augmentation procedures is related to augmentation 
material properties, the applied surgical technique and patient conditions. 
Recent literature, however, evaluating the clinical outcome after applying 
various bone substitute materials versus autologous bone could not identify 
significant advantages of using the one or the other. In view of this, the 
consequence of the biological performance on final dental implant survival is 
still unraveled. lt is questionable if histology and histomorphometry, which are 
considered the standard tools for the assessment of the biological performance 
of bone augmentation materials, provide sufficient information for adequate 
decision making. In addition, also alveolar crest bone height and patient age 
showed to be of significant influence on autologous bone graft resorption. An 
increased resorption was found for higher alveolar crest bone height and a 
decreased resorption for older patients. Thus, beside the augmentation material 
point of view also patient characteristics and the clinical outcome must be given 
full consideration when performing and assessing maxillary sinus floor augmen-
tation surgery. 
In spite of these patient specific factors, an increasing number of bone 
substitute materials is becoming (commercially) available for clinical use. The 
collaboration of experts from different scientific fields has resulted in an 
explosive growth of material based possibilities for bone reconstructive 
procedures. Such synthetic bone substitute materials have the general 
advantage of off-the-shelf availability and reduction of patient morbidity. 
Moreover, these bone substitute materials have highly standardized properties 
and allow production in relatively large amounts with a consequential predicta-
ble clinical outcome. Novel concepts for further innovation are based on the 
combination of scientific knowledge and clinical needs. Nowadays, especially 
improvement of clinical handling and bone regenerative properties bear high 
attention. 
Considering handling properties, CPCs from this study exhibited a high 
potential because of easy shaping and optimal defect filling. From a biological 
point of view, the introduction of porosity resulted in an interconnected porous 
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 structure with sufficient macroporosity for bone ingrowth within a controllable 
period after injection. Moreover, the investigated CPCs showed high 
biocompatibility as these did not elicit any adverse reactions upon implantation 
in a bony environment. However, a major disadvantage is that these CPCs are 
solely osteoconductive. While the inclusion of biologically active factors to 
obtain osteoinductive capacity is an expensive treatment option, the innovation 
of material based osteoinductivity overcomes this disadvantage. In view of this, 
the microstructured TCP granules used in this study possess intrinsic osteoin-
ductive capacity and excellent biological performance. On the other hand, 
handling properties of this material have been shown to be inferior to CPCs. 
Therefore, further research and development of synthetic materials for bone 
reconstructive procedures should continue. The possibilities to design new 
materials are numerous and a small modification of chemical properties might 
substantially affect the biological performance of such a bone substitute 
material. 
From a clinical point of view, clinicians should have the possibility to select the 
most appropriate augmentation material for each specific clinical situation. 
However, an important issue that needs to be addressed is the fact that despite 
the clinicians aim for the most optimal treatment for a given patient, reality 
proofs that not always the most suitable bone substitute material is selected. A 
wide range of options is available, however clinicians only have experience with 
limited types of materials. Furthermore, (private) medical centers are usually 
loyal to the company that supplied such materials in the past and the costs of 
new materials are usually higher. Moreover, due to the rapidly evolving 
development of augmentation materials, clinicians are not always aware of the 
existence and advantages of innovative bone graft substitute materials com-
pared to familiar equivalents. 
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 FUTURE PERSPECTIVES 
Although this thesis revealed relevant data on the use and development of 
bone substitute materials for augmentation purposes in the oral and 
maxillofacial area, several aspects need further investigation: 
-The primary outcome of the assessment of biological performance of bone 
substitute materials is defined as the histological and histomorphometrical 
findings of biopsies taken before implant placement. However, the outcome 
and consequence of such measurement on implant survival are still not 
completely unraveled yet and need to be further investigated. 
-The healing periods elapsed after maxillary sinus floor augmentation 
procedures in different studies varied to a great extent. Although this is an 
important factor in patient treatment, only for autologous bone a significant 
trend was found in one of the two meta-analytical studies. Therefore, further 
research should focus on determining ultimate graft healing time intervals for 
each specific bone substitute materials. 
-The height of the alveolar ridge was determined by CBCT to be of significant 
influence on autologous bone graft resorption. However, in most studies the 
height of the alveolar ridge was only considered as the base for the decision of 
immediate or delayed implant placement. In view of this, also the influence of 
the alveolar ridge on the biological performance of bone substitute materials 
should be further investigated. 
-From this study it is not possible to decide whether general diseases, smoking 
or other risk factors have an influence on the biological performance of bone 
augmentation materials. Because these aspects becomes more and more 
important in future medicine, further studies should assess these possible 
influences. 
-Further research is necessary to specifically tailor the degradation rate of 
incorporated PLGA microspheres and CPC itself in order to allow gradual bone 
ingrowth and material degradation over time for specific clinical applications. 
-The influence of biologically active factors to promote bone formation, or even 
better material based intrinsic osteoinductive capacity needs further investiga-
tion in order to perform more complicated augmentation procedures or to use 
such materials in patients with a compromised bone regeneration potential. 
-Considering the experiments as performed and knowledge as obtained from 
this thesis, it has to be recommended that clinical trials are initiated to 
investigate the safety and efficacy of osteoinductive microstructured TCP 
granules and (porous) calcium phosphate cements. Moreover, a maxillary sinus 
augmentation study is advisable as preclinical studies showed promising results 
compared to other bone augmentation procedures. 


167  
 
 SAMENVATTING EN EVALUATIE VAN DE 
DOELSTELLINGEN 
Het doel van het onderzoek, dat is beschreven in dit proefschrift, was om het 
gebruik van botvervangende materialen voor maxillofaciale botaugmentatie 
procedures te evalueren. Daarnaast werden innovatieve synthetische 
botvervangende materialen in preklinische modellen getest. In het algemeen 
kon worden geconcludeerd, dat de werking van botvervangende materialen in 
kaak- en aangezichtschirurgische procedures voornamelijk is gerelateerd aan de 
eigenschappen van het materiaal, de omgeving waarin het materiaal wordt 
aangebracht maar ook aan de individuele condities van de patient. 
Tegenwoordig wordt het autoloog bottransplantaat beschouwd als de gouden 
standaard in botaugmentatie procedures in het kaak en aangezichtsskelet. Het 
oogsten van een dergelijk bottransplantaat is echter geassocieerd met 
aanzienlijke nadelen. Het grootste bezwaar is de verlengde operatieduur als 
gevolg van de operatie aan de donorsite en de mogelijk ernstige donorsite 
morbiditeit die hiermee gepaard gaat. Er zijn daarom reeds een grote 
hoeveelheid (synthetische) bot vervangende materialen ontwikkeld. Klinische 
voordelen in vergelijking met een autoloog bottransplantaat zijn de kosten, 
veiligheid en directe en ongelimiteerde beschikbaarheid. In dit proefschrift 
werden een tweetal meta-analyses verricht om inzicht te verwerven in de 
keuzemogelijkheden voor wat betreft het augmentatiemateriaal voor 
sinusbodemelevatie procedure in individuele patienten. Daarnaast werd de 
mogelijke invloed van patient specifieke condities op de klinische uitkomst 
onderzocht middels een driedimensionale rontgenstudie. 
Onderzoek en ontwikkeling op het gebied van botvervangende materialen 
continueert zich en is gericht op het verbeteren van materiaaleigenschappen. 
Goede klinische toepasbaarheid van een botvervangend materiaal is afhankelijk 
van drie factoren. Voor succesvol gebruik zijn excellente peri-operatieve 
hanteringeigenschappen, degradatie in de tijd en gecontroleerde vervanging 
door bot nodig. Het onderzoek, dat is beschreven in dit proefschrift, richt zich 
daarom ook op het verbeteren van de hanteringeigenschappen, degradatie-
karakteristieken en het osteoinductieve karakter van botvervangende 
materialen. Er werd onderzoek gedaan naar calcium fosfaat cement (CPC), dat 
bot-defecten op een optimale wijze kan vullen en gemakkelijk is te vervormen. 
Porositeit van het CPC werd ge·lnduceerd om de degradatie en osteoconductive 
eigenschappen te verbeteren. Zowel het invangen van C02 bubbels tijdens het 
uitharden van het CPC, als de toevoeging van verschillende oplosbare poly 
(lactic-eo-glycolic acid) (PLGA) microsferen werd onderzocht. De biologische 
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 prestaties en het mogelijk klinische gebruik in de toekomst van dit materiaal 
werden zowel in kleine als grate diermodellen onderzocht. In het kader van 
osteoinductie werd een osteoinductief microstructured calcium fosfaat 
materiaal onderzocht in een groat diermodel. 
Autologe bottransplantaten voor sinusbodemelevatie procedures 
Tot op heden zijn er geen studies gepubliceerd waarin de histomorfometrische 
uitkomst is vergeleken van verschillende donorsites en methodes van autologe 
bottransplantatie na sinusbodemelevatie bij een groat aantal patienten. In het 
tweede hoofdstuk van dit proefschrift werd daarom een meta-analyse verricht 
van de in de literatuur gepubliceerde data. Pubmed en de volgende tijdschriften 
werden handmatige doorzocht: Clinical Oral Implants Research, International 
Journal of Oral and Maxillofacial Implants, International Journal of Periodontics 
and Restorative Dentistry en het Journal of Periodontology. Volgens de inclusie-
criteria van deze studie werden 25 van de 147 gevonden artikelen gebruikt voor 
meta-analyse. Het gros van deze publicaties beschreef prospectieve klinische 
studies, waarbij ook een tweetal gerandomiseerde prospectieve studies, een 
pilotstudie en een case serie werden gevonden. Na de statische analyse werd 
een referentiewaarde voor Totaal Bot Volume {TBV) van 47% gevonden. Als 
standaardgroep voor deze analyse werd bot uit de crista iliaca genomen. 
Sinusbodemelevatie met intra-oraal verkregen bot resulteerde in een hogere 
TBV; 11 o/o met kin bot en 14% met bot van een andere intra-orale donorsite. Er 
werd, onverwacht, geen correlatie gevonden tussen TBV en de inhelingstijd van 
het bottransplantaat. Histologische sectiedikte was wel een significante 
variabele, elke micrometer toename in dikte resulteert in 0.4% toename van het 
TBV. Uit de meta-analyse in hoofdstuk 2 kon daarom warden geconcludeerd 
dat bottransplantatie met bot uit de crista iliaca resulteert in een significant 
lagere TBV in vergelijking met bottransplantaties van een intra-orale donorsite. 
Echter, omdat de hoeveelheid intra-oraal bot dat geoogst kan warden relatief 
klein is, warden bottransplantaten uit de crista iliaca nog steeds als de gouden 
standaard beschouwd voor sinusbodemelevatie procedures in de ernstig 
atrofische maxilla. 
Botvervangende materialen voor sinusbodemelevatie procedures 
Naast studies voor autologe bottransplantaten zijn er oak geen uitgebreide 
studies naar botvervangende materialen bij grate groepen patienten gedaan. 
Daarom werd in het derde hoofdstuk van dit proefschrift een tweede meta-
analytische studie verricht. Pubmed en dezelfde tijdschriften als in het 
voorgaande hoofdstuk werden doorzocht. Volgens de inclusiecriteria bij deze 
studie werden 64 van de 147 gevonden publicaties gebruikt voor de 
meta-analyse. Een referentiewaarde van 63% werd berekend voor TBV op basis 
van autoloog bot als standaardgroep. Het gebruik van partikels verlaagt het TBV 
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 met 18o/o ten opzicht van bloktransplantaten. Verder werd een ?o/o lager TBV 
gevonden wanneer tandheelkundige implantaten in twee fasen werden 
geplaatst. TBV was 8o/o of respectievelijk 6o/o hoger als een biopt binnen 4.5 
maand of na 9.0 maanden na sinusbodemelevatie werd genomen. Het gebruik 
van allogene, xenogene of alloplastische botvervangende materialen (of combi-
naties daarvan) resulteerde in het algemeen in een significant lager TBV, 
varierend tussen 7o/o en 26o/o vergeleken met autologe bottransplantaties. Het 
effect van 'bioptie tijd' liet een significant hoger TBV zien voor 4.5 en na 9.0 
maanden of inhelingstijd vergeleken met de tussenliggende periode voor alleen 
autologe bottransplantaten. Dit effect werd niet gezien in de meta-analyse van 
het voorgaande hoofdstuk. Verrassend genoeg werd er geen significant effect 
van 'bioptie tijd' op het TBV gevonden bij de verschillende botvervangende 
materialen. Concluderend kon warden gesteld dat autoloog bot nog steeds als 
de gouden standaard moet warden beschouwd voor sinusbodemelevatie 
procedures vanwege het hogere TBV. Nochtans zijn de consequenties van dit 
hoge of lagere TBV op tandheelkundige implantaatoverleving nog niet geheel 
duidelijk. 
Voorspellende waarde van patient specifieke karakteristieken op bottrans-
plantaat resorptie. 
De uitkomst van een sinusbodemelevatie procedure is afhankelijk van 
verschillende factoren, dit zijn onder andere materiaaleigenschappen maar ook 
individuele patient karakteristieken. In het vierde hoofdstuk van dit 
proefschrift werd getracht middels maxillofaciale CT patient specifieke factoren 
te identificeren die een voorspellende waarde hebben op bottransplantaat 
resorptie na sinusbodemelevatie procedures. Er zijn in de literatuur geen studies 
beschikbaar die dergelijke voorspellende radiologische parameters beschrijven. 
Daarom was het doel, van deze studie in dit hoofdstuk, om verschillende 
parameters te onderzoeken op hun mogelijke invloed. In totaal werd bij twintig 
patienten op drie tijdspunten een driedimensionale analyse verricht van 
alveolaire botdimensies en bottransplantaatvolume na sinusbodemelevatie 
middels Cone Beam Computerized Tomography (CBCT). Alveolair botdimensies 
werden gemeten voorafgaand aan de sinusbodemelevatie procedure. 
Bottransplantaatvolume werd gemeten direct na sinusbodemelevatie en na een 
variabele inhelingstijd. Een multi-level extensie van regressie analyse werd 
verricht om de invloed van de variabelen: geslacht, leeftijd, alveolaire bothoogte 
en breedte en inhelingstijd te analyseren. Een residuele alveolaire bothoogte 
van 6.0 mm (50=2.2 mm) en 6.2 mm (50=3.6 mm) werd gemeten voor de 
respectievelijk linker- en rechterkant. Verder werd een alveolaire botbreedte van 
6.5 mm (50=2.2 mm) en 7.0 mm (50=2.3 mm) ter hoogte van de premolaren en 
8.8 mm (50=2.2 mm) en 8.9 mm (50=2.5 mm) ter hoogte van de molaar regia 
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 gevonden voor respectievelijk links en rechts. Bottransplantaatvolume 
verminderde met 25% {50=21 %) na een gemiddelde inhelingstijd van 4.7 
maanden {50=2.7 maanden, mediaan=4.0 maanden). De variabelen 
'leeftijd' (p=0.009) en gemiddelde 'alveolaire bothoogte' (p=0.043) bleken van 
significante invloed op deze bottransplantaat resorptie. Een volume verhoging 
van 1.0% (5E=0.3%) werd gevonden voor elk jaar dat de patient ouder was en 
een volume afname van 1.8% (5E=0.8o/o) werd gevonden voor elke pre-existente 
millimeter alveolaire bothoogte voorafgaand aan de ingreep. Er kon warden 
geconcludeerd, dat bottransplantaat resorptie optreedt na sinusbodemelevatie 
procedures en dat de leeftijd van de patient en de pre-existente bothoogte een 
significante invloed hebben op de mate van resorptie. Met een toename van 
resorptie bij hogere pre-existente bothoogtes en een verminderde resorptie bij 
een hogere leeftijd. Patient karakteristieken waarvan in studieverband is 
aangetoond dat ze een significante invloed hebben op bottransplantaat resorp-
tie moeten daarom ook alle aandacht krijgen wanneer een sinusbodemelevatie 
wordt verricht bij de individuele patient. 
Drie poreuze calcium fosfaat cementen voor bot augmentatie. 
Pre-implantologische chirurgie is een routinematige procedure voor patienten 
met een initieel tekort aan bot voor tandheelkundige implantaatplaatsing. 
Alhoewel het autologe bottransplantaat wordt beschouwd als de gouden 
standaard, is een groat aantal synthetische botvervangende materialen 
ontwikkeld. Een voorbeeld hiervan is calcium fosfaat cement (CPC). Het creeren 
van porositeit in dit CPC draagt bij aan een verbeterde degradatie met als 
gevolg een verhoogde mate van botingroei in het materiaal. Daarom zijn in 
hoofdstuk 5 van dit proefschrift een drietal methoden geevalueerd om 
porositeit te introduceren in het CPC en getest in een preklinisch augmentatie 
model. Direct poreus CPC (CPC-IP) werd zowel in vitro als in vivo vergeleken met 
vertraagd poreus CPC CPC-IP. CPC-IP werd verkregen door het invangen van 
vrijgekomen C02 bubbels tijdens het uitharden van het CPC. Vertraagd poreus 
CPC werd verkregen door het toevoegen van degradeerbare PLGA microsferen 
aan het CPC poeder. Additioneel aspect was het gebruik van zowel holle als van 
volledige gevulde PLGA microsferen (respectievelijk CPC-hPLGA en CPC-dPLGA). 
AI le drie de CPC composities lieten goede hanteringeigenschappen en een inter 
-geconnecteerde poreuze structuur zien met een totale porositeit van boven de 
70o/o. De in vitro degradatiestudie liet een graduele formatie van porien zien en 
een toegenomen CPC-matrix ontbinding in het CPCs met PLGA microsferen 
(dPLGA microsferen > hPLGA microsferen), terwijl er nagenoeg geen degradatie 
werd geobserveerd in CPC-IP. Voor de in vivo evaluatie van de CPCs werd 
gebruik gemaakt van een augmentatie model in ratten. CPCs werden 
ge"lnjecteerd in een Teflon ring die stevig op de schedel van deze ratten was 
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 ge'lmmobiliseerd. Histologisch evaluatie na een inhelingstijd van 12 weken liet 
botformatie zien in a lie drie de CPCs. Het botaugmentatievolume bereikte 10% 
van het augmentatiegebied met een maximaal gemiddelde augmentatiehoogte 
van 1 mm. Het gebruik van CPC-IP resulteerde in een significant grotere 
hoeveelheid bot en in een superieure botappositiehoogte vergeleken met beide 
CPCs met PLGA microsferen. Daarbij werd er geen significant verschil gevonden 
tussen het gebruik van dPLGA of hPLGA microsferen. 
Sinusbodemelevatie met CPC-PLGA composieten in schapen 
Het doel van de preklinische studie, die werd beschreven in hoofdstuk 6 van dit 
proefschrift, was om de biologisch prestaties van twee injecteerbare CPC-PLGA 
microsfeer composieten te evalueren in een sinusbodemelevatie model in 
schapen. De PLGA microsferen werden gemaakt van een laag moleculair-
gewicht PLGA (LMW; -17 kDa) acid-terminated PLGA (PLGAL-Ar) of van een hoog 
moleculairgewicht PLGA (HMW; -44 kDa) end-capped PLGA (PLGAH-Ed· Deze 
microsferen werden, net als in het vorige hoofdstuk, ge'lncorporeerd in het CPC 
poeder. Acht vrouwelijke Swifter schapen ondergingen een bilaterale 
sinusbodemelevatie procedure via een extra-orale benadering. CPCs werden 
volgens een split-mouth model ge'lnjecteerd in de sinus maxillaris en er werd 
een inhelingstijd van 12 maanden in acht genomen. De analyse van de 
biologische prestaties werd verricht middels histologie, histomorfometrie en 
evaluatie van sequentieel toegevoegde fluorochromen. Beide typen CPC-PLGA 
microsfeer composieten lieten een adequate biocompatibiliteit en een direct 
bot-cement contact zien. CPC-PLGAL-AT resulteerde in een grotere degradatie-
afstand vergeleken met CPC-PLGAH-Ec (1949 IJm ± 1295 IJm versus 459 IJm ± 267 
IJm; p<0.05). Verder liet CPC-PLGAL·AT een grotere hoeveelheid bot in het 
geselecteerde gebied van interesse zien {26.4% ± 10.5% versus 8.6% ± 3.9%; 
p<0.001) en significant minder residuaal CPC materiaal (61.2% ± 17.7% versus 
81.9% ± 1 0.9%; p <0.05). Er kon warden geconcludeerd, dat zowel CPC-PLGAL-AT 
als CPC-PLGAH-Ec beide veilige materialen zijn voor sinusbodemelevatie in een 
groat diermodel met een adequate biocompatibiliteit en direct botcontact. 
Echter vanuit het materiaaloogpunt liet CPC-PLGAL-AT een significant snellere 
degradatie en een significant hogere hoeveelheid nieuw gevormd bot zien 
vergeleken met CPC-PLGAHEC· 
Sinusbodemelevatie met een osteoinductief keramiek in schapen. 
Het doel van de studie, beschreven in hoofdstuk 7, was om de biologische 
prestaties van een osteoinductief micro-structured tricalcium fosfaat (MSTCP) 
keramiek te evalueren voor sinusbodemelevatie procedures in schapen. Om dit 
doel te bereiken werd er een unilaterale sinusbodemelevatie uitgevoerd met 
MSTCP partikels in acht Swifter schapen. Radiologische beeldvorming en 
histologische analyse werd uitgevoerd na een inhelingstijd van 12 weken. 
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 Maxillofaciale CT, histologie, histomorfometrie en sequentieel toegevoegde 
fluorochromen lieten zien dat MSTCP partikels een excellente scaffold bieden 
voor celingroei en botformatie. 12 weken na sinusbodemelevatie werd een 
sinusbodem verhoging van ongeveer 6 mm en een gemiddeld totaal 
botvolume van 43% gezien met daarbij significante degradatie van de 
ge"implanteerde MSTCP partikels. Het kon daarom warden geconcludeerd, dat 
het onderzochte MSTCP keramiek een geschikt botvervangend materiaal is voor 
sinusbodemelevatie procedures. 
SLOTOPMERKINGEN 
Het onderzoek, dat in dit proefschrift werd beschreven, richt zich op autologe 
bottransplantaten en botvervangende materialen voor botaugmentatie 
procedures in kaak- en aangezichtschirurgische toepassingen. Er werd een 
tweetal meta-analytische en een trohoc studie verricht die inzicht hebben 
gegeven in de huidige concepten, ontwikkelingen en biologische prestaties van 
dergelijke materialen. Op basis van deze studies kon warden geconcludeerd, 
dat het autologe bottransplantaat moeten warden beschouwd als de gouden 
standaard voor botaugmentatie procedures van het kaak- en aangezichtsskelet. 
Daarbij werd geconcludeerd, dat de biologische uitkomst na een augmentatie 
procedure afhankelijk is van augmentatiemateriaal eigenschappen, de 
chirurgische techniek en verschillende patient specifieke condities. Recente 
literatuur waarin uitsluitend de klinische uitkomst van verschillende 
botvervangende materialen voor sinusbodemelevatie werd vergeleken ten 
opzichte van het autologe bottransplantaat liet echter zien, dat er geen 
specifiek voordeel is voor een van deze therapieen. Er moet daarom warden 
opgemerkt, dat de relatie tussen de uitsluitend biologische uitkomst na het 
gebruik van een botaugmentatie materiaal en de tandheelkundige implantaat 
overleving nog niet geheel duidelijk is. Verder moet men zich afvragen of de 
standaard evaluatiemethoden, namelijk de histologie en histomorfometrie, 
voldoende informatie bieden om een adequate keus voor een augmentatie-
materiaal te kunnen maken. Bovendien liet het onderzoek in dit proefschrift ook 
zien, dat de alveolaire bothoogte en de leeftijd van de individuele patient een 
significante invloed hebben op de resorptie van een bottransplantaat. Er werd 
meer resorptie van het bottransplantaat gezien bij een hogere residuele 
alveolaire bothoogte en een verlaagde resorptie in oudere patienten. Op basis 
van deze bevindingen moet daarom warden geconcludeerd, dat de keuze voor 
een specifiek augmentatiemateriaal niet alleen af moet hangen van materiaal-
eigenschappen maar ook van individuele patientkarakteristieken die de 
klinische uitkomst be·invloeden. 
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 Er komt een groeiend aantal (commercieel) verkrijgbare bot vervangende 
materialen voor klinische gebruik op de markt. De intensieve samenwerking 
tussen experts op verschillende wetenschappelijke gebieden resulteerde in een 
explosieve groei van mogelijkheden tot het aanpassen van materiaal-
eigenschappen voor botreconstructieve toepassingen. Synthetische bot-
vervangers hebben het algemene voordeel dat ze direct beschikbaar en veilig 
zijn. Daarnaast is een belangrijk voordeel de reductie van de mogelijke 
morbiditeit zoals dit wordt gezien bij het oogsten van een autoloog 
bottransplantaat. Verder hebben deze botvervangende materialen gestandaar-
diseerde eigenschappen waardoor zein een grote hoeveelheid kunnen warden 
geproduceerd en een voorspelbare en betrouwbare klinische uitkomst bieden. 
lnnovatieve concepten voor de verbetering van deze materialen komt voort uit 
een combinatie tussen wetenschappelijke vooruitgang en behoeften vanuit de 
klinische praktijk. Tegenwoordig richt deze innovatie zich vooral op klinische 
hanteerbaarheid en het verbeteren van de botregeneratieve capaciteit. 
Calcium fosfaat cement (CPC) heeft het voordeel, dat het materiaal zich 
gemakkelijk laat vormen en een optimale defectvulling geeft resulterend in een 
uitstekende hanteerbaarheid. De introductie van porositeit in het CPC draagt bij 
aan een geinterconnecteerde macroporeuze structuur voor gecontroleerde 
botingroei. Verder lieten de CPCs, die in de preklinische diermodellen zijn 
onderzocht, een goede biocompatibiliteit zien. Een beperking van de 
onderzochte CPCs is, dat zij uitsluitend een osteoconductief karakter hebben. 
Daarbij is het zo, dat het incorporeren van biologisch actieve stoffen zoals groei-
factoren kostbaar is. De ontwikkeling van osteoinductieve materialen voorkomt 
dit probleem. De onderzochte microstructured TCP granules hebben een reeds 
bewezen osteoinductief karakter en het gebruik resulteerde in een excellente 
biologische prestatie. Daarentegen zijn dergelijke granules minder goed te 
hanteren in een complexe klinische toepassing dan CPC. Onderzoek en 
ontwikkeling op het gebied van botregeneratieve materialen zal verder gaan. 
De mogelijkheden tot het ontwikkelen van botvervangende materialen zijn 
omvangrijk en het is reeds aangetoond dat kleine veranderingen van 
bijvoorbeeld chemische eigenschappen een substantieel effect op de biologisch 
prestaties kunnen hebben. Clinici hebben een uitgebreide keuze uit diverse 
augmentatiematerialen voor iedere individuele procedure. Hierbij moet echter 
warden benadrukt, dat de realiteit vaak anders is en niet altijd het meest ge-
schikte materiaal wordt gekozen voor de individuele patient. De expertise en 
ervaring van clinici beperkt zich vaak tot een geselecteerde hoeveelheid materi-
alen en daarnaast zijn medische instellingen vaak loyaal aan een bepaalde fabri-
kant. Verder is de kostprijs van nieuwe materialen vaak hoger. Bovendien blijkt, 
dat de snelle ontwikkelingen op het gebied van botvervangende materialen 
niet door iedereen bij te houden is en dat clinici vaak niet op de hoogte zijn van 
de voordelen van dergelijke innovatieve materialen. 
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 TOEKOMSTPERSPECTIEVEN 
In dit proefschrift warden de bevindingen beschreven uit het onderzoek naar 
het gebruik en de ontwikkeling van botvervangende materialen voor 
botaugmentatie procedures in het mond-, kaak- en aangezichtsgebied. 
Voortbordurend op deze resultaten zijn er nog een aantal aanvullende punten 
die kunnen leiden tot vervolgonderzoek. 
- De primaire uitkomst van het onderzoek naar de biologisch prestaties van 
botvervangende materialen wordt bepaald door histologische en 
histomorfometrische metingen aan het biopt dat is genomen voordat 
tandheelkundige implantaten warden ingebracht. De invloed en consequenties 
van deze uitkomst op de overleving van tandheelkundige implantaten is echter 
nog niet geheel ontrafeld en dienen daarom verder te warden onderzocht. 
- De inhelingstijd na een sinusbodemelevatie procedure wordt beschouwd als 
een belangrijk factor op de klinische uitkomst. Ondanks de grate variatie in de 
literatuur werd alleen voor autologe bottransplantaten een significante trend 
gevonden in een van de twee meta-analytische studies. Er kan daarom verder 
onderzoek warden verricht naar de optimale inhelingstijd voor individuele 
botvervangende materialen. 
- De hoogte van de alveolair botrand bleek van significante invloed op de 
resorptie van het autologe bottransplantaat na een sinusbodemelevatie proce-
dure. In de literatuur wordt deze waarde slechts gebruikt om een keuze te 
maken tot directe of vertraagde tandheelkundige implantaat plaatsing. In het 
licht van deze bevinding is het een vervolgonderzoek aan te raden naar de 
invloed van deze alveolaire bothoogte op de biologische prestaties van 
botvervangende materialen. 
- Op basis van studies beschreven in dit proefschrift kan niet warden geconclu-
deerd of (systeem)ziekten, roken of andere risicofactoren een invloed hebben 
op de biologische prestaties van botervervangende materialen. Omdat deze 
aspecten steeds belangrijker warden in de geneeskunde zal hier verder 
onderzoek nodig zijn. 
- Vervolgonderzoek is noodzakelijk om verder inzicht en sturing te geven aan de 
degradatie eigenschappen van in CPC ge·lncorporeerde PLGA microsferen. Op 
deze wijze kan botingroei en materiaal degradatie gedurende de inhelingstijd 
beter warden afgestemd op een individuele klinische situatie. 
- De invloed van biologisch actieve factoren om botaanmaak te stimuleren, of 
nog beter, materiaal dat een intrinsieke osteoinductieve capaciteit heeft, zal 
verder moeten warden ontwikkeld om succesvolle botaugmentatie procedures 
in patienten met een gecompromitteerde botregeneratieve capaciteit mogelijk 
te maken. 
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 - Het onderzoek en de resultaten daarvan, zoals in dit proefschrift beschreven, 
geven aanleiding tot het opzetten van klinische studies waarin zowel de os-
teoinductieve TCP granules als het (poreus) CPC op veiligheid en doelmatigheid 
worden geevalueerd. De sinusbodemelevatie procedure kan hiervoor worden 
aangeraden. 
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Bachelorexamen, waarna hij direct startte met zijn coschappen in diverse aan het 
UMC St Radboud geaffilieerde instellingen. 
Een groot deel van zijn Enschedese studententijd woonde hij op studentenhuis 
Huize Probitas. Hij was bestuurslid van studievereniging Paradoks en hield zich 
bezig met verschillende onderwijsgerelateerde zaken. Hij was vice-voorzitter van 
de Opleidings Commissie Technische Geneeskunde en lid van verschillende 
evaluatie- en kwaliteitscommissies. Daarnaast werkte hij als student-assistent bij de 
opleidingen Technische Geneeskunde, Biomedische Technologie en Geneeskunde. 
Tijdens zijn afstuderen aan de Universiteit Twente was hij een van de initiatief-
nemers voor de oprichting van de beroepsvereniging voor Technische 
Geneeskunde (NVvTG) en was lid van het oprichtingsbestuur van 2008 tot 2011. 
Binnen deze bestuursfunctie was hij verantwoordelijk voor het organiseren van 
wetenschappelijke bijeenkomsten, de huidige beroepscode en het kwaliteits-
register voor Technisch Geneeskundigen. 
Na het afronden van het artsexamen zal Reinoud in september 2013 beginnen met 
de geconcentreerde opleiding Tandheelkunde voor artsen (TOVA) waarna hij in 
2015 zal starten met zijn opleiding tot medisch specialist in de Mondziekten, Kaak-
en Aangezichtschirurgie (opleider prof. dr. S.J. Berge, UMC St Radboud Nijmegen). 
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